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ABSTRACT
Investigations were conducted into the factors that 
modulate the activation of the potent food-related mutagens; 
the heterocyclic aromatic amines (HAAs) formed during the 
cooking process and the pyrolysis of amino acids in order to 
assess the possible human health risk from these compounds.
The food constituents anthraflavic acid, ellagic acid 
and retinol were all found to decrease the in vitro metabolic
activation of IQ to mutagens in the Ames test. Anthraflavic
acid and retinol inhibited cytochrome P450I proteins and thus 
the cytochrome P450lA2-mediated activation of IQ, furthermore 
anthraflavic acid also inhibited a cytosolic activation step 
which potentiates microsomal-activation. Ellagic acid did not 
inhibit the metabolic activation of IQ and the mechanism by 
which it inhibits IQ mutagenesis may involve either binding to 
and protecting critical sites on DNA and/or by a chemical 
interaction with a reactive metabolite of IQ although, the 
latter appears unlikely.
Administration of ellagic acid at a dose previously 
decribed as anticarcinogenic, resulted in toxicity, and 
bearing in mind its poor absorption characteristics it was
considered to be an unlikely inhibitor of the initiation of
carcinogenesis. Anthraflavic acid when administered to rats 
increased hepatic cytochrome P450I proteins and hence would 
increase the rate of production of genotoxic species from 
numerous chemical carcinogens in vivo. It was thus concluded 
that in vitro antimutagenicity studies are irrelevant as tests
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for anticarcinogens, unless the mechanism of action is clearly 
understood and shown to be operative in vivo. Retinol was the 
only compound tested that could possibly modulate 
carcinogenicity as its inhibitory effect on the activation of 
precarcinogens was demonstrated at near physiological 
concentrations.
The activation of the HAAs was found to be greatly 
enhanced by exposure of experimental animals to environmental 
aromatic amine contaminants, which induce cytochrome P450I 
activity, showing that dietary HAA-induced carcinogenesis may 
be exacerbated by environmental chemicals. Similarly IQ 
enhanced its own activation by inducing cytochrome P450I 
activity, indicating that upon repeated exposure its 
carcinogenic potential is increased by acting as a carcinogen 
and a co-carcinogen.
The patho-physiological condition of type I insulin- 
dependent diabetes was demonstrated to enhance the activation 
of dietary mutagens such as HAAs and nitrosamines, since 
diabetes could increase the levels of some forms of hepatic 
cytochromes P450 in particular those that activate carcinogens 
namely, P450I and P450IIE proteins.
It is concluded that HAAs are potentially hazardous to 
health, particularly to individuals having high tissue 
levels of cytochrome P450I proteins either due to exposure to 
various inducing agents, genetically determined, or a 
patho-physiologiacal condition that is likely to confer a high 
level of cytochrome P450I on the individual.
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CHAPTER 1 : INTRODUCTION
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1.1 Chemical carcinogenesis.
The association between cancer and exposure to 
environmental chemicals was first perceived by Percival Pott 
in 1775, when he observed that the high incidence of scrotal 
cancer among chimney sweeps could be ascribed to their 
exposure to soot in pre-adolescence. Subsequently many other 
forms of cancer were shown to be associated with exposure to 
specific chemicals. Chemical carcinogenesis is usually a 
multifactorial process in its causation and multistep in its 
evolution. The current concept of the fundamental reactions 
that occur in chemical carcinogenesis can be summarised into 
three discernible stages; initiation, promotion and 
progression (Fig 1.1).
CHEMICAL
CARCINOGEN
REACTIVE 
METABOLITES -
(ELECTROPHILIC,
MUTAGENIC)
NON-ELECTROPHILIC 
METABOLITES
EXCRETA
TUMOR PROMOTERS 
(ENDOGENOUS OR 
EXOGENOUS)
NORMAL CELLS
i
»(DNA ADDUCTS)
i
INITIATED CELLS 
(WITH HERITABLE 
MODIFICATION OF DNA)
TUMOR CELLS
i
CLONES
i
GROSS TUMORS
i
MORE MALIGNANT 
TUMORS
INITIATION
PROMOTION
&
PROGRESSION
Figure 1 .1 : Diagrammatic representation of the stages of chemical carcinogenesis (Miller 
and Miller, 1977%
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1.1.1 Initiation.
Many chemical carcinogens are per se innocuous 
environmental contaminants/ termed procarcinogens, that 
require metabolic activation to form more toxic/carcinogenic 
intermediates, termed proximate carcinogens, which are further 
metabolised to form highly reactive species termed the 
ultimate carcinogens; alternatively they may be directly 
converted to the ultimate carcinogen. The procarcinogen is, 
thus, metabolically activated to one or more ultimate 
carcinogenic intermediates which are electrophiles that 
covalently bind to nucleophilic groups in informational 
macromolecules such as DNA, RNA or proteins (Miller and Miller
1977). ; It would appear that specif ic alterations (mutations) 
in one or more of these informational macromolecules are 
fundamental in the process of initiation. In all cases the 
procarcinogen, the proximate and ultimate carcinogens are also 
subjected to inactivating metabolism, which suppresses or even 
abolishes the effectiveness of the carcinogenic agent. 
Although most chemical carcinogens produce their effect by 
inducing mutations in informational molecules there is 
considerable evidence to support an additional "epigenetic", 
indirect-acting mechanism operating in the case of some 
chemical carcinogens (Miller 1978). Initiating activity can be 
assessed by measuring DNA damage or ability to induce mutation 
in prokaryotes and eukaryotes.
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1.1.2 Promotion.
Tumour promoters can be defined as compounds which have 
a very weak or no carcinogenic effect, but markedly enhance 
tumour yield when applied repeatedly following low or 
suboptimal doses of an initiator (Berenblum, 1941 ; 1982). 
Early studies indicate that promoters, in contrast to the
initiating agents, do not bind to DNA but instead produce 
their effects at the epigenetic level. Promoting activity 
cannot, as in the case of initiators, be determined by ability 
to induce mutations. Typical promoters such as tetradecanoyl- 
phorbolacetate (Hecker, 1967; Van Duuren, 1969) induce many
cancers when applied to mouse skin that has been treated with 
a suboptimal dose of a carcinogen such as dimethylbenz- 
anthracene. Hence carcinogenic hazard is due to both 
initiators and promoters with most typical carcinogens 
possessing both activities (complete carcinogens).
1.1.3 Progression
Progression is the process that involves the conversion 
of a benign tumour to a malignant one, a stage, characterised 
by increased de-differentiation, which can be considered as an 
open-ended process, as tumours often continue to increase in 
their degree of malignancy and heterogeneity.
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1.2 Metabolism of chemical carcinogens.
Chemical carcinogens are generally subjected to two 
stages of metabolism, namely biotransformation (phase I 
metabolism) and subsequently conjugation (phase II 
metabolism). In the detoxication of chemicals, the oxidative 
reactions (phase I) result in the formation of metabolites 
that subsequently undergo conjugation (phase II) to form 
products that are readily eliminated from the organism. Most 
chemical carcinogens undergo metabolic transformation to form 
reactive intermediates, which can bind to DNA or are subject 
to further metabolic activation.
1.2.1 Phase I.
Phase I oxidations can be mediated by i) the 
flavoprotein monooxygenase (eg. the Ziegler enzyme), ii) free 
radicals in, for example, non-enzymic hydroxylations iii)the 
mixed-function oxidases (cytochromes P450) iv) monoamine 
oxidases and v) co-oxidation during arachidonic acid 
metabolism mediated by the prostaglandin endoperoxide 
synthetase enzyme system.
1.2.2 Phase II.
Phase II reactions, in general result in the 
detoxication of reactive intermediates by conjugation with 
endogenous ligands (e.g. glucuronic acid, glutathione, amino 
acids and sulphate) to form metabolites which are extremely 
polar and readily excreted. Conjugation reactions can also 
alter the mutagenic and carcinogenic effect of a compound 
(Hongslo et ai., 1983); for example glucuronides and sulphates 
are generally, but not always, less reactive than their parent
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compounds. However it has been demonstrated that sulphation 
is, in the case of the carcinogen 2-acetylaminofluorene 
(2AAF), an activation step where the sulphate ester of 
N-hydroxy 2-acetylaminofluorene (NOHAAF) is the proximal 
carcinogen (Meerman et al,, 1981 ; Miller, 1978; Mulder, 1981). 
Similarly the N-0-glucuronide of phenacetin is probably a 
proximal carcinogen responsible for cancer of the urinary 
tract (Camus et ai., 1982). The role of glucuronidation has 
also been clearly established in the urinary bladder 
carcinogenesis caused by 2-naphthylamine (Miller, 1978) . The 
N-glucuronide of N-hydroxy-2-naphthylamine, which is readily 
formed in the liver, is transported to the kidney where it 
enters the urine. Under the acidic conditions or as a result 
of glucuronidase activity of the urinary bladder the 
N-glucuronide decomposes to eventually form the ultimate 
carcinogen, an aryl nitrenium ion. Furthermore glucuronides 
with high molecular weights (>300 in rats or >400 in man) are 
preferentially secreted from the liver, in bile, into the 
intestine where upon hydrolysis, by bacterial 8-glucuronidase 
may lead to the release of proximal carcinogens eg. 
3-hydroxybenzo(ajpyrene glucuronide (Kinoshita and Gelboin,
1978). Such biliary excretion may be the major factor for the 
high incidence of intestinal neoplasms produced by the 
subcutaneous injection of 3-methyl-2-naphthylamine to male 
rats (Williams et al., 1981). Hence generalisation about the 
detoxifying role of phase II metabolism is unjustified and in 
some cases, misleading as it may act as an activation step as 
in the case of aromatic amine carcinogenesis.
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1.3 Role of cytochrome P450 in the activation of chemical 
carcinogens.
Cytochrome P450 is recognized as the major group of 
enzymes involved in the metabolism of chemical carcinogens 
(loannides and Parke, 1987; Parke, 1985). Cytochrome P450 
enzymes are all b class haemoproteins which serve as terminal 
oxidases and catalyse the metabolism of a variety of 
chemicals. The cytochrome P450 super family comprises many 
inducible gene families and sub-families whose protein 
products markedly differ in their substrate specificities 
and molecular characteristics (Table 1.1).
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TABLE 1.1 INDUCIBLE P450 GENE SUPERFAMILY
Fam ily, sub fam ily  and 
gene des ignation .____
Some o f  the  e x is t in g  
names in  the  l i te r a tu r e
Typ ica l inducing  
agents________
S p e c if ic a l ly  
ca ta ly s e d  re a c tio n
P450I
Only one subfamily 
P450IA1
P450IA2
P450II
450IIA subfamily 
P450IIA1
P450IIB subfamily 
P450IIB1
P450IIB2
Rat c, mouse Pi, 
rabbit form 6 , 
human Pi
Rat d, mouse P3 , 
rabbit form 4 
human P3
Rat a
Rat b, rabbit form 2
Rat e
PAHs eg B(o)P
Isosafrole
3MC, phénobarbital
Phénobarbital
Phénobarbital
Ethoxyresorufi n 
0 -deethylase
Glu-P-1
N-hydroxylase
Testosterone 
7a-hydroxy1ation
Pentoxyresorufi n 
0 -depentylase
P450IIE subfamily 
P450IIE1
P450III
Only one subfamily 
P450IIIA1
P450IIIA2
P450IV
Only one subfamily 
P450IVA1
Rat j, rabbit form 3a
Rat pen 1
Rat pen 2
Rat LA
Ethanol
PON, phénobarbital
PCN
Clofibrate
Dimethylnitrosamine 
N-demethylase
Erythromyein
N-demethylase
Testosterone
6 6 -hydroxylase
Laurie aeid 
1 2 -hydroxylase
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Activation of a large number of chemical carcinogens by 
oxidative biotransformation to their proximate or ultimate 
carcinogenic/mutagenic forms is principally mediated by the 
cytochrome P450I family of proteins which, in hepatic 
microsomes comprises at least two forms, a low spin form 
P450IA1 (mol. wt. 55,000-56,000 dalton) and a high spin form 
P450IA2 (mol. wt. 52,000-54,000 dalton) (Kamataki et al., 
1983; Ryan et ai.,1979; 1980; Goldstein and Linko 1984;
Goldstein at ai., 1982; Guengerich at ai., 1982a; 1982b).
Many major groups of chemical carcinogens are 
activated by cytochrome P450I proteins including
polycyclic aromatic hydrocarbons (PAHs), polyhalogenated 
biphenyls, aromatic amines and amides, heterocyclic aromatic 
amines (HAAs) and azo compounds (Table 1.2).
Chemical compound Type of reaction Example
PAHs Arene oxidation B(a)P
Planar polyhalogenated 
biphenyls Arene oxidation? 3,4,3',4'tetrachlorobiphenyl
Aromatic amines N-hydroxylation 4-ami nobi phenyl
Heterocyclic amines N-hydroxylation IQ
Aromatic amides N-hydroxylation 2-acetyl ami noflourene
Ami noazobenzenes N-hydroxylation N-methylaminoazobenzene
Mycotoxins Arene oxidation Aflatoxin B-,
Drugs N-oxidation Paracetamol
Flavonoids Arene oxidation? a-Naphthof1avone
Furans ? Ipomeanol
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Although cytochrome P450I proteins are primarily 
involved in the activation of many chemicals other cytochrome 
P450 proteins also make a contribution to the activation 
process. For example cytochrome P450IIE is associated with the 
activation of many nitrosamines (Garro et al., 1981) and 
cytochrome P450IIIA with the activation of aflatoxin Bi 
(Halvorslon et al., 1988).
The other major inducible family of cytochrome P450 
proteins is P450IXB, a family that is preferentially induced 
by phénobarbital. This family is generally associated 
with the detoxication of chemical carcinogens, by 
oxygenation, at sterically unhindered positions, as in the 
ring hydroxylation of 2AAF. Thus the fate and potency of a 
chemical carcinogen is dependent upon the rates of the 
activation/detoxication pathways (Fig 1.2).
PHASE 1 
M E T A 8 0 L IS M
PHASE 2 
K T A 8 0 L IS M
E xcretion
C hem ical
non-hindered  
oxygenation
hindered
oxygenation
M etabolites
conjugations
R eactive
Interm ediates
GSH, proteins, 
th iol enzymes, DM A
C ovalent Binding 
Toxic ity  and Carcinogenicity
-¥ ■  Conjugates
D E T O X IC A T IO N
A C T IV A T IO N
Figure 1.2: Metabolism of chemical carcinogens.
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Any change in the rates of these pathways, whether by 
enhancement or inhibition disturbs the balance of 
activation/detoxication and consequently alters the body's 
handling of the chemical carcinogen. Evidence for the roles 
of cytochromes P450 in tumour initiation are provided in 
vitro, by experimental studies where mutagenesis and DNA 
adduct formation were often modulated by changes in the P450 
composition. Many examples exist; the change in P450 
composition can be brought about by enzyme induction (Table
1.3, Shimada et al., 1987) or reconstitution of purified 
enzymes (Table 1.4, Shimada et al., 1987).
Table 1.3
Activation of u m u  gene expression by procarcinogens and promutagens 
in liver microsomes from untreated and PB-, M C -  and KC-500-treated rats
Cone
(mM )
Activation of u m u  gene expression (units/min/nmol P450)
Untreated P B - treated MC-treated KC-500-treated
Trp-P-l 0.01 290 + 30 100 + 10* 790 + 100* 420 + 30*
Trp-P-2 0.01 160 + 20 30 + 10* 760 + 80* 390 + 40*
Glu-P-1 0.01 100 + 2 0 30 + 10* 810 + 70* 390 + 30*
IQ 0.01 500 + 80 210 + 20* 1200 + 110* 450 + 40
M e l Q 0.01 1000 + 120 550 + 60* 600 + 40* 430 + 40*
Mel Q x 0.01 1 9 0 +  10 50 + 20* 820 + 30* 620 + 50*
2 - A A O.OI 480 + 40 140 + 10* 790 + 80* 560 + 50
A P B , 0.01 1300 + 120 790 + 80* 1010 + 120 850 + 90*
B(a)P 0.01 5 0 +  10 60 + 10 190 + 20* 90 + 20
1,2,3,4-DBA 0.01 3 0 +  10 30 + 10 140 + 20* 50 + 10
2 - A A F 0.01 40 + 10 40 + 20 5 0 +  20 40 + 10
7 , 1 2 - D M B A 0.01 40 + 10 40 + 20 140 + 30* 70 + 20
M C 0.01 <10 <10 9 0 +  10* 30 + 10*
A a C 0.08 <10 <10 530 + 70* 110 + 20*
M e A a C 0.08 1 6 0 +  10 <10 540 + 40* 410 + 50*
Each value represents the m e a n  of duplicate determinations + SD.
* P  <0.05, as compared with the activities of liver microsomes from untreated rats.
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Table 1.4
Activation of u m u  gene expression by procarcinogens and promutagens 
in a reconstituted monooxygenase system containing three forms of P450
Activation of u m u  gene expression (units/min/nmol P450)
Cone
(mM) P 4 50nB P450IA1 P450IA2
Trp-P-l 0.01 <10 4200 + 380 5900 + 520
Trp-P-2 0.01 90 + 10 4700 + 490 5100 + 650
Glu-P-1 0.01 90 + 10 500 + 40 5500 + 430
IQ 0.01 400 + 50 1900 + 200 5400 + 490
M e l Q 0.01 200 + 40 2300 + 150 6500 + 380
M e l Q x 0.01 140 + 20 1200 + 110 4100 + 410
2 - A A 0.01 1800 + 90 1800 + 200 3000 + 250
AF B ,
B(a)P
0.01 610 + 80 1700 + 1 2 0 2000 + 190
0.01 480 + 40 1400 + 90 380 + 70
1,2,3,4-DBA 0.01 190 + 20 520 + 50 360 + 40
2 - A A F 0.01 270 + 30 270 + 60 470 + 40
7, 1 2 - D B M A 0.01 <10 420 + 60 <10
M C 0.01 <10 120 + 20 60 + 20
A a C 0.08 240 + 20 2500 + 150 3300 + 310
M e A a C 0.08 230 + 30 2700 + 250 2300 + 330
Each value represents the m e a n  of duplicate determinations + SD.
1.4 Induction of cytochrome P450I proteins.
Inducers of cytochromes P450 stimulate the synthesis of 
proteins primarily by enhancing the rate of transcription, but 
alternative mechanisms are also involved in the induction of 
some families eg protein and mRNA stabilisation in the case of 
cytochrome P45011E1 (reviewed by Gonzalez, 1988). The hepatic 
microsomal cytochrome P4501 proteins are induced by a number 
of xenobiotics including PAHs such as 3-methylcholanthrene 
3MC, flavonoids such as 5,6-benzoflavone and 2,3,7,8-tetra- 
chlorodibenzo-p-dioxin (TCDD) (loannides and Parke 1987).
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There is considerable evidence to suggest that the 
induction of cytochrome P450IA1 is associated with the 
non-covalent binding of the inducing chemical to a cellular 
cytosolic protein called aromatic hydrocarbon (Ah) receptor 
(Nebert and Gonzalez 1985;1987). Binding of the inducer, 
or a metabolite, to the receptor results in the formation 
of a binary inducer-receptor complex that translocates into 
the nucleus and leads to an increased transcription and 
synthesis of the Ah receptor protein, menadione reductase, 
protein kinase c, other enzymes, and especially cytochrome 
P450I apoproteins, which in the cytosol interacts with haem to 
form the cytochrome P450I holoenzyme (Fig 1.3).
TCDD
8«niot*lpYT«n# 
•nd  olhar 
tnvironoianlal 
poHuUnti
Fomwtioo , , _  . . ,
•xc rau b t* I I Critic»!
inoocuout \  I
I
body iW f'd MatAbown
♦ntermadiata
n i m t r r
Receptof
m cytosol
Incofporatton
of P i*460 into
membfanm
Normal 
ligandreceptor 
compte* ca Translation of induction- 
specific proteins 
(cytochrome P i -450)Inducer receptor complex in cytosol
Inside nucleus Unknownmature m RNA
critical \  I
pre-m RNA  
Transcriptional activation 
/ /  of P ,-460 and P3-45O genes
Critical
physiologic
function
Message
Inducer reducer 
complex in nucteus
Bindir^g 
reactive 
intermediate 
to critical 
targetToxfcfty
and/or
Initiation
Unknown 
site in nucteus
Figure 1.3: The mechanism of induction of cytochrome P450I proteins via the ah receptor
(Nebert and Gonzalez, 1985).
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Cytochrome P450IA1 and P450IA2 proteins appear to be 
co-induced by a number of xenobiotics in rat liver (Kelley et 
ai.,1987). However the levels of each are differentially 
increased in the liver and in extrahepatic tissues; in 
general, only the low spin form is induced (Goldstein and 
Linko, 1984; Degawa, 1987b), thus indicating they are not 
under co-ordinate control. Furthermore cytochrome P450IA2, 
unlike the low-spin form, is induced to the same extent in 
both "Ah responsive”, a strain with a high affinity receptor, 
and "Ah non-responsive" mice (Thomas et ai., 1984), a strain 
with a low affinity receptor resulting in the poor 
inducibility of P450IA1 protein (Okey at ai., 1989; Poland and 
Glover, 1974). At present the actual mechanism of induction of 
cytochrome P450IA2 is not established but the lAl and IA2 
genes are non-coordinately (reviewed Gonzalez, 1988) although 
to some extent, post-transcriptional control may also play a 
significant role (Pasco at ai., 1988; Soderkvist et ai.,1988 ; 
Silver at ai., 1988).
The Ah receptor is a very important factor in 
determining the inducibility of cytochrome P450I proteins 
in animals and man, and hence susceptibility to tumour 
initiation by chemicals (Nebert at ai., 1974; 1978; Levitt at 
ai., 1979a; loannides and Parke 1987; Kouri et ai., 1973a;
1974). Neoplastic transformation by 3-methylcholanthrene (3MC) 
can be enhanced following pretreatment of mice with TCDD 
(Kouri at ai., 1978), with the enhanced carcinogenicity 
presumably being due to the P450I induction by TCDD, thus 
increasing the conversion of 3MC to the ultimate carcinogen. 
From structural studies (Lewis at ai., 1986; 1987), it has
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been demonstrated that the overall conformation of the active 
site of cytochrome P450I proteins is similar to that of the
Ah receptor. Hence substrates and competitive inhibitors 
of these proteins have molecular structures that are likely to 
induce de novo synthesis of cytochrome P450I proteins. This 
has been shown to be the case with PAHs and cytochrome 
P450IA1 induction (Ayrton et al., 1988c); aromatic amines and 
cytochrome P450IA2 induction (Steele and loannides, 1986;
Degawa et ai., 1986; Sato et ai., 1981). In fact it has been 
postulated that chemical carcinogens exacerbate their 
carcinogenicity by selectively inducing their own metabolic 
activation; indeed "Ah responsive" mice are much more prone to 
developing tumours from exposure to PAHs administered by 
various routes than "non-responsive" mice (Kouri and Nebert, 
1977; Nebert at ai., 1978; Kouri et ai., 1973; Kouri, 1974;
Legraverend at ai., 1980), a difference which can be directly 
correlated with cytochrome P450I and arylhydrocarbon 
hydroxylase induction. Furthermore it has also been postulated 
that the inducibility of these activating enzymes may be 
resonsible for the sex and strain differences in HAA-induced 
carcinogenesis (Degawa at ai., 1985; Hashimoto et ai., 1982a). 
However it must be emphasised at this point that not all 
substrates of cytochrome P4501 proteins are inducers and not 
all substrates are carcinogens; indeed cytochrome P450I 
proteins have been shown to participate in the metabolism of 
endogenous substrates (Wood at ai.,1983; Sonderfan et ai.,
1987), albeit at very low rates.
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It has also been reported that administration of 
cytochrome P450I inducers causes a decrease in aromatic amine- 
and PAH-induced tumour incidence (Tawfic, 1965; Richardson et 
al., 1952; Miller et al., 1958; Wattenberg and Leong, 1970; 
Meechan et ai., 1953). However it is essential to consider a) 
the time of exposure to the inducer in relation to the 
administration of the carcinogen, as simultaneous 
administration of an inducer will result in competitive 
inhibition of cytochrome P450I activation; b) the route of 
administration (Legraverend et al., 1984), as induction in
different tissues will result in altered pharmacokinetics of 
the carcinogen and c) the effect of the inducer on other 
enzyme systems, such as those involved in detoxifying phase I 
and II reactions.
1.5 Diet and cancer.
There is extensive evidence linking dietary factors to 
the prevalence of certain forms of cancer (Doll and Peto, 
1981). It has been estimated that cancers related to diet may 
be as high as 60% of all cancers for women and approximately 
40% for men (Wynder and Gori, 1977). International data and 
migration studies have shown that cancer of the colon and 
breast are related to environmental factors (Segi, 1974; 
Haenszel at ai., 1973; Higginson, 1969; Doll and Peto, 1981), 
moreover international studies also suggest that cancer of 
the colon, breast, pancreas and prostate are associated with 
dietary habits, in particular consumption of diets high in 
meat and fat (Armstrong and Doll, 1975; Rose at ai., 1986; 
McKeown-Eyssen and Bright-See 1984). It is therefore not 
suprising that life long vegetarian populations have a lower
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incidence of nutritionally related cancers (Phillips et al,, 
1980). The high incidence of diet-related cancers must be 
largely attributable to the mutagens/carcinogens present in 
the diet (section 1.6), tor example nitrosamines, or their
precursors,dialkylamines and nitrate are often found in 
foods. Indeed the average nitrate intake per capita can be 
closely correlated to gastric cancer mortality (Ames 1983; 
Mirvish 1983). This is, however a controversial point as much 
evidence also exists to show that no correlation exists 
between cancer and nitrate intake (WHO, 1984).
1.6 Mutagens and carcinogens in the diet.
Much effort has been expended on the identification and 
determination of mutagenic and carcinogenic compounds in food. 
Some mutagens have been shown to occur naturally (eg 
quercetin) or to be produced by the action of microorganisms 
(eg aflatoxin B-, ) . Others have been isolated from cooked meats 
and fish, and are believed to be generated during the process 
of cooking. An example of the latter is the PAH series
encountered in charcoal broiled meat (Lijinsky and Shubik,
1964; Lijinsky and Ross, 1967) the source of which is the 
smoke generated during incomplete combustion of the hot coals.
The development of the Ames Salmonella/mammalian 
microsome assay (Ames et ai., 1975) enabled the rapid
screening of many environmental chemicals for mutagenic 
activity. After assaying several types of high priority cooked 
foods (Plumlee et ai., 1981) it has been estimated that the 
mutagenic equivalent of 5600 revertants per day (Ames test) is 
consumed per person (Bjeldanes et ai., 1982b; 1982c). However
page 17
bearing in mind results obtained by Doll and Peto (1983), the 
mutagenic activity may be twice that estimated, and even this 
does not take into account cooking and extraction methods 
which may have profound effects on the amount of mutagenic 
activity present. Recent investigations have shown that 
broiled fish, particularly sardines (Kasai et al., 1980), 
fried beef (Kasai et ai., 1981), commercial beef extracts, 
protein pyrolysates (Yoshida et ai.,1978) and egg fried at 
high temperatures (Grose, et al., 1986), contain substances 
that are highly mutagenic in the Ames test and could not 
be accounted for by the mutagenicity of PAHs (Commoner et 
ai., 1978; Nagao et ai., 1977; Sugimura, 1982). Subsequent 
studies (Kasai et ai., 1980; 1981 ; Hargraves and Pariza, 1983; 
Commoner et ai., 1978; Spingarn et ai., 1980; Felton et ai., 
1986a) concluded that the substances responsible for the 
mutagenic activity in certain foods are a series of 
heterocyclic aromatic amines (HAAs) formed by the pyrolysis 
of proteins during the cooking process (Fig. 1.4).
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Figure 1.4: Mutagens isolated from protein and amino acid pyrolysates.
1.7 Quantitation of HAAs.
When the HAAs were satisfactorily isolated from food 
extracts, the concentrations of the mutagens could be 
estimated using the known specific activity of the synthetic 
compound. In the case of the aminoimidazoazaarenes (AIAs) this 
has been achieved using commercial beef extract (Hargraves and 
Pariza, 1983; Turesky et al., 1983; Hikoya et al., 1983). 
Although this method is not rigorous it can provide an 
initial, preliminary estimate of the amounts of AIAs present 
in the food sample. The levels reported in commercial beef 
extract using this method have tended to vary: IQ 18ppb, MelQx
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3ppb and MelQ 34ppb (Hargraves and Pariza, 1983 ), as compared 
to IQ 41-142ppb. MelQ not detected, MeIQxT42-527ppb (Turesky 
et al., 1983), and IQ 20-40ppb, MelQx 200-300ppb, MelQ not 
detected (Hikoya et ai., 1983).
A more analytical approach has been proposed for 
estimation of IQ in food extracts, utilizing HPLC for 
separation and UV absorption for detection and quantitation 
(Barnes et ai., 1983a). However the limit of detection was low 
(O.ippb), but more recently a combination of HPLC and 
electrochemical detection has extended the limits of detection 
down to 0.5-1.5 pmol. No analysis of actual food products was 
carried out in this report (Grivas and Nyhammer, 1985), but 
Takahashi et ai., (1985a; 1985b), using a similar method have 
quantified IQ, MelQx, and 4,8-DiMeIQX in a commercial beef 
extract, the levels being 41;6, 58.7, and 10.0 ng/g,
respectively.
1.8 Formation of heterocyclic aromatic amines.
The AIAs are produced when beef is cooked by 
conventional methods at temperatures ranging from 150-300°C 
(Knize et ai., 1985). A possible route for their formation has 
been suggested based on the appearance of mutagenicity when 
mixtures of plausible precursors were heated together 
(Jagerstad et ai., 1986; Negishi et ai., 1984; Nyhammer et 
ai., 1986; Grivas et ai., 1985; 1986). In this proposed route 
the imidazole group of the AIA compound originates from the 
creatine present in all muscle food and the aromatic 
heterocycles may be generated by Maillard (non-enzymic 
browning) reactions (Fig 1.5). Taylor et ai., (1984; 1985)
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supported this proposal by reporting that all precursors 
of AIAs are water-soluble compounds of less than 500 daltons 
and confirmed the participation of free amino acids and 
muscle creatine phosphate.
MAILLARD REACTION
♦ R C H
NHjIf»
hexose 
ALDOL
CONDENSATION
AMADORI
REARRANGEMENT
STEŒCKER
DEGRADATION
amino acid
N
PYRIDINE 
<Z=C) 
or 
FRAZINK 
(Z=N)
R C H
0
♦ O H O \,
ALDEHYDE
HN: .NH,
H O O C
XHj
CREATINE
0 O
Y
X
X Y Z R
IQ: H H C H
MclQ: H He C H
MelQx: H Me N H
TOiMeJQx: Me Me N H
AOiMcIQx: H Me N Me
Figure 1.5: Proposed pathway for the formation of AIAs (Jagerstad et ai., 1986).
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Glu-P-1 and Glu-P-2 were isolated from glutamic acid 
pyrolysate (Yamamoto et al,, 1978) and Glu-P-2 also from 
charred dried cuttlefish (Yamaguchi at al., 1980b). The 
pyrolysis of soyabean globulin generated 2-amino-a-carboline 
(AaC) and 2-amino-3-methyl-a-carboline (MeAaC) (Yoshida et 
al., 1978). Trp-P-1 and Trp-P-2 were isolated from the 
pyrolysis of tryptophan (Sugimura et al., 1977b), also from 
broilled fish (Yamaizumi et al., 1980) and broiled beef 
(Yamaguchi et al., 1980a). Mutagenic compounds have also been 
isolated from pyrolysates of L-phenylalanine (Tsuji et 
al., 1978; Felton et al., 1986b; Sugimura et al., 1977b) 
and L-lysine (Wakabayashi et al., 1978). The amounts of HAAs 
found in cooked foods is shown in Table 1.5.
Table 1.5: Amounts of heterocyclic amines encountered in cooked foods.
Heterocyclic amine Identified in
ng/g of heated 
material Reference
Trp-P-1 Broiled sun-dried 
sardines
13.3 Yamaizumi et al.. 1980
Broiled beef 53 ng/g 
of raw beef
Yamaguchi et al., 1990a
Trp-P-2 Broiled sun-dried 
sardines
13.1 Yamaizumi et al., 1980
Glu-P-2 Broiled sun-dried 
sardines
280 Yamaguchi et al.. 1980b
IQ Broiled sun-dried 
sardines
158 Yamaizumi et al., 
unpublished data
Boiled beef 0.59 Wakabayashi et al. 
unpublished data
/
MelQ Boiled sun-dried 
sardines
72 Yamazumi et al., 
unpublished data
Table adapted from Sugimura 1980.
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1.9 In vitro genotoxicity of heterocyclic aromatic amines.
1.9.1 The Ames Salmonella assay.
All the pyrolysis products are extremely mutagenic in 
the Ames Salmonella test, only in the presence of an 
activation system. All of the HAAs were strongly mutagenic in 
Salmonella tester strain TA98 (Sugimura and Sato, 1983; 
Sugimura, 1986a) whereas Salmonella tester strains with intact
repair systems showed a much weaker response towards IQ and
Trp-P-2 (Thompson et al. , 1983; Wild et al., 1985). The most
potent mutagens were the AIAs (Table 1.6).
Table 1.6: Specific mutagenic activities of the compounds
isolated from pyrolysates (Sugimura, 1982).
Histidine Revertants/uQ
S. typhimurium TA98 S . typhimurium TAl 00
MelQ 661,000 MelQ 42,000
IQ 433,000 MelQx 14,000
MelQx 145,000 IQ 7,000
Trp-P-2 104,200 Glu—P—1 3,200
Glu-P-1 49,000 Trp-P-2 1 ,800
Trp-P-1 39,000 Trp-P-1 1,700
Glu-P-2 1,900 Glu-P-2 1,200
AaC 300 MeAaC 120
MeAaC 200 Lys-P-1 99
Lys-P-1 86 Phe-P-1 23
Phe-P-1 41 AaC 20
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The HAAs without exception require metabolic activation 
to express their mutagenic effect (Sugimura, 1982; Felton et 
al., 1986a) and this is achieved with greatest efficiency by 
S9 (liver 9000g supernatant) systems derived from Aroclor 1254 
pretreated rats; S9 fractions derived from untreated BALB/C 
mice, Syrian hamsters and Rhesus monkey were also effective 
in activating HAAs to mutagens (Alldrick and Rowland 1985; 
Ishida, et al., 1987). Similarly, S9 preparations from the
small intestine and kidneys of Aroclor 1254 pretreated rats 
were capable, although not as effective as the liver, in 
converting HAAs to mutagens (Holme et al., 1987b; DeWaziers 
and Decloitre, 1983). Primary monolayer cultures of
hepatocytes also provide an efficient activation system for 
HAAs (Decloitre at al.,1984; Holme et al., 1987b; Gayada and 
Pariza 1983; Aune and Aune, 1986).
1.9.2 Mammalian assays.
The pyrolysis products induce chromosomal aberrations 
and sister chromatid exchanges in cultured human cells (Sasaki 
et ai. , 1980 ; Tohda et ai., 1980) and in Chinese hamster ovary 
cells. DNA damage, assayed by alkaline elution, was detected 
in radiation-induced mouse leukaemia cells treated with IQ, 
MelQ and MelQx in the presence of an activation system
(Caderni et ai., 1983; Dolara et ai., 1985). In a forward
mutation system in Chinese hamster pulmonary cells, using 
diphtheria-toxin resistance as a selective marker, the most 
potent response was achieved with Trp-P-2 followed by Trp-P-1, 
MelQ,IQ, and MelQx (Nakayasu et ai., 1983; Terada et ai.,
1986). Each carcinogen required metabolic activation, as in 
the Ames Test, to exert its genotoxic effect except for
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Trp-P-1. Mutagenic metabolites of IQ and MelQ have also been 
detected in the livers of rodents in the host-mediated assay 
using Ames tester strains (Wild efc al., 1985; Howes, 1987). 
Sister chromatid exchanges and chromosomal abberations were 
produced in the bone marrow of mice by both Trp-P-2 and IQ, 
although IQ gave only a very weak response (Minkler and 
Corrano, 1984).
1.10 Carcinogenicity of heterocyclic amines formed during the 
cooking process.
Long-term animal carcinogenicity tests of the food 
pyrolysis products have demonstrated that these compounds 
are without exception carcinogenic in mice and/or rats 
(Sugimura, 1985). IQ was carcinogenic in both mice (Ohgaki et 
al., 1984; 1986) and rats (Takayama et al.,1984b; Tanaka et 
al., 1985), Fisher 344 rats maintained on a diet 
containing 300 ppm IQ developed hepatocellular carcinomas, 
intestinal adenocarcinomas, squamous cell carcinomas of the 
skin and zymbal gland tumours (Takayama 1984a). MelQ displayed 
carcinogenicity in mice giving rise to tumours in the liver, 
forestomach, intestine and lung (Ohgaki et al., 1985). 
Several studies have also indicated that Trp-P-1 and Trp-P-2 
are carcinogenic in rodents. Subcutaneous injections of 
Trp-P-1 to golden Syrian hamsters or rats induced 
fibrosarcoma at the injection sites (Ishikawa et al., 1979); 
oral administration of the carcinogen to mice induced 
hepatocellular carcinoma, the effect being significantly more 
pronounced in females (Matsukura 1981); finally rats fed a 
diet containing Trp-P-1 and Trp-P-2 developed
hepatocellular carcinoma and intestinal adenocarcinoma
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(Takayama,1985). Similarly Glu-P-1 and Glu-P-2 when given 
orally, as 0.03% of the pellet diet, to Fisher 344 • rats
induced tumours in the liver, small and large intestines
(Sugimura 1985). Furthermore a subcutaneous injection of 
either Glu-P-1, Glu-P-2, Trp-P-T or Trp-P-2 to newborn ICR 
mice resulted in liver tumours and malignant lymphoma (Fuji! 
et ai.,1987; 1988). Tanaka et ai., (1985) have also
demonstrated the formation of tumours in the mammary glands, 
ear ducts, liver, pancreas and bladder in female Sprague* 
Dawley rats given IQ (0.4 mmol/kg) orally by gavage on a 
weekly regimen for 31 weeks. MelQx was recently shown to 
induce tumours in the liver, lung and haematopoietic system of 
CDF1 mice (Ohgaki et al., 1987) and in the liver, Zymbal
gland, clitoral gland and skin in Fisher F344 rats (Kato et 
al., 1988). The carcinogenicity of MelQ was tested in Fischer
F344 rats where it induced liver and forestomach tumours, and
recently was shown to induce tumours in the oral cavity, 
Zymbal gland, colon, skin and, in female rats, also in the 
mammary glands (Kato et ai., 1989).
TD50 is one of the parameters of carcinogenic potency 
of a chemical and is defined as the amount of a 
carcinogen which induces tumours in 50% of experimental 
animals exposed to the chemical for their whole life-span 
(Peto et ai., 1984). TD50 of both MelQx (Kato et ai.,
1988) and IQ (Sugimura, 1986b) was calculated to be 0.7 
mg/kg/day for hepatocellular carcinoma and for MelQ 0.2 
mg/kg/day (Kato et ai., 1989), markedly lower than the TD50 of 
2AÀF (3.78 mg/kg/day) and much higher than that of Aflatoxin 
Bi (932ng/kg/day)(Gold et ai., 1984). It must be noted that
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the doses given during carcinogenicity tests were much 
greater than the estimated human daily intake of HAAs which 
per capita per day is lOOpg (Sugimura 1985).
1.11 Jn vitro Metabolism and metabolic activation of 
heterocyclic aromatic amines.
1.11.1 Microsomal.
All the carcinogenic protein pyrolysates require 
metabolic activation to express their mutagenic activities. It 
has been demonstrated that S9 fractions prepared from the 
livers of rats pretreated with 3MC were more efficient than 
that of control or phénobarbital (PB)-treated rats in 
activating these compounds to mutagens (Ishii et ai., 1980a; 
Abu-Shakra, 1986). Furthermore reconstituted purified 
cytochrome P450I proteins isolated from the livers of 
3MC-treated rats were more effective in activating Trp-P-1 and 
Trp-P-2 than cytochrome P450IIB proteins isolated from the 
liver of rats treated with PB (Ishii et ai., 1980b). 
Consistent with these findings is that the activation of these 
compounds is preferentially inhibited by antibodies raised to 
cytochrome P450I proteins (Wanatabe et ai., 1982; Harries et 
ai., 1986) and also by specific inhibitors of this family of 
proteins, such as 7,8-benzoflavone and ellipticine (Alldrick 
et ai., 1986). Nebert et ai., (1979) using S9 derived from the 
livers of benzo(a)pyrene-treated Ah "responsive" and 
"non-responsive" mice, demonstrated that cytochrome P450I 
proteins were far more active than other cytochrome P450 
proteins in activating HAAs. Furthermore S9 systems isolated 
from untreated hamsters, which have a higher constitutive
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level of P450I proteins than the rat (Hyde et al., 1987) were 
more efficient at activating HAAs to mutagens than S9 obtained 
from untreated mice (Matsushima et al., 1980) . It was also 
demonstrated that rat liver nuclei isolated from 3MC or 
polychlorinated biphenyl (PCB)-pretreated rats were more 
effective in transforming Trp-P-2 to mutagens in the Ames test 
than nuclei isolated from PB or untreated animals (Mita 
et al., 1981a). Furthermore, similar to the microsomal 
experiments, activation was inhibited specifically by 7,8 
benzoflavone.
It is now well established that the initial step 
in the metabolic activation of the protein pyrolysates 
is N-hydroxylation of the exocyclic amino group, forming 
the N-hydroxylamine (Okamoto et al., 1981; Yamazoe efc ai., 
1983; Kato efc al., 1983; Niwa efc al., 1982; Ishii efc ai., 
1981 ; Holme efc ai., 1989). The N-hydroxylation is catalysed 
specifically by the cytochrome P450I proteins (Ishii efc ai., 
1980b; Mita efc ai., 1981b; Snyderwine and Battula, 1989;
McManus efc ai., 1988a; 1988c), in particular the high spin
form cytochrome P450IA2 (Kamataki and Kato, 1985; Shimada and 
Nakamura, 1987; Yamazoe efc ai., 1983; Kamataki efc ai., 1983; 
Yamazoe efc ai., 1984). Glu-P-1 activation is highly dependent 
on the presence of cytochrome P450IA2 whereas the activation 
of Trp-P-2 can be efficiently catalysed by both cytochromes 
P450IA1 and P450IA2 (Yamazoe, efc ai., 1984; Kamataki and Kato, 
1985).
An additional system capable of activating the 
pyrolysate products is the prostaglandin H synthetase, which
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in the presence of arachidonic acid and oxygen can convert 
Trp-P-2 and Glu-P-1 to species that covalently bind to protein 
and also activate IQ to mutagens in the Ames test (Wild et 
al.f 1987; Petry at ai.,1986). However, in contrast it has 
also been demonstrated that the mutagenicity of IQ can be 
effectively inhibited by an intestinal peroxidase (Dolara at 
ai., 1984).
1.11.2 Cytosolic metabolism of HAAs.
The cytosol can potentiate the DNA-binding and the 
mutagenic activity of either the microsomal generated 
metabolites or synthetic N-hydroxy (NOH) derivatives of HAAs 
(Abu-Shakra at ai., 1986; Snyderwine at ai., 1988a; Hashimoto 
at ai., 1982a; Nemoto at ai., 1979), thus demonstrating the 
involvement of soluble factor(s) in the activation of these 
compounds. Possible pathways of activation of HAAs by the 
cytosol are shown in Fig 1.6.
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Figure 1.6: Proposed pathways for the cytosolie-mediated activation of HAAs.
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1.11.2.1 Role of glutathione and sulphydryl grpups.
It has been demonstrated that NOHGlu^P^-1 covalently 
binds to DNA and RNA at neutral pH, but the binding is 
markedly decreased, as in the case of NOHTrp-P-2, in the 
presence of compounds containing sulphydryl groups (Saito et 
al,, 1980a; Salto and Kato 1984). NOH derivatives of 
Trp-P-2 and Glu-P-1 are very unstable at 37°C and pH7.4 
possibly due to oxidation to the nitroso and/or the nitro 
derivatives, but, in the presence of glutathione the NOH 
derivatives were found to be stable even under aerobic 
conditions. On the other hand the nitroso derivatives of 
Glu-P-1 and Trp-P-2 were stable in the absence of 
glutathione and were rapidly reduced to the N-hydroxy 
derivatives in the presence of glutathione (Saito et al., 
1980a; 1980b). These findings indicate that the glutathione
present in the cytosol may prevent oxidative decomposition 
of NOHHAAs, so that more of the mutagenic NOH derivative is 
available for interaction with the DNA. In contrast 
addition of glutathione to the Ames test has been shown to 
inhibit the mutagenicity of Trp-P-1 (De Waziers and Decloitre 
1984) and of the AIAs, IQ and MelQ (Alldrick et ai.,1986) 
whereas it enhanced the mutagenicity of Trp-P-2. In the 
presence of rat liver cytosol and glutathione, NOHTrp-P-2 
produced at least three glutathione conjugates, one of which 
exhibited mutagenicity that was seven-fold greater than that 
of the parent hydroxylamine (Saito et al., 1984). Hence the 
role of glutathione in activation is complex and unclear at 
the present.
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1.11.2.2 Role of acétylation and sulphation.
Nagao efc al., (1983) proposed that the ultimate 
mutagenic forms of IQ, MelQ and MelQx are the sulphate 
esters of the NOH derivatives as all three AIAs failed to 
induce a mutagenic response in the esterifying enzyme 
deficient Salmonella strain TA98/1,HDNPs. In addition 
pentachlorophenol (PCP), an aryl sulphatase inhibitor, 
inhibited the mutagenicity of HAAs in TA98. However it was 
subsequently realised that TA98/1,8DNPG was also deficient in 
another enzyme which could be involved in the activation of 
HAAs namely bacterial acetyl-CoA-dependent 0-acetyltransferase 
of the arylhydroxylamines; moreover this enzyme was also 
strongly inhibited by PCP (Kato et al., 1984). Furthermore 
2,6-dichloro-4-nitrophenol, an inhibitor of sulphotransferase 
and not of the bacterial 0-acetyltransferase had no effect on 
the mutagenicity of NOHGlu-P-1 in TA98. Similarly the 
mutagenicity of NOHIQ was also inhibited more selectively by 
PGP (Snyderwine efc al., 1988a). The acetyl CoA dependent 
0-acetyltransferase was isolated from TA98 and was found to 
be capable of transforming NOHTrp-P-2 to a reactive 
derivative that bound to DNA in the presence of acetyl 
CoA, and was selectively inhibited by phenolic
compounds and the antibiotic thiolactomycin (Saito efc 
al., 1985). The addition of purified N-hydroxyarylamine 
0-acetyl transferase and acetyl CoA to the mutagenesis assay 
of NOHGlu-P-1 with TA98, markedly decreased mutagenic activity 
(Saito efc al., 1985) thus indicating the importance of the
transport of a reactive intermediate into the bacterial 
cell prior to formation of the ultimate mutagen.
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Certain carcinogenic N-hydroxylamines are able to 
covalently modify DNA in vitro, particularly under mildly 
acidic conditions. However further activation appears to be 
essential for DNA-binding especially at physiological pH 
(Weisburg and Weisburg 1973 ; Beland and Kadlubar 1985) . A 
possible activation pathway for the HAAs could be 
acétylation or sulphation. It has been suggested that the 
hydroxyamino group is acylated to form a more reactive 
compound which interacts more readily with DNA. The 0-acyl 
derivatives of Trp-P-2 and Glu-P-1 can alkylate DNA without 
further activation (Hashimoto et al,, 1980; 1982b),
furthermore the mammalian 0-acetyltransferase can enhance the 
in vitro covalent binding of the N-hydroxy derivatives of 
Glu-P-1 and Trp-P-2 (Shinohara et ai.,1985; 1986b) and that 
this is inhibited by PCP and 1-nitro-2-naphthol(Shinohara et 
al,, 1986a), thus lending further support to the role of 
acétylation in the activation of HAAs.
1.11.2.3 Role of acyl-tRNA synthetase.
Yamazoe and co-workers (1981b; 1982; 1985) proposed the 
involvement of seryl- and prolyl-tRNA synthetase in the 
further activation of NOHTrp-P-1 to an alkylating agent. Using 
rat hepatic cytosol they found that L-proline was more 
effective than L-serine in enhancing the covalent binding of 
NOHTrp-P-2 to DNA, in the presence of ATP. Additionally, 
marked species differences in the activity of this enzyme was 
observed which paralleled a species difference in the ability 
of cytosol to catalyse the covalent binding of NOHTrp-P-2 to 
DNA (Yamazoe et al,, 1982).
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1 11.2.4 Role of antioxidant enzymes.
NOHIQ is extremely unstable with a half life of 
approximately 1 min (Okamoto et al,, 1981; Yamazoe et al,, 
1983) and covalently binds to DNA at neutral pH. Hiramoto et 
al, (1988) postulated that superoxide dismutase (SOD), a 
cytosolic enzyme, in biological systems could promote 
oxidation and convert N-hydroxylamines into the more stable 
nitroso groups and hence act as a reservoir for reactive 
intermediates. However in contrast the mutagenicity of NOHIQ 
has been shown to be enhanced in the presence of the 
antioxidahts ascorbic acid and NADPH (Snyderwine et al,, 
1988a), which presumably act by preventing oxidation of the 
NOH derivative.
1.12 In vivo metabolism of HAAs
When HAAs were administered to rats, either i.p. or 
orally the presence of N-acetyl derivatives in the urine and 
faeces was detected (Peleran et al,, 1987; Rafter and
Gustafsson 1986; Stormer et al,, 1987). All the acetyl 
derivatives of the AIAs and Glu-P-1 possessed significant 
mutagenic activity after metabolic activation (Hayatsu et 
al,, 1987; Stormer et al,, 1987; Negishi et al,, 1986; 
Brunborg et al., 1988) and thus N-acetylation cannot be 
regarded as a detoxication route for these compounds. However 
this is in contrast to the results obtained with Trp-P-1 and 
Trp-P-2 in which N-acetylation resulted in lower 
mutagenic activity (Nagao et ai., 1980; Kato et ai., 1983).
A major route of detoxication in vivo appears to be 
sulphation of MelQx and IQ to form sulphamates which are
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non-mutagenic in the Ames test (Turesky et al., 1986; 1988). 
MelQx and Trp-P-2 are also detoxified through ring 
hydroxylation and glucuronidation (Turesky, 1988; Kato, 1986).
1.13 Inhibitors of chemical carcinogenesis.
Current data suggests that chemical carcinogens play a 
significant role in the aetiology of human cancer. However 
there is also data showing that a number of chemicals have 
the ability to inhibit the neoplastic process. 
Experiments on the inhibition of chemical carcinogenesis date 
back to 1929, when it was demonstrated that 
dichloroethylsulphide inhibited tumour formation in the skin 
resulting from the repeated application of carcinogenic tar 
(Berenblum, 1929).Subsequently a number of other compounds 
were also found to exhibit similar effects on epidermal 
neoplasia such as hydrolysable halogen compounds eg valeryl 
chloride and benzene sulphochloride (Crabtree, 1941), and 
several low molecular weight aromatic hydrocarbons such as 
naphthalene, anthracene and phenanthrene (Crabtree, 1946). The 
mechanisms of most inhibitors of carcinogenesis, both 
synthetic and naturally occurring, are poorly understood and 
the lack of information makes it difficult to organise them 
into a cohesive pattern. One means of providing an 
organisational framework is to classify inhibitors according 
to the stage in the carcinogenic process at which they are 
effective (Fig 1.7).
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Figure 1.7: Classification of chemopreventive agents on the basis of the stage during 
carcinogenesis at which they exert their protective effects (Modified from 
Wattenberg, 1982).
The first group consists of compounds that inhibit the 
formation of carcinogens from precursors. Compounds of this 
type are exemplified by ascorbic acid which prevents the in 
vitro and in vivo formation of nitrosamines from nitrite and 
precursor amines and amides (Mirvish, 1981a; 1981b). Under
these conditions addition of ascorbic acid prevents the 
formation of nitroso compounds and the occurrence of nitrate 
related cancers. a-Tocopherol (Newmark and Mergens, 1981) and
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phenols such as caffeic acid, ferulic acid and gallic acid 
(Kuenzig et al,, 1984; Newmark and Mergens, 1981) have also 
displayed a similar capacity to inhibit nitroso formation. 
The second group of inhibitors are called blocking agents, 
which are easily detected by short term tests and act by 
preventing the carcinogen from reaching and reacting with the 
nucleophilic macromolecular sites of DNA and other 
informational macromolecules. Blocking agents can be further 
subdivided into 3 groups which are categorised according to 
the mechanism by which the inhibitor acts (Fig 1.8), examples 
of which are given in Table 1.7.
ACTIVATING
SEQUENCE
BLOCKING MECHANISM
GENOTOXIC COMPOUNDS 
REQUIRING 
METABOLIC ACTIVATION
Activating
Enzymes
ULTIMATE GENOTOXIC 
SPECIES
COVALENT BINDING 
TO A CRITICAL 
NUCLEOPHILIC SITE
Inhibition of 
Activating enzymes 
(eg fl-naphthoflavone)
Enhancement of 
Detoxication processes 
(eg phenols and thiols)
Nucleophilic 
Trapping reaction 
(eg ellagic acid)
Detoxication
product.
Detoxication
Product
Figure 1.8: Schematic representation of the mechanisms of action of blocking agensts.
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Table 1.7: Synthetic and naturally occurring blocking agents.
Chemical oowpounds References
Phenols:
ellagic acid, ferulic acid, 
caffeic acid, p-hydroxycinnamic add 
hydroxyanisol, BHT.
Indoles:
1ndole-3-aceton1tr11e, 1ndole-3-carb1no1, 
3,3'-d1Indoylmethane.
Aromatic Isothiocyanates: 
benzyl Isothiocyanate, 
phenylethyl isothicyanate, 
phenyl Isotiocyanate.
Coumarins: 
coumarin, limettin.
Flavones:
B-naphthoflavone, a-naphthoflavone, 
quercetin pentamethylether.
Lesca, 1983,
Mukhtar e t  a l . , 1984,
Rao e t  a h ,  1984,
Tatsuta e t  a h ,  1983, 
Wattenberg, 1978, 1981, 1983, 
Wattenberg e t  a h ,  1980, 
Wattenberg and Flala, 1978, 
Wattenberg and Lam, 1983.
Wattenberg, 1979
Wattenberg, 1978, 1979.
Wattenberg, 1979
Diamond et a h ,  1972, 
Wattenberg 1977,
Wattenberg and Leong, 1970.
Diterpenes: 
kahweol palmitate
Phenoth 1 az 1 nes : 
phenothlazine
Barbiturates:
phénobarbital
Trimethylqulnolines: 
ethoxyquin__________
Wattenberg, 1983, 
Wattenberg and Lam, 1984.
Wattenberg, 1978, 1981.
Yamamoto e t  a h ,  1971.
Wattenberg, 1978.
Table modified from Wattenberg (1985).
The final group are the supressing agents which are 
compounds that inhibit carcinogenesis when administered 
subsequent to initiation. Unlike the blocking agents, there 
are no short term genetic tests to indicate the likelihood of 
a compound being a supressing agent. The most extensively 
studied supressing agents are the retinoids (Moon et al., 
1983; Sporn, 1983; Sporn and Newton 1981).
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1.14 Dietary Modulators of chemical mutagenesis.
When considering the health risk posed by food-related 
mutagens, it must be borne in mind that diet is a complex 
mixture of chemicals. As already discussed it contains 
mutagens and carcinogens (section 1.6), but it may also 
contain chemicals capable of modulating mutagenesis and may, 
by implication modulate carcinogenesis. Many of the inhibitors 
of mutagenesis have been detected using the Ames test. These 
chemicals may influence the metabolic activation of a 
promutagen by some enzymic and non-enzymic processes such as 
complex formation with the promutagen prior to activation; 
decrease or increase the capacity for enzymic or non-enzymic 
detoxification; or modulate the further activation of the 
generated reactive intermediates. Kada et al,, (1978) reported 
that the addition of several vegetable juices to the S9 
fraction in the Ames test resulted in a marked decrease in the 
mutagenic activity of food pyrolysates. One of the 
antimutagenic constituents was identified as a haemoprotein, 
exhibiting peroxidase activity, and another was a vegetable 
fibre (Inoue at al., 1981; Kada at al., 1984). It has also 
been shown that cytochrome c, myoglobin and haemoglobin can 
inhibit the mutagenicity of the direct acting mutagens, 
NOHTrp-P-2 and NOHGlu-P-1 (Arimoto at al., 1987). Arimoto at 
ai., (1980) also reported the weak antimutagenic effect of 
biliverdin against Trp-P-1 in the Ames test which may be 
attributed to its antioxidant activity (Stocker, 1987). The 
biogenic amines, tryptamine, serotonin and tyramine are potent 
inhibitors of the mutagenic activity of AIAs in the Ames test, 
and this decrease is due to impairment of the cytochrome 
P450-mediated activation of these mutagens (Abu-Shakra at al.,
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1987; Alldrick and Rowland 1987a). The mutagenicity of HAAs 
can also be suppressed by dietary fat (Hayatsu et al., 1981; 
Alldrick and Rowland,1987b; 1987c). It was later realised that 
the inhibitory effect of oleic acid against Trp-P-2 is 
primarily due to inhibition of hepatic mixed function oxidase 
activity (Saito et ai:, 1983a).
1.15 Antimutagenicity of plant phenolics.
Epidemiology indicates an inverse relationship between 
the consumption of vegetables and the incidence of cancer 
(Hirayama, 1979; 1981; Graham at ai., 1978; Mettlin et ai., 
1980). The search for protective components in these 
vegetables has focused on 8-carotene, vitamin A and ascorbic 
acid. However this inverse relationship between cancer and 
vegetable consumption may also involve other plant compounds. 
Of the many dietary antimutagens, the most interesting are the 
secondary plant products found in edible plants. These 
compounds are of great interest as they are heat stable and, 
in general, consumed in large quantities, up to a gram per day 
(Brown at ai., 1980). Many plant phenols have been shown to 
possess antimutagenic activity, with many phenols in 
particular ellagic acid demonstrating marked blocking ability, 
by inhibiting the S9-mediated activation of benzo(ajpyrene and 
aflatoxin Bt to mutagenic intermediates in the Ames test 
(Hayatsu et ai., 1988; Chang at al., 1985; Mandai at al.,
1987), , The mechanism of action is thought to involve either
inhibition of metabolism or trapping of the ultimate reactive 
intermediate. Indeed it has been shown that ellagic acid can 
trap the ultimate carcinogen of benzo(a)pyrene, benzo(a)pyrene 
diol-epoxide (Fig 1.9) and hence prevent its mutagenicity in
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the Salmonella and cultured Chinese hamster V79 assays (Wood 
et ai., 1982).
OH OH
OH
H
HO
HO
Figure 1.9: Computer-generated molecular model showing interaction between ellagic acid 
and benz[g]pyrene diol-epoxide (Sayer et al., 1982).
Similarly plant phenols have also been shown to scavenge the 
direct-acting mutagen MNNG and thus decrease its mutagenicity 
towards Ames tester strains (Chan et ai., 1986 ). In some test 
systems plant phenols, such as ellagic acid, can bind to, and 
protect nucleophilic DNA sites from alkylation by ultimate 
carcinogenic species (Teel, 1986; Teel et ai., 1987b). A 
structurally related group of compounds shown to inhibit 
mutagenicity are the flavonoids, which, like the phenols, are 
consumed when food of plant origin is ingested. They are 
potent inhibitors of the cytochrome P450 system, a mechanism 
by which the flavonoids inhibit the activation of many 
promutagens in vitro such as benzo(a)pyrene and Aflatoxin Bi 
(Buening et ai., 1981).
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Although it is difficult to extrapolate results from in 
vitro test systems to the intact animal, the antimutagenic 
properties of both plant phenolics and flavonoids may be of 
significance in vivo and hence merit further investigation, 
especially in relation to the possible inhibition of dietary 
mutagens, as they are consumed concurrently in many diets. 
Indeed a number of plant derived compounds, when administered 
orally or i.p. have been shown to significantly protect 
against chemically-induced neoplasia. These include indoles 
such as indole 3-carbinol (Wattenberg and Loub, 1978), 
lactones such as coumarin (Wattenberg, 1979) and phenols such 
as ellagic acid (Lesca, 1983).
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1.16 Aims of the work
In order to assess the potential hazard of dietary 
exposure of HAAs to man it is also important to assess the 
role, if any, of each of the components of the diet in 
carcinogenesis. Both HAAs and antimutagenic factors are 
present in the diet and thus may interact and prevent or 
enhance carcinogenesis. The aims of the work are to establish 
how the metabolic activation of food mutagens is affected by 
dietary factors, in particular antimutagens. This will be 
investigated by:
1. Investigating the possible antimutagenic effects of dietary 
plant phenols against the HAAs, in particular IQ.
2.Elucidating the mechanisms by which dietary antimutagens 
may elicit their antimutagenic effect.
3. Extrapolating the antimutagenicity results obtained in 
vitro to a possible in vivo situation and hence possible 
anticarcinogenic action. This will be achieved by 
investigating the effects of exposure of experimental animals 
to antimutageniccompounds, on hepatic carcinogen metabolising 
enzymes.
4. Studying the effects of exposure of animals to HAAs and 
other carcinogenic amines on the metabolic activation of 
protein pyrolysates.
5. Assessing of the role of various liver sub-fractions on 
the activation of IQ to reactive intermediates.
6. Investigating the role of some physiological factors that 
may alter the activation of the HAAs and hence their 
carcinogenic potential.
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CHAPTER 2: MATERIALS AND
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2.1 Materials.
Ethoxyresorufin, pentoxyresorufin, resorufin (Molecular 
Probes, Eugene, OR., USA); Aroclor 1254 (Robens Institute of 
Health and Safety, Guildford, Surrey); anthraflavic acid, 
3,4-dichloronitrobenzene (Aldrich Chemicals Co. Ltd., 
Gillingham, Dorset); Triton X-100, sodium dithionite, 
aniline-HCl (BDH Chemicals Ltd., Poole, Dorset);
benzoxyresorufin, proteinase K (Boehringer, Lewes, East 
Sussex); Isoamylalcohol (Koch Light, Haverhill, Sulfolk); 
DMSO, Optiphase (FSA, Loughborough, Liecs.); Cytochrome c, 
menadione, ellagic acid, reduced glutathione, calf thymus DNA, 
NADPH, NADP, glucose-6-phosphate and glucose-6-phosphate 
dehydrogenase (Sigma, Poole, Dorset) were purchased.
Sheep and rabbit peroxidase-antiperoxidase, peroxidase 
labelled donkey anti-rabbit and peroxidase labelled donkey 
anti-sheep, and donkey anti-rabbit and donkey anti-sheep were 
obtained from Guildhay Antisera, Guildford, Surrey. 
Anti-cytochrome P450IIB was a generous gift from Dr. G.G. 
Gibson (Biochemistry Dept. University of Surrey, Guildford, 
Surrey). The purification and characterisation of cytochrome 
P450I and the production of antibodies has already been 
described (Rodrigues et ai., 1988). Acrylogel, Bisacrylogel 
(National diagnostics, Aylesbury, Bucks.); N,N,N'N'-tetra- 
methylethylenediamine, sodium dodecyl sulphate, ammonium 
persulphate, bovine serum albumin, Folin-Ciocalteau phenol 
reagent (Sigma, Poole, Dorset); Nitrocellulose sheets 
(Anderman & Co., Ltd., Kingston-upon-Thames, Surrey) and all 
other reagents of the highest available grade (BDH Chemicals
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Ltd., Poole, Dorset) were purchased.
Plastic disposable tubes (Sterilin, Teddington, 
Middlesex) Lab M agar (London Analytical & Bacteriological 
Media Ltd., Salford, Lancs.) and Vogel Bonner E plates 
(Gibco, Paisley, Scotland) were routinely used in the Ames 
test. Oxoid No. 2 nutrient broth (Oxoid Ltd., Basingstoke, 
Hants.) was used for culturing and diluting the Salmonella 
typhimurium strains, which except for TA98NR and TA98/1 ,8DNPe 
(kindly donated by Prof. H. Rosenkranz, Cleveland, USA), were 
all generous gifts from Dr. B.N. Ames (Berkeley, USA).
Glu-P-1, Glu-P-2, Trp-P-1, Trp-P-2, IQ (Wako Fine 
Chemicals, 4040 Neuss 1, FRG); [^ /*C]IQ ,MeIQ, and MelQx 
(Toronto Research Chemicals inc., Ontario, Canada) were also 
~
2.2 Methods.
2.2.1 Animals and Animal pretreatment.
Male Wistar albino rats (150-200 g) were purchased from 
the Animal Breeding Unit, University of Surrey. The animals 
were housed at the University of Surrey in cages with sawdust 
bedding, being allowed food (Spratts Animal Diet No.1) and 
water ad libitum. A 12hr light-dark cycle was in operation 
(0700-1900 light) at 22°C and 50% humidity. Unless otherwise 
described the animals received Aroclor 1254 (200 mg/ml
dissolved in corn oil), as a single i.p. dose (500 mg/kg body 
weight) and were sacrificed by cervical dislocation on the 
fifth day following dosing.
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2.2.2 Preparation of the various hepatic subcellular 
fractions.
Hepatic subcellular fractions were prepared essentially 
as described previously (loannides and Parke, 1975); livers 
were excised immediately and washed in sterile, ice-cold 1.15% 
(w/v) KCl to remove excess blood. The livers were subsequently 
weighed, scissor minced and homogenized in 3 volumes of 
ice-cold, sterile 1.15% (w/v) KCl using a motor driven
Potter-Elvehjem glass teflon homogeniser. The homogenate was 
adjusted to 25% (w/v) by further addition of sterile 1.15% 
(w/v) KCl and centrifuged at 9,OOOg (11,200 rpm) for 20 
minutes using a JA17, 14 x 50ml aluminium angle-head rotor in 
a Beckman J2-21 centrifuge.The supernatant (S9 fraction) was 
decanted off slowly and stored at -20°C until required. The 
S9 fraction was never stored for periods longer than 3 months.
Microsomal suspensions (105,000g pellet resuspended) 
were prepared from the S9 fraction by centrifugation using a 
Beckman LS-65 ultracentrifuge with a Ti-65 (8 x 10 ml titanium 
angle head rotor) or a Ti-60 (8 x 40ml titanium angle head
rotor) at 45,000 rpm for 60min. The resulting supernatant, the 
cytosolic fraction (105,000g supernatant), or the pellet which 
was resuspended by hand homogenisation in sterile 1.15% (w/v) 
KCl (microsomal fraction), were used immediately . All 
solutions and equipment used were previously sterilized in an 
autoclave at 120°C.
page 46
2.2.3 Protein determination using the Lowry proceedure.
Protein determination was determined by the Lowry method
(Lowry et ai.,1951), using bovine serum albumin (Fraction V) 
as standard.
Copper sulphate (1 % w/v), sodium potassium tartrate (2% 
w/v) and sodium carbonate (2% w/v) were mixed (1:1:100) 
immediately prior to use, and termed the "copper reagent". 
Protein samples were diluted, 1:20 for microsomes, 1:50 for 
cytosol and 1 :100 for S9. Protein standard solution (500pg/ml) 
was diluted to give standards in the range of 0-250]ig bovine 
serum albumin per tube (0.5ml).The protein standards, blanks 
and samples ( 0 .5ml) were further diluted 1 :2 prior to mixing 
with "copper reagent" (5ml) and allowed to stand for 10 min. 
Folin-Ciocalteau phenol reagent was diluted 1:2 with distilled 
water and then added (0.5ml) to each tube and the solution 
mixed immediately. After allowing to stand for 30 min, the 
absorbance at 720nm was recorded. The protein concentration 
for each sample was calculated from the standard curve.
2.2.4 The solubilisation of hepatic microsomal preparations 
for SDS-PAGE and western blotting analysis.
Microsomal suspensions (25% w/v) were prepared as 
described above and were maintained at 4°C. Solubilisation of 
the microsomal proteins was achieved by adding lOpl of 
solubilisation buffer (0.1M potassium phosphate buffer, pH 
7.4, containing 10% w/v sodium cholate and 2% v/v Emulgen 911) 
for every mg microsomal protein and mixing for 40min on ice. 
The preparations were ready for use and stored at -20°C.
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2.2.5 Discontinuous sodium dodecyl sulphate polyacrylamide 
slab gel electrophoresis of hepatic microsomal proteins.
The method of Laemmli (1970) was used to separate 
microsomal proteins. The proceedure was performed at room 
temperature.
Reagents
Lower Gel Buffer: 1.5M Tris-HCl, pH8.8, containing 0.4% w/v
(Buffer 1) sodium dodecyl sulphate (SDS)
Upper Gel Buffer: 0.5M Tris-HCl, pH6.8, containing 0.4% w/v
(Buffer 2) SDS
Electrode Buffer 
(Buffer 3)
25mM Tris-HCl, pH8.3, containing 192mM 
glycine and 0.1% w/v SDS
Sample Buffer: 125mM Tris-HCl (pH6.8) containing 4.6% w/v 
SDS, 30% v/v glycerol, 0.002% w/v bromo- 
phenol blue and 10% v/v B-mercaptoethanol.
Method.
A vertical slab gel apparatus made in the Biochemistry 
Department Workshop was used. The gel was cast in a glass 
cassette, with perspex side and bottom spacers, held together 
with bull-dog clips. The dimensions of the cast gel were 120mm 
X 100mm X 1.5mm.
The glass front and back plates were washed with Decon 
detergent, rinsed with tap and then distilled water and 
finally cleaned with acetone and left to dry. The cassette was
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assembled and sealed with 2% w/v molten agar and then clamped 
in a vertical position. The lower running gel was prepared by 
gently mixing Buffer 1 (6.25ml), Bisacrylagel (3.38ml),
Acrylagel (8.11ml) and distilled water (7.14ml). 
Polymerisation was initiated with (TEMED) N,N,N',N'-tetra- 
methylethylenediamine ( 2 0 ] jl1 )  and freshly prepared ammonium 
persulphate 10% w/v (125pl). This amount was sufficient for 1 
gel at à final acrylamide concentration of 10% w/v. The 
solution was poured into the glass cassette to a height of 
8cm. A thin layer of distilled water was added above the gel 
mixture to ensure a flat interface between the lower, 
separating gel and the upper, stacking gel. Polymerisation of 
the lower gel took approximately 40-50min, at the end of which 
time the thin layer of water was removed. The upper gel 
consisted of buffer 2 (2.5ml), Bisacrylagel (0.4ml), Acrylagel 
(1ml) and distilled water (6ml). Again polymerisation was 
initiated by addition of TEMED (20pl) and freshly prepared 
ammonium persulphate 10% w/v (lOOpl), which was sufficient for 
1 gel and gave a final acrylamide concentration of 3% w/v. The 
upper gel was poured into the glass cassette above the lower 
gel and a perspex comb was introduced into the upper gel prior 
to polymerisation to form thé sample wells; polymerisation 
took approximately 1 h. The comb was removed after 
polymerisation and a small amount of buffer 3 (electrode 
buffer) was introduced into the sample wells to maintain their 
integrity. The bottom perspex spacer was removed from the 
cassette and the cassette was then placed into the 
electrophoresis tank. The solubilised microsomal (see section
2.2.4) were siluted 1 in 2 with sample buffer and boiled for 
3min in a waterbath prior to loading into the sample wells
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using a IOOy.1 syringe. Electrode buffer was then placed in
the upper and lower reservoirs of the tank, and any air
bubbles trapped beneath the gel removed with a clean syringe.
Electrophoresis was carried out immediately after sample 
loading. For electrophoresis the electrical field was provided 
by a Pharmacia power supply model EPS 560/400 with a constant 
current of 20mA per gel until the bromphenol blue band was 
observed to enter the lower gel. The current was subsequently 
increased to 40mA until the bromphenol blue band was at the 
lower edge of the lower gel when the electrical field was
switched off. The cassette was then removed from the
electrophoresis tank, the glass plates separated, and the 
lower gel removed. The lower gel was either directly stained 
for protein or the proteins transfered onto nitrocellulose for 
western blot analysis.
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2.2.6 Western blot analysis of microsomal cytochrome P450 
proteins.
This technique involved the electrophoretic transfer of 
proteins from polyacylamide gels to nitrocellulose sheets 
which were then subjected to immunological staining (Towbin et 
al., 1979).
Reagents
Transfer buffer: 25mM Tris, 190mM glycine in 30% v/v
(Buffer 4) methanol.
Washing buffer: 50mM Phosphate buffered saline (PBS)
(Buffer 5) containing 0.2%v/v Triton X-100 and
1% w/v BSA (fraction V).
Substrate Solution: lOOmM Tris-HCl buffer, pH7.5 containing
1.4mM 3,3'diaminobenzidine
and 0.02% (v/v) hydrogen peroxide (30%w/v)
Method
SDS-PAGE was carried out as described above using 
microsomal samples. The resulting gel was washed in buffer 4 
for 60 min to remove salts and pre-shrink the gel. Transfer 
was achieved using a Biorad sandwich system. Nitrocellulose 
(0.45)im pore size) was soaked in buffer 4 and placed on top of 
two sheets of Whatman 3MM paper, lying on top of a Scotch 
Brite scouring pad. The gel was carefully placed on top of the 
nitrocellulose paper followed by two sheets of Whatman 3MM 
paper and a second Scotch Brite scouring pad. The whole 
assembly was clamped in a plastic grid and soaked to remove 
air bubbles. The complete assembly was inserted into a Biorad 
Electroblot tank with the nitrocellulose paper on the anode 
side of the gel. The tank was filled with buffer 4 and
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electrophoretic transfer was achieved with a constant voltage 
(60 volts) for 2.5h, after which the nitrocellulose paper was 
removed arid placed in buffer 5 and left overnight at 4°C.
The transferred proteins were detected immunologically 
either as described in detail previously (Rodrigues et al., 
1988) or as follows, all steps being performed at room 
temperature with slow agitation:
1. The first antibody, rabbit anti-cytochrome P450IIB or sheep 
anti-cytochrome P450I, previously characterised (Rodrigues et 
al., 1988) was diluted appropriately (1:12,000 for anti-P450l 
and 1:2,000 for anti-P450IIB1) in buffer 5 to a final volume 
of 50ml. The respective nitrocellulose sheets were then 
incubated for 60 min in the presence of the antibody.
2. Nitrocellulose sheets were washed 3 times each for 10 min 
in buffer 5.
3. The second antibody, peroxidase-labelled donkey anti-rabbit 
or peroxidase-labelled donkey anti-sheep was diluted (1:1000) 
with buffer 5 and incubated with the appropriate 
nitrocellulose sheet for 1h.
4. The nitrocellulose sheets were washed as decribed in 2.
5. The nitrocellulose sheets were washed in PBS for 10 min.
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6. After washing with PBS, substrate solution (100ml/sheet) 
was added and the reaction allowed to proceed for 3 min. 
Termination was achieved by washing with several aliquots of 
ice-cold distilled water. Sheets were then photographed.
2.2.7 Microsomal enzyme assays.
2.2.7.1 Spectrophotometric assays.
Spectrophotometric determinations were carried out using 
either a Varian/Gary model 2200 split beam spectrophotometer 
or a Kontron Uvikon 860 spectrophotometer.
Cytochrome P450 determination.
Microsomal cytochrome P450 was determined essentially as 
described by Omura and Sato (1964). Total cytochrome P450 was 
measured as the difference spectrum of the reduced P45O-CO 
bound complex versus reduced P450. The difference spectrum was 
recorded between 390-500nm.
Microsomal suspension (25%) was diluted 1 :6, by adding 
0.5ml of the microsomal suspension to 2.5ml of potassium 
phosphate buffer 0.1 M, pH 7.6. Following the addition of 
sodium dithionite (approximately 30mg) the diluted microsomes 
were mixed and divided between two 1.5ml disposable plastic 
cuvettes.Microsomal suspension (25%) was diluted 1:6, by 
adding 0.5ml of the microsomal suspension to 2.5ml of 
potassium phosphate buffer 0.1 M, pH 7.6. A baseline for the 
reference and test cuvettes was recorded between 390-500 nm. 
Carbon monoxide was then bubbled through the test cuvette 
(approximately 30 bubbles) and the difference spectrum 
recorded. The cytochrome P450 content was calculated from the
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absorbance difference employing an extinction
coefficent of SlmM"**cm"'* .
Cytochrome bs determination.
Microsomal cytochrome bs was determined essentially as 
described by Omura and Sato (1964). Cytochrome bs content was 
determined from the difference spectrum (peak at 426nm/ trough 
at 4TOnm) produced by reducing the cytochrome bs in the sample 
cuvette only. Microsomal suspension (25%) was diluted 1:6, by 
adding 0.5ml of the microsomal suspension to 2.5ml of 
potassium phosphate buffer 0.1 M, pH 7.6. A baseline for the 
reference and test cuvettes was recorded between 390-500 nm. 
Sodium dithionite (a few grains) was then added to the sample 
cuvetts and the difference spectrum recorded under aerobic 
conditions. The cytochrome bs content was calculated from the 
absorbance difference A^ze-^n oram employing an extinction 
coefficent of 185mM”■’em"
NADPH-cytochrome c reductase activity.
NADPH-cytochrome P450 reductase (EC 1.6.2.4) was assayed 
using the reduction of the non-physiological electron 
acceptor, cytochrome c (Williams and Kamin, 1962). The 
reaction was carried out at 37°C and the following were added 
into the reference (R) and sample (S) cuvettes:
R S
ml ml
50mM Potassium phosphate buffer, pH 7.6
containing lOmM KCN 1.8 1.9
0.1mM Cytochrome c 1.0 1.0
Microsomal suspension (25%) 0.2 0.2
page 54
After a suitable pre-incubation period to obtain a 
steady baseline, 0.1ml of NADPH (30mM in 1% NaHCOs) was added 
to the sample cuvette only. The reduction of cytochrome c was 
monitored at 550nm. The concentration of ferrous cytochrome c
formed with time was calculated using the extinction
coefficient 1 8. 5mM“ c m ~ .
Aniline hydroxylase activity.
The microsomal hydroxylation of aniline was performed 
essentially as decribed by Guarino et ai., (1969). The
following reaction mixture was prepared in duplicate and 
incubated at 37°C in a shaking water bath for 15 min:
0.3M Tris-HCl buffer, pH 7.6 0.5ml
0.04M Aniline hydrochloride pH 7.6 0.5ml
0.1M MgClz 0.1ml
0.01M NADP 0.1ml
0.1M G-6-P 0.1ml
Microsomal suspension (25%) 0.5ml
The reaction was terminated by the addition of solid 
NaCl and the product, p-aminophenol extracted into ether 
containing 1.5% v/v isoamylalcohol. Ether aliquots (10ml) were
then added to 0.5M tri-potassium orthophosphate (4ml), to
which phenol (1%w/v) was added prior to use, and extracted for 
30 min. The resulting blue colour was read at 620nm after 
removal of the phenol layer.
page 55
Dimethylnitroscanine N-demethylase activity.
The determination of dimethylnitrosamine N-demethylase 
activity was based on the method described by Holtzman et ai., 
(1969). The following incubation mixture was prepared:
50mM Phosphate buffer, pH 7.24 0.6ml
150mM MgClz 0.1ml
60mM Dimethylnitrosamine 0.1ml
Microsomal suspension (25%) 0.1ml
The reaction mixture was pre-incubated at 37°C in a shaking
water bath prior to initiation of the reaction by the addition
of 0.1ml of an NADPH-generating system (NADP, 0.98mM, G-6-P, 
1OmM and G-6-PDH, 10 units/ml). After a further incubation of 
1Omin the reaction was terminated by the addition of ice-cold 
TCA (12.5% w/v). The tubes were left on ice for 5min and then 
centrifuged for 15min in a bench centrifuge. Supernatant (1ml) 
was added to freshly prepared Nash reagent (4M ammonium 
acetate containing 4ml/l acetylacetone, 1ml) and heated in a 
water bath at 58°C for 10 min. After cooling the absorbance at 
412nm was recorded. Blanks and formaldehyde standards 
(0-120nmoles/ml) were carried through the same procedure.
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2.2.7.2 Fluorimetric assays
Determination of alkoxyresorufin 0-dealkylase activity.
The method used was essentially as previously described 
(Burke and Mayer, 1974). The 0-dealkylation of three 
alkoxyresorufins, namely pentoxy-, ethoxy- and
benzoxy-resorufin, was monitored by the generation of 
resorufin. The reactions were followed fluorimetrically using 
a Perkin Elmer LS5 luminescence spectrophotometer set to an 
excitation wavelength of 51Onm, and an emission wavelength of 
586nm with emission and excitation slit widths, 2.5 and 10 nm 
respectively.
The following reagents were added to a 3ml quartz 
fluorimeter cuvette:
0.1M Tris-HCl buffer, pH 7.8 2.00ml
Microsomal suspension (25%) 0.05ml
And either
0.53mM Ethoxyresorufin 3]jl1
or
1 . OOmM Pentoxyresoruf in 5]il
or
I.OOmM benzoxyresorufin 1 0]jl1
A base line was recorded prior to initiation of the 
reaction by the addition of 1 0]jl1 NADPH (50mM in 1% NaHCOs). 
The reaction was monitored continuously and the initial rate 
of the reaction calibrated from the slope. Calibration was 
achieved by adding 10^1 aliquots of resorufin (O.OImM) to an
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incubation mixture comprising all the components except the 
substrate.
Determination of ethoxycoumarin-0-deethylase.
The production of 7-hydrbxycoumarin was followed 
fluorimetrically at the excitation wavelength of 375nm and the 
emission wavelength of 454nm (Ullrich and Weber, 1972). The 
following reaction mixture was prepared in a 3ml fluorimeter 
quartz cuvette:
0.1M Tris-HCl buffer, pH 7.8 1.80ml •
Microsomal suspension (25%) 0.10ml
2.OmM Ethoxycoumarin 0.10ml
A base line was recorded prior to initiation of the 
reaction by the addition of 1 0)jl1 NADPH ( 1 OmM in 1 % NaHCOs ) . 
The reaction was monitored continuously and the initial rate 
of the reaction calibrated from the slope. Calibration was 
achieved by adding lp.1 aliquots of 7-hydroxycoumarin (0.25mM) 
to an incubation mixture comprising all the components except 
the substrate.
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2.2.8 Cytosolic glutathione-S-transferase activity.
Glutathione-S-transferase activity in the cytosolic 
fraction was determined by an adaptation of the method 
described by Habig et al., 1974.
1,2-dichloronitrobenzene (DCNB) is a good substrate for 
many of the glutathione-S-transferase enzymes, with
conjugation resulting in the formation of S-( 2-Chloro, 4-|nitro 
phenyl) glutathione. This can be measured spectrophoto- 
metrically as an increase in absorbance at 2145hm and is 
proportional to the enzyme activity in the sample.
The reaction was carried out at 25®C and involved the 
use of a reference (R) and sample (S) cuvette set up as 
follows :
R S
ml ml
1.8 1 .9
0.1 0.1
0.5 0.5
Ô.1M sodium phosphate buffer, pH 7.5 
25.0mM DCNB (in absolute ethanol)
5.OmM reduced glutathione
After recording a baseline, 0.1ml of cytosolic fraction 
(25%, diluted 1:5), was added to the sample cuvette, mixed, 
and the change in absorbance measured using a Varian 220 
spectrophotometer set at 345 nm. All solutions were prepared 
immediately prior to use and kept on ice.
Glutathione-S-transferase activity was calculated from 
the initial rate of the reaction, assuming a molar extinction 
coefficient of 8. 5 m M ~ c m ~ .
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2.2.9 The Ames Salmonella mutagenicity test.
Mutagenicity was determined by the proceedure of Ames et 
al, (1975) with slight modifications. All glassware and heat 
stable solutions were autoclaved at 120°C for 20 min prior to 
use, and all experimental manipulations were performed in a 
class 2 flow cabinet.
2.2.9.1 The bacterial tester strains.
Salmonella strains TA98r TA98/^ iSUÎlFG TA98NR TA1530, 
TA1535 and TA1538 were stored as permanent frozen culture 
maintained at -80°C using DMSO as a cryopreservative (0.8% 
v/v). When the strains were used, an overnight culture was 
prepared from the frozen stock. This was achieved by 
inoculating nutrient broth containing ampicillin (25^g/ml) or 
nutrient broth without ampicillin for strains TA1530, 1535 and 
1538, with the frozen culture using a platinum loop and 
incubating at 37°C in a shaking waterbath for 10h. The 
resulting culture was either used in the Ames test (2.2.9.3 or
2.2.9.4) or was used to prepare masterplates for future use.
2.2.9.2 Testing for strain properties.
The Salmonella tester strains contain different types 
of histidine mutations, with TA98 and TA1538 able to detect 
frameshift mutagens and TAI00 and TA1535 able to detect 
base-pair substitutions. In addition to this mutation each 
strain also has two other mutations which greatly increase 
their susceptibility to mutagens. These are the loss of 
excision repair system CuvrB) &nd the inability to synthesise 
the lipopolysaccharide cell wall (rfa), In some strains 
sensitivity has been further enhanced by the introduction of a
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plasmid (pKMlOl), which confers both ampicillin resistance and 
an error-prone repair system to the bacteria (Table 2.1). 
Strain TA98NR is a strain that is deficient in nitroreductase 
and strain TA98/1,8DNPe is a strain that is deficient in 
several esterifying enzymes including sulphotransferase and 
0-acetyltransferase (McCoy et al,, 1983).
Table 2.1: Genotypes of the TA strains used.
Histidine mutation LPS Repair R-factor
hisD3052 hisG46
TA1538 TAI535 rfa AuvrB -R
TA98 TA100 rfa AuvrB +R
— -------- TAI530 gal AuvrB -R
TA98NR —  —  — rfa AuvrB +R
TA98 1,8DNP6 --------— rfa AuvrB +R
All strains were originally derived from Salmonella 
typhimurium LT2. The deletion 0) through uvrB also include 
the nitrate reductase ichl) and biotin (bio) genes. The gai 
and the rfa/uvrB strains have a single deletion through gral 
chi bio uvrB, R=pKMl01.
Each new bacterial culture was tested for viability and 
spontaneous mutation rate. Cultures were also routinely 
checked to ensure that all strain characteristics were 
maintained. All tests were performed in duplicate.
Test for histidine requirment: 0.1ml of "test histidine/biotin 
solution" (O.lM histidine and 0.5mM biotin) was spread onto 
the surface of a Vogel Bonner E plate and allowed to dry. An 
overnight bacterial culture was then streaked onto the plate 
and also onto a histidine-free plate. The plates were 
incubated overnight at 37°C. The histidine mutation was still 
present if bacterial growth was observed on the plate 
supplemented with histidine.
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Tests for the rfa mutation and the R-factor: Bacterial culture 
was added (0.1ml) to 2ml of "test" agar (agar 0.6% w/v and 
NaCl 0.5% w/v, containing 5mM histidine and 25pM biotin), and 
immediately poured onto Vogel Bonner E plates. When the agar 
had solidified, a sterile filter paper disc (1 cm in diameter) 
containing either crystal violet (I OOy.1 of a 1 mg/ml solution), 
for the rfa test, or ampicillin (lOOjil of 8mg/ml in 0.02N 
NaOH), for the R factor test, were placed in the centre of the 
plate, which was incubated overnight at 37°C. The presence of 
a clear zone of inhibition around the disc indicated the 
presence of either the mutation or the plasmid.
Test for bacterial viability: The viability of an overnight 
culture was assesed by colony growth on agar (2ml) with a high 
histidine concentration (5mM histidine and 25)iM) . The 
bacterial culture was serially diluted in nutrient broth to a 
final dilution of 1 in 10®. 0.1ml of the final dilution was
added to "test" agar (described above) mixed and poured onto 
Vogel Bonner E plates. These were then incubated overnight, 
after which the total number of colonies was counted and the 
viability (number of bacteria/ml) of the original culture 
calculated.
Test for spontaneous reversion rates: The spontaneous
reversion rate was tested during each Ames test by 
incorporating a blank ie solvent only replacing the mutagen 
solution, into the test. Typical spontaneous reversion rates 
are shown in Table 2.2.
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Table 2.2: Spontaneous reversion rates for typically used 
bacterial strains.
Number of spontaneous revertants per plate
without S9 with S9
Mean Range Mean Range
s. typhimurium 
TA1535 9.9 3-18 11.3 2-21
TAI538 9.8 4-18 11.3 5-22
TA98 20.3 1-46 25.6 7-63
TAI GO 90.3 45-179 100.3 46-184
Table adapted from Venitt et al., (1987).
2.2.9.3 The plate incorporation method.
Top agar (agar 0.6% w/v and NaCl 0.5% w/v, containing 
0.05mM histidine and 0.05mM biotin) were added (2ml/tube) into 
13mm X 100mm capped culture tubes maintained at 45°C. To the 
agar, fresh overnight culture of the tester strain (0.1ml), 
the test mutagen (0.1ml) and the activation system (0.5ml) 
prepared as described below (2.4.8.5) were added. The tubes 
were mixed and were then poured onto Vogel Bonner E plates. 
The plates were incubated at 37°C for 48h. The resulting 
revertant colonies were manually counted using an Anderman 
colony counter.
2.2.9.4 The preincubation method.
The activation system (0.5ml/tube) was added to the 
culture tubes and maintained at 4°C on ice. Fresh overnight 
culture (0.1ml) and test mutagen (0.1ml) were added to the
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activation system, mix^d and incubated at 37®C in a shaking
waterbath, for various time intervals as descibed in each
chapter. On completion of the incubation, top agar (2ml) was
added and the contents of the tubes mixed and poured onto 
Vogel Bonner E plates. The plates were then incubated at 37°C 
for 48h, and the resulting revertant colonies were counted 
using an Anderman colony counter.
In some experiments two incubations were used, in order 
to determine the function of the cytosolic fraction in the 
potentiation of the microsomal-mediated mutagenicity of 
compounds as previously described (Ayrton efc ai., 1987b).
Briefly this involved an initial incubation period with a 
microsomal activation system, as described above, followed by 
the addition of 900]jlM menadione (IOOy.1) to the incubation 
which terminated microsomal metabolism. Subsequently a 
cytosolic activation system (0.5ml/tube) or buffer 
(0.5ml/tube) was added, mixed and then incubated for a further 
period at 37°C. Following the completion of the second 
incubation period, top agar (2ml) was added and the plates 
poured and incubated overnight as described above.
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2.2.9.5 The activation system.
Liver fractions were prepared as described above (2.4.2) 
and a 10% activation system was prepared as follows:
Liver fraction 0.05ml
0.33M KCl 0.05ml
0.08M MgClz 0.05ml
0.20M NaPhosphate buffer, pH 7.4 0.25ml
0.02M NADPH and 0.025M G-6-P 0.10ml
If microsomal suspension was used as the liver fraction, the 
activation system was supplemented with 1 unit of G-6-PDH 
( lunit/pLl) .
This activation system contains 10% liver fraction and is 
termed a 10% activation system. To alter the % composition of 
the activation system, the amount of the liver fraction added 
was changed and the amount of buffer was adjusted such that 
the total volume of the system was unaltered.
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2.2.10 In vitro covalent binding of [*’^ C]IQ to nucleic acid 
catalysed by rat liver fractions.
Liver fractions (S9, microsomes and cytosol) were 
prepared as described (2.4.2). The incubation mixture unless 
otherwise stated contained:
Liver fraction (25%)
Purified calf thymus DNA (2mg/ml) 
['‘‘*C]IQ(1mg/ml; dOpCi/ml)
0.33M KCl 
0.08M MgClz
0.20M NaPhosphate buffer, pH 7.4 
0.02M NADPH and 0.025M G-6-P 
If microsomes were used 
G-6-PDH (lunit/pl)
0.05ml 
0.50ml 
0.05ml 
0.05ml 
0.05ml 
0.25ml 
0.10ml
]^ll
The incubations were carried out in Sterilin tubes, 
covered with aluminium foil, at 37°C. The reaction was 
terminated by extraction with ethyl acetate (1 ml) . DNA was 
purified as described below after removal of the organic 
layer. In control experiments incubations were carried out 
either without the addition of DNA or without the addition of 
the liver fraction.
2.2.11 Purification of DNA.
Proteinase K 1 m l  (1 mg/ml) and 10% SDS (1ml) were added 
to each tube, and the mixture was incubated at 37°C for 1 h. 
The mixture was then extracted twice with phenol saturated 
with 0.1M Tris-HÇl buffer, pH8, and then twice with 
chloroform/isoamyl alcohol (24:1). DNA was precipitated with
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2.5 vol. of ice cold absolute ethanol. The mixture was left 
overnight at -20°C, prior to centrifugation at 9,000rpm in a 
Beckman J2-21 centrifuge at 0°C. The supernatant was decanted 
off and the pellet dried at 45°C under vacuum. The DNA was 
dissolved in distilled water (1ml), and the concentration of 
DNA determined from the UV absorbance at 260nm. An aliquot of 
the mixture (0.5ml) was added to Optiphase scintillation 
cocktail (4.5ml) and radioactivity was determined on an LKB 
1216 rackbeta liquid scintillation counter. The counter was 
calibrated using CCI* as a chemical quenching agent.
Statistical analysis was carried out using the Student's 
t-test.
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CHAPTER 3 : THE ANTIMUTAGENICITY OF VARIOUS PLANT PHENOLS
TOWARDS THE MUTAGENICITY OF THE FOOD MUTAGEN IQ
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3.1 Introduction.
There is increasing evidence linking Chemical components 
of the diet to the genesis of certain types of cancer (Doll 
and Peto, 1981); however evidence has also been produced which 
suggests that protective factors may also exist in the diet 
(Newmark, 1984). Indeed, the consumption of vegetables has 
been correlated with reduced rates of cancers of the stomach 
(Graham et ai., 1972; Haenszel et ai., 1972; 1976), colon
(Modan et ai., 1975; Graham et ai., 1978;) breast (Armstrong 
and Doll, 1975) and prostate (Graham et ai., 1972; Armstrong 
and Doll, 1975; Correa, 1981). Cruciferous vegetable 
consumption, in particular, has been associated with a reduced 
rate of cancer in several studies (Graham et ai., 1972; 1978; 
Modan et ai., 1975; Manousos et ai., 1983). In addition, the 
intake of green and yellow vegetables has been suggested to 
reduce the risk of stomach cancer in non-smokers (Hirayama, 
1977). Many of the putative anticarcinogenic factors have been 
identified by the use of short term assays, particularly the 
Ames test, and it has been demonstrated that several 
inhibitors of mutagenesis, antimutagens, may possess 
anticarcinogenic potential (Hayatsu et ai., 1988). Hence the 
search for antimutagens may be useful in the development of 
anticarcinogenic agents.
Extracts from a number of plants can reduce the 
mutagenicity of a number of diverse genOtoxins (Ishii et al,, 
1984; Kada et ai., 1978; Ames, 1984; Huang et ai., 1985; Kushi 
et ai., 1980; Steele et ai., 1985; Morita et ai., 1978; 
Negishi et ai., 1989b; Tanaka et ai., 1987). Of the many
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plant-derived compounds which have been demonstrated to 
possess anti-mutagenic activity, non-nutritive organic 
compounds such as hydroxylated anthraquinones, ellagic acid, 
tannic acid and hydroxylated cinnamic acids have been shown to 
markedly inhibit the mutagenicity of behzo(a)pyrene
diol-epoxide (B(a)PDE) (Huang et ai., 1985), presumably by
interacting non-enzymically to form products devoid of 
genotoxicity. Furthermore many plant phenols have also been 
identified as antimutagenic agents toward the promutagens 
benzo(a)pyrene (B(a)P) and aflatoxin Bn (Epsino and sullivan, 
1987; San and Chan, 1987; Mandai ét ai., 1987) as well as the 
mutagenicity of the direct acting mutagen
N-methyl-N-nitrosourea (Dixit and Gold, 1986). In this chapter 
studies into the possible antimutagenic effects of naturally 
occurring plant phenols towards IQ and the mechanism by which 
these compounds may inhibit mutagenicity are decribed.
3.2 Materials.
Ellagic acid, menadione, catechin, chlorogenic acid, 
caffeic acid (Sigma Co., Poole, Dorset), anthraflavic acid 
(Alldrich Chemicals, Gillingham) and abscissic acid (Fluka AG, 
Buchs, Switzerland) were all purchased. Salmonella typhimurium 
strain TA98, all other chemicals, reagents, substrates and 
cofactors were obtained as cited in chapter 2 (section 2.1).
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3.3 Methods.
3.3.1 Animals and animal pretreatment.
Male Wistar albino rats (200-230g) were purchased from 
the Animal Breeding Unit, University of Surrey, Induction of 
the mixed function oxidases was achieved by a single i.p. 
administration of Aroclor 1254 (500 mg/kg), as previously
described (section 2.2.1)
3.3.2 Determination of mixed function oxidase activity.
Hepatic fractions were prepared as previously described
(section 2.2.2), and the following determinations 
carried out on the microsomal fraction:
ethoxyresorufin-O-deethylase, pentoxyresorufin-O-depentylase
and NADPH-cytochromec reductase activities, total cytochrome 
P-450 and protein, all as previously described (section 
2.2.7) .
3.3.3 Mutagenicity studies.
Activation of the various carcinogens to reactive 
mutagenic intermediates was determined using the Ames 
test (2.2.9) employing Salmonella typhimurium strain TA98. 
Activation systems contained 10% of the various hepatic 
fractions in the "S9" mix and the plate incorporation 
method was used. When activation systems comprised microsomes 
only, the activation system was supplemented with 1 unit/plate 
of glucose-6-phosphate dehydrogenase. To study the effects of 
various plant phenols on the metabolic activation of IQ to 
mutagens, the plant phenols were added to the activation 
system concurrently with IQ. Plant compounds and IQ were
-'y
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dissolved in DMSO so that less than 100]jl1 of the solvent was 
added to each plate. When the effect of the plant compounds on 
the cytosolic potentiation of IQ was examined (section 
2.2.9.4), IQ, microsomal activation system (10%) and bacteria 
were preincubated for 20 minutes prior to termination of the 
microsomal reaction by the addition of IOOp.1 per plate of 
menadione (900pM). This was followed by the addition of the 
plant compound incorporated in either buffer or cytosol (10% 
activation system).
Tests to determine the effect of magnesium ions on the 
39 mediated activation of IQ and inhibition by ellagic acid, 
were performed as descibed above in the presence or absence of 
MgClz (8mM) in the "S9" mix. ,
3.3.4 Jj2 vifjTO microsomal enzyme inhibition studies.
Studies of the in vitro inhibition of hepatic 
mixed-function oxidase activity involved the incorporation of 
various concentrations of the plant compound dissolved in 10pil 
DMSO into the complete enzyme assay system, prior to the 
addition of NADPH. Inhibition by plant compounds was 
investigated using 4 model microsomal enzyme reactions, 
namely, ethoxyresorufin-O-deethylase, ethoxycoumarin-O-deethy- 
lase, pentoxyresorufin-0-depentylase and the NADPH-dependent 
cytochrome c reductase, which were carried out as previously 
described (2.2.7).
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3.3.5 Molecular shape calculations.
The molecular geometries of anthraflavic and ellagic 
acids were determined using the GOSMIC package (written by 
J.G. Vinter, A.Davies and M.R. Saunders) from Smith, Kline and 
French Ltd. The Pluto crystallographic package was used to 
generate the molecular plots, which are viewed in and 
perpendicular to the molecular plane. The following van der 
Waals radii were used to generate the molecular plots: carbon 
1.6Â, oxygen T.4Â and hydrogen 1.2Â.
3.4 Results.
3.4.1 Inhibition of IQ mutagenicity by plant compounds.
As expected, IQ was a potent mutagen in the presence of 
an hepatic S9 activation system derived from Aroclor 1254 
pretreated rats. Chlorogenic acid, catechin, abscissic acid 
and caffeic acid showed no antimutagenic effects against IQ 
even at the highest concentration, 0.1 mM (Table 3.1). However 
incorporation of ellagic acid and anthraflavic acid into the 
activation system resulted in a marked inhibition of the 
mutagenicity of IQ. None of the plant compounds, at the 
concentrations used, were mutagenic either in the presence or 
absence of an activation system, or demonstrated bacterial 
toxicity.
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3.4.2 Modulation of the activation of IQ to mutagens by the 
plant phenols anthraflavic acid and ellagic acid.
As shown in Fig. 3.1, the inhibition of the mutagenic 
activity of IQ is related to the concentration of both the 
mutagen and the inhibitors, when the S9 fraction is utilized 
as the activation system.
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Figure 3.1; Inhibition of the S9-mediated mutagenicity of IQ by either ellagic acid (a) or 
anthraflavic acid (b).
IQ was incubated with Salmonella typhimurium strain TA98 and an Aroclor 
1254-induced hepatic S9 activation system (10%) in the absence (A) and presence 
of the respective plant phenol at concentrations of 5X10"'^ (■), 10"®M (+),
5X10~®M (♦)! 10“®M (x) and 5X10~®M (•). The plates were incubated for 48h
at 37°C and the induced histidine revertants were counted. Results are 
presented as MeantSD for triplicates. The spontaneous reversion rate of 22±5 
has already been subtracted.
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When the activation system comprised microsomes only, in 
the absence of the soluble fraction, IQ still exhibited a 
mutagenic response which was however markedly lower than that 
observed with the complete S9 system, ie, microsomes plus 
cytosolic fraction. Once again inhibition of the mutagenicity 
was shown to be dependent on the concentration of both the 
inhibitor and mutagen (Fig. 3.2).
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Figure 3.2; Inhibition of the microsomal-mediated mutagenicity of IQ by either ellagic acid 
(a) or anthraflavic acid (b).
IQ was incubated with Salmonella typhimurium strain TA98 and an Aroclor 
1254-induced hepatic microsomal activation system (10% supplemented with 1 
unit/plate glucose-6-phosphate dehydrogenase) in the absence (A) and presence 
of the respective plant phenol concentrations 5 X 1 ( ■ ) ,  10~®M (+), 5X10“®M 
(♦), 10"®M ( X )  and 5X1Q-®M (•). The plates were incubated for 48h at 37°C and
the induced histidine revertants were counted. Results are presented as MeaniSD 
for triplicates. The spontaneous reversion rate of 19±8 has already been 
subtracted.
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When the microsome-mediated activation of IQ was 
terminated by the addition of menadione, subsequent addition 
of the cytosolic fraction into the incubation system resulted 
in an enhanced mutagenic response (table 3.2).
Table 3.2: Cytosolic potentiation of the
microsome-mediated mutagenicity of IQ.
Activation system Histidine revertants/plate
Microsomes + cytosol 253±21
Microsomes + buffer 138±25
Cytosolic potentiation 114±15
IQ (lOng) was pre-incubated for 20 min with 
Salmonella typhimurium strain TA98 and Aroclor 
1254-induced microsomal activation system (10%, 
supplemented with 1 unit/plate glucose-6-phosphate 
dehydrogenase). The reaction was terminated by the 
addition of lOO^ il of menadione (900)iM). Buffer or 
cytosol was then added and a further incubation of 
20 min carried out. Results are presented as Mean 
±S.D. for 3 plates. The spontaneous reversion rate 
of 25±5 has already been subtracted.
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Incorporation of anthraflavic acid into the cytosolic 
fraction resulted in a concentration-dependent decrease in the 
cytosol-mediated potentiation of the mutagenicity of IQ. 
Incorporation of the same concentrations of anthraflavic acid 
into buffer, instead of cytosol had no significant effect on 
the mutagenicity of IQ (Fig. 3.3a). Ellagic acid had no effect 
on the mutagenicity of IQ when it was incorporated into the 
cytosol, however at a concentration of 5X10~®M, ellagic acid 
caused a significant decrease in the mutagenicity when 
incorporate in the buffer (Fig. 3.3b).
300230
400200
è 4
900ISO
200100
a 100a 30
KT*wr*
ANTHRAFLAVIC ACID OONCENTRATICN (M)
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Figure 3.3; Effect of anthraflavic acid and ellagic acid on the cytosolic potentiation of the 
microsome-mediated mutagenicity of IQ.
IQ(IOng) was pre-incubated with Salmonella typhimurium strain TA98 and an Aroclor 
1254-induced hepatic microsomal activation system (10% supplemented with 
1unit/plate glucose-6-phosphate dehydrogenase) for 20min at 37°C in a shaking 
waterbath. The reaction was terminated by addition of lOOpl menadione (900jjM). 
Cytosol (A) or buffer ( ■ )  containing various concentrations of either 
anthraflavic acid (a) or ellagic acid (b) were then added and a further 
pre-incubation at 37®C was carried out for 20min. Control values ie in the 
absense of plant phenol are shown on the Figures. Results are presented as 
HeaniSD for triplicates, the spontaneous reversion rate of 25±7 have already been 
subtracted.
page 78
3.4.3 In vitro modulation of hepatic microsomal enzyme 
activity by anthraflavic and ellagic acids.
Anthraflavic acid gave rise to a marked 
concentration-dependent decrease in the 0-deethylation of 
ethoxyresorufin, with virtually no activity being detectable 
at 50pM. A similar, marked inhibition was also seen with the 
0-deethylation of ethoxycoumarin. In contrast, anthraflavic 
acid had no effect on the O-depentylation of pentoxyresorufin 
even at the highest concentration used (50pM). At the same 
concentration range anthraflavic acid had no effect on the 
NADPH-dependent reduction of cytochrome c (Fig. 3.4).
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Figure 3.4: Inhibition of mixed-function oxidase activity by anthraflavic acid.
Anthraflavic acid was incubated with Aroclor 1254-induced microsomes during the 
determination of the following activities: pentoxyresorufin-O-depentylase (■), 
ethoxyresorufi n-O-deethy 1 ase (A) and NADPH-cytochrome c reductase (•). Control 
activities for the dealkylations of ethoxy-, and pentoxy-resorufin were 
3.85±0.42 and 0.14±0.02 nmol/min per mg protein respectively, and the
NADPH-dependent reduction of cytochrome c was 29.5±1.3 nmol/min per mg protein. 
Results are presented as MeanfSD for three animals.
page 79
Ellagic acid showed no inhibition of the hepatic enzyme 
activities measured (Fig. 3.5).
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Figure 3.5: Inhibition of mixed-function oxidase activity by ellagic acid.
Ellagic acid was incubated with Aroclor 1254-induced microsomes during the 
determination of the following activities: pentoxyresorufin-O-depentylase (■), 
ethoxyresorufinO-deethylase (A) and NADPH-cytochrome c reductase (#). Control 
activities for the dealkylations of ethoxy- and pentoxy-resorufin were 
3.75±0.20, and 0.16±0.06 nmol/min per mg protein respectively, and the 
NADPH-dependent reduction of cytochrome c was 29.7±0.2 nmol/min per mg protein. 
Results are presented as MeaniSD for three animals.
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3.4.4. Modulation of the microsomal activation of Glu-P-1 to 
mutagens by anthraflavic and ellagic acids.
As expected Glu-P-1 was mutagenic in the presence of an 
activation system comprising microsomes from Aroclor 1254- 
pretreated rats. Incorporation of anthraflavic acid, but not 
ellagic acid, into the activation system resulted in a 
concentration-dependent inhibition of mutagenicity (Fig. 3.6)
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Figure 3.6; Inhibition of the microsome-med1ated mutagenicity of Glu-P-1 by either ellagic 
acid (a) or anthraflavic acid (b).
Glu-P-1 was incubated with Salmonella typhimurium strain TA98 and an Aroclor 
1254-induced hepatic S9 activation system (10%) in the absence (A) and 
presence of the respective plant phenol concentrations SXIQ-^M (■), 10~®M (+), 
5X10“®M (♦)! 10“®M (x) and 5X10“®M (•). The results are presented as MeantSD 
for triplicates. The spontaneous reversion rate of 25±6 has already been 
subtracted.
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3.4.5. Molecular shape calculations.
The computer-optimised dimensions of anthraflavic acid 
were: length, 13.6Â; width, 8.2Â; and depth, 3.2Â; giving an 
area/depth ratio of 34.9Â, showing that it is essentially a 
planar molecule (Fig 3.7). The computer-optimised dimensions 
of ellagic acid were: length, 12.1Â; width, 10.2Â; and depth, 
3.2Â; giving an area/depth ratio of 38.6Â, showing that it is 
essentially a planar molecule (Fig 3.8).
Figure 3.7; Space-filled model of anthraflavic acid.
The PLUTO computer program was used to draw the model using the following van der Waals radii to 
generate the computer-graphical plot of the molecular geometry: carbon 1.6Â, hydrogen 1.2Â and 
oxygen 1.4Â.
Figure 3.8: Space-filled model of ellagic acid.
The PLUTO computer program was used to draw the model using the following van der Waals radii to 
generate the computer-graphical plot of the molecular geometry: carbon 1.6Â, hydrogen 1.2Â and 
oxygen 1.4Â.
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3.4.6 Effect of Magnesium ions on the S9-mediated activation 
of IQ to mutagens
Magnesium ions were shown to have no effect on the 
activation of IQ to mutagens by the microsomal fraction (Table 
3.3). Similarly the inhibition of the microsomal-activation of 
IQ by ellagic acid was unaltered by the omission of Mg=+ from 
the activation system.
Table 3.3; Effect of Mg2+ ions on the microsome- 
mediated activation of IQ.
____________________histidine revertants per plate
+ Mgclz - Mgclg
DMSO (50pl) 2711±474 2638±284
Ellagic acid 779±140 736+ 60
(5X10-=M)
IQ (20ng) was pre-incubated for 20 min with bacteria and 
microsomes from Aroclor 1254-pretreated rats in the 
presence or absence of Mgclz. Results are presented as 
Mean ±S.D. for 3 plates. The spontaneous reversion rate 
of 25±5 has already been subtracted.
3.4.7 Effect of preincubation of bacteria with ellagic acid.
Preincubation of the bacteria with ellagic acid, 
followed by successive washing with nutrient broth to remove 
the phenol failed to remove completely the antimutagenic 
effect of ellagic acid (Table 3.4), an effect that was 
dependent upon the concentration of ellagic acid. Incubation 
of bacteria with ellagic acid had no effect on the bacterial 
viability or spontaneous reversion rate.
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Table 3.4: Effect of pretreatment with ellagic a d d  on the response of 
Salmonella typhlmurlum TA98 to the microsome-medlated 
mutagenicity of IQ
Ellagic acid concentration(M)______________________Histidine revertants per plate
0 (DMSO 50pl) 792±60
5X10-7 781±38
5X10-= 734±47
5X10-= 728±50
5X10-* 659±78
Bacteria and ellagic acid were preincubated at 37°C for Ih in a shaking water 
bath. The bacteria were then washed 3 times in nutrient broth prior to use in 
the Ames test. IQ (lOng/plate), the pretreated bacteria and an Aroclor 
1254 microsmal activation system (10%, supplemented with 1 unit of
glucose-6-phosphate dehydrogenase per plate) were incubated for 48h at 37°C. 
The spontaneous reversion rate of 29±9 has already been subtracted.
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3.5 Discussion.
There are many factors that are believed to modulate the 
mutagenicity of many premutagens in the 3a2moneila/mammalian 
microsomal assay system, induced by a wide variety of mutagens 
(Hayatsu et ai., 1988). Such antimutagenic factors have been 
identified in the vegetable component of the human diet. 
Extracts from a number of edible plants have been shown to 
ameliorate the effects of a number of genotoxins. For example, 
Kada and coworkers (1978) reported that the juices prepared 
from a variety of vegetables, when added to the S9 fraction in 
the Ames test, markedly decreased the number of revertants 
induced by the mutagenic components found in tryptophan 
pyrolysate. Not only plant extracts but a number of individual 
compounds from plants, such as plant phenols (Wood et ai.y 
1982), are known to inhibit the mutagenicity of several bay 
region diol-epoxides of polycyclic aromatic hydrocarbons 
(PAHs). In this chapter the effects of several plant phenols 
on IQ-induced mutagenesis in Salmonella typhimurium are 
described. The initial screen for antimutagenic potential 
revealed that at concentrations that may possibly be attained 
in vivo, only two of the tested phenolics, anthraflavic acid 
and ellagic acid showed any significant inhibition of the 
S9-mediated mutagenicity of IQ.
Ellagic acid is a phenolic lactone, that occurs widely 
in woody dicotyledonous plants, where it is present mainly in 
the form of ellagitannins (Haslam, 1979). In addition, high 
concentrations of ellagic acid are found in strawberries, 
grapes and certain nuts (Bate-Smith, 1956). Anthraflavic acid,
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a hydroxylated anthraquinone, is much less common and found 
mainly in rhubarb, in particular the medicinally used Rheum 
officinale (Dawidowicz-Grzegorzewska, 1976). Both compounds 
suppressed the mutagenicity of IQ,* their effect being 
dependent on both the concentration of the mutagen and the 
concentration of the antimutagen. It was demonstrated that 
phenols inhibited mutagenesis independent of whether 
microsomes or S9 fractions were used as the activation system. 
It has previously been shown that many plant-derived 
compounds, such as flavonoids are potent in vitro inhibitors 
of the hepatic, microsomal cytochrome P450 system. As the 
initial step in the metabolic activation of IQ involves a 
cytochrome P450 catalysed N-hydroxylation to yield the 
proximate mutagen (Yamazoe et ai., 1983), the possible
mechanism of in vitro inhibition by the plant phenols on this 
system was examined. Results showed that ellagic acid had no 
inhibitory effect on the cytochrome P450-dependent activities 
studied, such as the 0-deethylation of ethoxyresorufin, which 
is catalysed preferentially by cytochrome P4501 family of 
proteins that also catalyses the microsomal activation of the 
carcinogenic PAH, B(a)P (Phillipson efc ai., 1985). This enzyme 
has previously been shown to be inhibited by ellagic acid 
using B(a)P as a substrate (Mukhtar efc ai., 1984a). However 
this assay gives rise to many products and it is possible that 
some of these products may interact chemically with ellagic 
acid, resulting in loss of fluorescence which may be 
interpreted erroneously as inhibition of metabolism. 
Ethoxyresorufin is a probe for the specific activity of the 
low spin cytochrome P450I protein, cytochrome P450IA1 
(Guengerich efc ai., 1982a; Phillipson efc ai., 1984), and does
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not reflect the activity of the high spin isoenzyme cytochrome 
P450IA2, which more specifically catalyses the N-hydroxylation 
of IQ. The latter may be monitored by determining the 
microsome-mediated activation of the food promutagen Glu-P-1 
in the Ames test (Kato efc al,, 1983; Yamazoe efc ai., 1984). To 
examine the possible inhibition of this cytochrome P450 
protein, inhibition of the N-hydroxylation of Glu-P-1 by 
ellagic acid was examined; once again the phenol showed no 
significant inhibition, and thus it was concluded that ellagic 
acid does not inhibit the cytochrome P450 enzymes active in 
the metabolism of IQ. These results were not as predicted from 
computergraphic techniques, where analysis of molecular 
structure showed ellagic acid to a planar molecule that would 
interact strongly with cytochrome P450I proteins, however the 
very polar nature of the molecule may explain its lack of 
interaction. It is also possible that the insoluble complexes 
formed with Mg=* ions (Press and Hardcastle, 1969) as well as 
the possible hydrolysis of the lactone rings may also 
interfere with the possible interaction of ellagic acid with 
cytochrome P450I proteins.
Anthraflavic acid showed a contrasting picture to that 
obtained with ellagic acid. Using computergraphic techniques 
it was calculated that the anthraquinone has a small depth of 
3.2Â and an area/depth ratio of 34.9Â which places it firmly 
amongst the compounds exhibiting high affinity for cytochrome 
P450I proteins (Lewis efc al., 1986; 1987) and it would be 
expected to interact preferentially with this family of 
proteins as a competitive inhibitor. The results obtained 
confirmed the prediction with anthraflavic acid demonstrating
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potent inhibition of the two cytochrome P450I assays, namely 
the 0-deethylations of ethoxycoumarin and ethoxyresorufin, 
whilst showing no inhibition of the cytochrome P450IIB- 
mediated 0-depentylation of pentoxyresorufin (Lubet efc ai., 
1985). Anthraflavic acid demonstrated potent inhibition of 
cytochrome P450I activity, having an Iso of 10~®M, similar to 
that seen with other established inhibitors of cytochrome 
P450I activities such as ellipticine and its 9-hydroxy 
derivative (Lesca efc ai., 1978; Delaforge efc ai., 1980), 
moreover anthraflavic acid caused a marked concentration- 
dependent inhibition of the microsome-mediated mutagenicity of 
Glu-P-1, hence demonstrating a potent inhibition of cytochrome 
P450IA2. Thus the inhibition of the activation and 
mutagenicity of IQ in the Ames test by anthraflavic acid is 
most probably the result of inhibition of the cytochrome 
P450IA2 mediated N-hydroxylation of IQ to the proximate 
mutagen.
A possible mechanism of action is that anthraflavic acid
interferes with the electron transfer from NADPH to cytochrome
P450 by inhibiting the reductase as is the case with catechin
(Steele efc ai., 1985) and the mutagen quercetin (Buening efc
. ellagic and
ai., 1981). However this was not the case withAanthraflavic 
acids, which is not suprising as the inhibition of cytochrome 
P450 activity was isoenzyme selective with the latter and no 
inhibition was observed with the former.
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A possible alternative mechanism of action might be 
direct interaction with microsome-generated proximate 
mutagen(s) of IQ with the plant phenols to generate an 
inactive complex as shown between B(a)PDE and ellagic acid
out
(Sayer et ai., 1982). This mechanism can be ruled a  for 
anthraflavic acid, by the observation that incorporation of 
anthraflavic acid into the microsomal activation system 
following termination of metabolism failed to decrease the 
mutagenicity of IQ. Ellagic acid on the other hand showed an 
inhibitory effect which was however not concentration- 
dependent and was only significant at the highest 
concentration of the phenol (5X10~®M) suggesting that ellagic 
acid, at least at high concentrations may scavenge a
microsome-generated reactive intermediate. It must be noted 
that although ellagic acid interacted with the B(a)PDE the 
interaction is acid catalysed (Sayer et ai.,1982) proceeding 
only at low pH and not at a pH of 7.4, used here in the Ames 
test, which may be the reason for its poor scavenging activity 
with the reactive intermediates of IQ.
The N-hydroxy derivative of IQ is only the proximate 
mutagen and requires further activation by Aroclor 
1254-inducible cytosolic components to yield further 
metabolites and ultimate mutagenic species (Abu-Shakra et al. , 
1986; Kato, 1986). Anthraflavic acid inhibited the cytosolic 
potentiation of the microsome-generated metabolites of IQ. 
Hence the decrease in S9-mediated (microsomes + cytosol) 
activation of IQ caused by anthraflavic acid can be attributed 
to inhibition of both microsomal and cytosolic activation. 
Ellagic acid, on the other hand, again showed no inhibition.
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Ellagic acid has been shown to complex with divalent 
cations such as magnesium and calcium (Press and Hardcastle, 
1969). As many cytochrome P450 reactions rely upon the 
presence of Mg^^, the effect of ellagic acid on the magnesium 
dependent activation of IQ was examined. The results showed 
that microsome-mediated activation of IQ was equally efficient 
either in the presence or absence of Mg^ *^  and that ellagic 
acid also demonstrated the same degree of inhibition in both 
systems with and without Mg^^y Another possible mechanism of 
antimutagenicity that may explain ellagic acid-mediated 
inhibition of IQ-induced mutagenicity is enhancement of 
detoxication pathways. However this mechanism can be virtually 
excluded in the Ames test as cofactors required for
a
detoxifying conjugation reactions such as glutathione and 
UDPGA are not incorporated into the activation system, hence 
an enhancement in these reactions would not be observed.
It has been suggested that ellagic acid or a metabolite 
mediates the antimutagenic effect by binding to DNA, and 
hence protecting critical binding sites from attack by the 
ultimate mutagen (Teel, 1986; Teel et ai. , 1987), This is one 
of the possible mechanisms of action that cannot be excluded 
it is this mechanism which may be a possible antimutagenic 
action of ellagic acid. A possibility that is partly 
demonstrated by the weak inhibitory effect of ellagic acid 
when preincubated with the bacteria prior to use in the Ames 
test.
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3.6 Conclusions.
In conclusion the present study demonstrates that 2 
naturally occurring plant phenols, anthraflavic and ellagic 
acids are potent inhibitors of the mutagenicity of IQ in the 
Âmes test. Anthraflavic acid acts by virtue of its ability to 
inhibit both the microsomal and cytosolic activation pathways. 
Ellagic acid and/or a metabolite exerts their effect by a 
mechanism that remains elusive but by experimental exclusion 
is probably due to its ability to bind reactive intermediates 
and/or to bind to critical sites on the DNA. However this is 
only a hypothesis which requires further analysis and which 
could be best elucidated using radiolabelled ellagic acid and 
analysing the extent of DNA binding and its relationship to 
antimutagenicity. As an antimutagen^ anthraflavic acid has the 
potential to inhibit a wide range of mutagens requiring 
cytochrome P4501 proteins for their activation to mutagenic 
species. Since plant phenols have demonstrated antineoplastic 
properties in vivo (Lesca, 1983; Muhktar et al., 1984b; 1986; 
1988), the possible effects of anthraflavic and ellagic acids 
on IQ-induced neoplasia merits further investigation.
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THE EFFECTS OF I.P. ADMINISTRATION OF THE
ANTIMUTAGENIC PLANT PHENOLICS:ANTHRAFLAVIC ACID
AND ELLAGIC ACID ON THE ACTIVATION OF THE
CARCINOGEN IQ.
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4.1 Introduction.
Ellagic acid and anthraflavic acid, two naturally 
occurring plant phenols have been shown to possess potent in 
vitro antimutagenic activity against IQ (chapter 3; Ayrton et 
ai., 1987a; 1988a). However, antimutagenic activity recognised 
using in vitro techniques such as the Ames test cannot 
immediately be translated into anticarcinogenicity; such a 
possibility must be explored experimentally.
The first report of the antitumour activity of ellagic 
acid was by Bhargava and Westfall (1968); ellagic acid, 
administered i.p., was shown to depress the growth of 
spontaneous and transplanted mammary tumours in mice. 
Furthermore ellagic acid applied subcutaneously protected 
against 3-methylcholanthrene (3MC)-induced skin tumours in a 
complete carcinogenesis model using BALB/c mice (Muhkhtar et 
ai., 1984b). In other studies administration of ellagic acid 
inhibited the formation of skin tumours induced in mice by 
7,12-dimethybenzo(a)anthracene and benzo(a)pyrene diol-epoxide 
(B(a)PDE), oesophageal carcinoma induced by methyIbenzyl- 
nitrosamine in rat (Mandai et ai., 1986; Barch and Fox, 1988a) 
and polycyclic aromatic hydrocarbon (PAH)-induced lung tumours 
in mice (Lesca, 1983). Finally ellagic acid exhibited a 
moderate anti-tumour effect against B(a)PDE in the lungs and 
skin of new-born mice; however, no inhibition was observed 
when the parent compound, benzo(a)pyrene (B(a)P) was used 
(Chang et ai., 1985), nor did ellagic acid exhibit an 
anti-tumour effect againt 3MC-induced skin tumour formation.
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Anticarcinogens are thought to act through one or more 
of the following mechanisms; a) inhibition of enzymes 
participating in the metabolic activation of a chemical 
carcinogen, b) enhancement of a metabolic pathway leading to 
detoxication of the carcinogen, c) direct interaction with the 
reactive intermediates rendering them inactive and d) blocking 
the carcinogen target sites on informational molecules such as 
DNA. In experiments designed to elucidate the mechanism of the 
anticarcinogenic action of plant phenols, ellagic acid and 
anthraflavic acid have been demonstrated to inhibit the 
epidermal and lung metabolism and DNA binding of B(a)P in mice 
(Muhktar et ai.y 1984a; 1984d; Shugart and Kao, 1984; Teel et 
al., 1985; Del Tito et ai., 1983). Similarly we had previously 
demonstrated that anthraflavic acid inhibited the metabolic 
activation of IQ to mutagens by preferential interaction with, 
and inhibition of the cytochrome P450I proteins (Ayrton et 
ai., 1987a; 1988a), a mechanism which may occur in vivo thus 
affording protection against the carcinogenicity of compounds 
that require activation by cytochrome P450I. On the other 
hand, ellagic acid exerted its antimutagenic effect, at a 
post-activation stage demonstrating no potential to inhibit 
cytochrome P450-mediated reactions (chapter 3).
In this chapter, the possible anticarcinogenic activity 
of the two antimutagens, ellagic acid and anthraflavic acid 
towards IQ, was investigated following pretreatment of animals 
with the antimutagen and subsequent use of their hepatic 
subcellular fractions as activation systems in the Ames test. 
Their effects on activation and detoxication enzymes were also 
investigated.
page 94
4.2 Materials.
Ellagic acid, menadione, reduced glutathione (Sigma Co., 
Poole, Dorset, U.K.), anthraflavic acid (Aldrich* Chemicals, 
Gillingham, U.R) were all purchased. Salmonella typhimurium 
strain TA98, all other chemicals, reagents, substrates and 
cofactors were obtained as cited in chapter 2.
4.3 Methods.
4.3.1 Animals and animal pretreatment.
Male wistar albino rats (150-180g), obtained from the Animal
Breeding Unit, University of Surrey, received single daily, 
i.p. administrations of anthraflavic acid (IGOmg/kg) or 
ellagic acid (100mg/kg) for five days, whilst controls 
received the corresponding volume of vehicle, namely 0.9% w/v 
NaCl in 0.ImM phosphate buffer pH7.4. Animals were killed by
cervical dislocation 24h after the final dose.
4.3.2 Determination of mixed function oxidase activity.
Hepatic fractions were prepared as previously described 
(section 2.2.2), and the following determinations 
carried out on the microsomal fraction: ethoxycoumarin-O-de- 
ethylase, ethoxyresorufin-O-deethylase, pentoxyresorufin-O-de- 
alkylase, NADPH-cytochrome c reductase, total cytochrome P-450 
and protein, all as previously described (section 2.2.7).
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4.3.3 Determination of cytosolic enzyme activity.
Cytosolic fractions were prepared as previously described and 
glutathione-S-tranferase activity and total cytosolic protein 
determined as previously described (section 2.2.8).
4.3.4 Western blot analysis of microsomal cytochrome P450 
proteins.
Hepatic microsomal suspensions (2mg microsomal 
protein/ml) isolated from control, anthraflavic acid, ellagic 
acid, 3MC- and phénobarbital (PB)-pretreated rats were 
solubilized as previously described (section 2.2.4), by 
incubation at 4°C for 40 minutes with cholate (Img sodium 
cholate/mg microsomal protein) and Emulgen 911 (0.14% v/v) and 
treated with SDS prior to separation by SDS-PAGE 
electrophoresis. Separated proteins were transferred overnight 
onto nitrocellulose paper and immunostained as described 
previously (section 2.2.5 and 2.2.6).
4.3.5 Mutagenicity studies.
Metabolic activation of the various carcinogens to 
reactive mutagenic intermediates was determined using the 
Ames test (section 2.2.9) employing Salmonella typhimurium 
strain TA98. Activation systems contained 20% of the various 
hepatic fractions in the "89" mix and the Ames test was 
performed using a 60min pre-incubation period at 37°C in a 
shaking water bath.
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4.4 Results.
4.4.1 Effect of administration of plant phenols on total body 
weight and some liver parameters.
Pretreatment of rats with anthraflavic acid had no 
significant effect on body weight, total cytochrome P450, 
protein levels, NADPH-cytochrome c reductase or total 
microsomal protein; however a significant increase was 
observed in the liver/body weight ratio (table 4.1).
Table 4.1: Effect of anthraflavic and ellagic acids on some rat liver parameters
Results are presented as Mean ±SEM for five animals. Animals were given 
intraperitoneal doses of the phenol (100 mg/kg) daily for five days while controls 
recieved the corresponding volume of vehicle, namely 0.9% w/v PBS. All animals were 
killed 24h after the last administration i.e. on the sixth day.
Parameter Control Anthraflavic
acid
Ellagic
acid
Body weight gain (g) 6.6±5.5 3.0+2.5 -8.0±3.0*
Liver weight (g) 7.8±0.3 8.5±0.3 7.5±0.3
Liver/body weight X 100 4.7±0.1 5.3±0.2* 5.3±0.2“
NADPH-cytochrome c reductase 
(nmol/min/mg protein)
18.5±1.6 15.4±0.5 11.9±0.3
Total cytochrome P450 
(nmoles/mg protein)
0.47±0.01 0.52±0.04 o.25±o.or
Cytosolic protein 
(mg/g liver wet wt.)
88.9±4.6 80.9±5.9 66.5±2.2*
Microsomal protein 
(mg/g liver wet wt.)
17.8±1.B 15.7±2.0 13.8±0.4
* P<0.05
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Pretreatment of rats with ellagic acid gave rise to a 
significant decrease, in total cytochrome P450 levels and 
total microsomal protein. Similarly a significant decrease in 
body weight during the ellagic acid treatment period was 
observed but,in contrast there was a significant increase in 
the liver/body weight, ratio. NADPH-cytochrome c reductase was 
unaffected by ellagic acid treatment.
4.4.2 Effect of plant phenols on rat hepatic microsomal enzyme 
activities.
Pretreatment of rats with anthraflavic acid resulted in 
a significant increase in ethoxyresorufin-O-deethylase and 
ethoxycoumarin-O-deethylase, which was evident both when 
expressed in terms of total cytochrome P450 levels and total 
microsomal protein (Table 4.2). An increase in the 
0-depentylation of pentoxyresorufin was also observed which, 
however, was not statistically significant (p>0.05). Ellagic 
acid, however, gave rise to a marked decrease in all enzyme 
activities studied when expressed in terms of microsomal 
protein, but not when activities were expressed per nmol total 
cytochrome P450.
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Table 4.2: Hepatic microsomal and cytosolic drug metabolism following treatment
of rats with anthraflavic and ellagic acids
Results are presented as Mean ±SEM for five animals. Animals were given 
intraperitoneal doses of the phenol (100 mg/kg) daily for five days while controls 
recieved the corresponding volume of vehicle, namely 0.9% w/v phospate buffered 
saline. All animals were killed 24h after the last administration i.e. on the sixth 
day.
Parameter Control Anthraflavic
acid
Ellagic
acid
Ethoxycoumarin 0-deethylase
(pmol/min/mg pt) 41.8± 7.4 86.6± 13.2*
ipmol/min/nmol P450) 89.0±12.8 164.7± 17.8*
Ethoxyresorufin 0-deethylase
{pmol/min/mg pt) 92.0± 0.1 314.0± 50.0*
{pmol/min/nmol P450) 200.0±10.0 590.0±100.0*
Pentoxyresorufi n 0-depentylase
{pmol/min/mg pt) 15.0± 2.4 30.9± 7.8
{pmol/min/nmol P450) 33.3± 5.9 58.8± 13.2
20.3± 3.4* 
88.9±23.9
68.0±10.0
270.0±40.0
11.1± 0.9 
45.7± 3.6
Glutathione S-transferase(DCNB) 
{nmol/min/mg pt) 77.7± 4.8 71.2± 11.3 54.1± 4.5*
*• P<0.05
4.4.3 Effect of plant phenols on the levels of hepatic 
cytochrome P450I and P450IIB apoproteins.
When solubilised microsomes were resolved by SDS-PAGE 
employing 10% gels, blotted onto nitrocellulose paper and 
probed with antibodies against cytochrome P450I proteins, it 
could be seen that the low spin P450IA1 and the high spin 
P450IA2, were clearly induced by anthraflavic acid 
pretreatment, when compared to controls (Fig. 4.1 ). 
Microsomes from 3MC-treated rats, used as a positive control, 
gave the expected responses.
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Figure 4.1: Immunoblot analysis employing anti-cytochrome P450IA1 polyclonal antibodies of solubilised 
hepatic microsomes derived from rats pretreated with either anthraflavic or ellagic acid.
Solubilised microsomes were resolved by 10%(w/v) SDS-PAGE and transferred electrophoretically 
to nitrocellulose. The immunoblot was carried out with sheep anti-cytochrome P450IA1(diluted 
1:12,000) followed by peroxidase-labelled donkey anti-sheep IgG(diluted 1:1,000). Solubilised 
microsomes were loaded as follows: Lane 1, anthraflavic acid (lOpg protein). Lane 2,
phenobarbitone (2.5pg protein). Lane 3, 3-methylcholanthrene (2.5pg protein), Lane 4, ellagic 
acid (lOpg protein). Lane 5, isosafrole (2.5pg protein) and Lane 6, control (lOpg protein). 
Bands are labelled a and b to show cytochromes P450IA1 and A2 respectively.
Figure 4.2: Immunoblot analysis employing anti-cytochrome P450IIB1 polyclonal antibodies of solubilised
hepatic microsomes derived from rats pretreated with either anthraflavic or ellagic acid.
Solubilised microsomes were resolved by 10%(w/v) SDS-PAGE and transferred electrophoretically 
to nitrocellulose. The immunoblot was carried out with sheep anti-cytochrome P450IIB1(diluted 
1:2,000) followed by peroxidase-labelled donkey anti-sheep IgG(diluted 1:1,000). Solubilised 
microsomes were loaded as follows; Lane 1, ellagic acid (lOpg protein). Lane 2 phénobarbital 
(2.5pg protein), Lane 3, anthraflavic acid (lOpg protein) and Lane 4, control (lOpg protein). 
Bands are labelled a and b to show cytochrome P450IIB1 and B2 proteins respectively.
When the transferred proteins were probed with 
antibodies against cytochrome P450IIB there was no obvious 
difference between the anthraflavic acid-pretreated microsomes 
and control (Fig. 4.2 ), however microsomes from ellagic 
acid-treated animals showed a small decrease in the levels of 
both P450IIB proteins. Microsomes from PB-treated rats, used 
as a positive control, gave the expected response.
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4.4.4 Effect of plant phenols on the hepatic microsomal 
activation of Glu-P-1 to mutagens in the Ames test.
Isolated microsomes from anthraflavic acid pretreated 
rats were markedly more efficient in activating Glu-P-1 to 
mutagens in the Ames test (Fig. 4.3). Ellagic acid on the 
other hand showed no significant change in the microsomal 
activation of Glu-P-1 when compared to control microsomes. 
Results are expressed as revertants/nmol total cytochrome 
P450.
6000
5000 ■
I
4000 ■
3000
2000
1000
ELLAGIC ACID ANTHRAFLAVIC ACID
ANIMAL PRBTKEAaWEOT
Figure 4.3: The activation of Glu-P-1 to mutagens by control anthraflavic acid and ellagic acid prtreated
microsomal preparations
The metabolic activation of Glu-P-1 to mutagens in the Ames test was determined 
using Salmonella typhimurium strain TA98. Bacteria, microsomal activation 
systems(20%) and Glu-P-1(2pg/plate) were preincubated for 60 min at 37°C in a 
shaking waterbath. Microsomes were obtained from either control, anthraflavic acid 
or ellagic acid pretreated rats. The spontaneous reversion rate of 15±4 has already 
been subtracted. Results are presented as MeantSD for triplicates
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4.4.5 Effect of pretreatment with anthraflavic acid on the 
hepatic activation of IQ to mutagens in the Ames test.
When IQ was employed as the mutagen, anthraflavic 
acid-induced S9 preparations (microsomes + soluble fraction) 
were more effective than control in converting it to mutagens. 
A similar, but less pronounced, increase was seen when 
microsomes only were used as the activation system (Fig. 4.4/).
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Figure 4.4: The activation of IQ to mutagens by hepatic microsomal and S9 preparations from control and
anthraflavic acid-treated rat
The mutagenicity of IQ in the Ames test was determined using Salmonella typhimurium 
TA98 and 20% activation systems either S9(b) or microsomes(a). Hepatic fractions 
wer^ derived from either control ( A )  or anthraflavic acid-troted rats (□). When 
microsomes were used for activation, activation systems were supplemented with 1 
unit/plate glucose-6-phosphate dehydrogenase. Activation system, IQ and bacteria 
were preincubated for Ih at 37°C in a shaking water bath. The spontaneous reversion 
rate of 26±4 has already been subtracted. Results are presented as MeantSD for 
triplicates.
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When IQ was preincubated with microsomes and the 
microsomal metabolism terminated by the addition of menadione 
prior to supplementation of the activation system with cytosol 
from either control or anthraflavic acid treated rats, it was 
evident that the latter was markedly more efficient in 
potentiating the mutagenicity of IQ (Fig. 4.5).
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Figure 4.5: Effect of treatment with anthraflavic acid on the cytosolic potentiation of the mutagenicity 
of IQ
IQ (200ng) was preincubated at 37°C for Ih with bacteria and microsomes from either 
control or anthraflavic acid-treated animals. The reaction was terminated by the 
addition of lOOpl menadione (900pM). Bufferfg) or cytosol from either control(g) or 
anthraflavic acid-treated rats were added and a further Ih incubation at 37°C was 
performed. The spontaneous reversion rate of 20±5 has already been subtracted.
Results are presented as MeaniSD for triplicates.
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4.4.6 Effect of plant phenols on hepatic soluble cytosolic 
glutathione-s-transferase activity.
Anthraflavic acid pretreatment had no effect on 
glutathione transferase activity (table 4.2), but ellagic acid 
pretreatment gave rise to a marked decrease in this activity 
which was paralleled by a significant decrease in cytosolic 
protein.
4.5 Discussion.
Several plant phenols have been shown to inhibit the 
mutagenicity of various, structurally diverse genotoxins (see 
section 1.15 for review) and it is claimed that these 
compounds by virtue of their abilities to inhibit mutagenesis 
in vitro, may prove to be anticarcinogenic in vivo. Hence many 
compounds have been screened in vitro for antimutagenic 
activity. In the previous chapter the antimutagenic potential 
of some dietary plant phenols toward the mutagenicity of IQ 
was investigated with ellagic and anthraflavic acids 
demonstrating potent antimutagenic activity. These two 
compounds were administered i.p. to rats and the resulting 
effects on the activation of food mutagens and carcinogen 
metabolising enzymes were studied.
Anthraflavic acid has previously been demonstrated to 
inhibit IQ-induced mutagenicity, as predicted by
computergraphic techniques, by specifically inhibiting the 
N-hydroxylase activity of cytochrome P450IA2 (Ayrton et al,, 
1987a; chapter 3), and this may be a possible mechanism by 
which anthraflavic acid could inhibit carcinogenesis.
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Pretreatment of rats with anthraflavic acid enhanced the 
microsomal 0-deethylation of ethoxyresorufin, a reaction which 
is exclusively catalysed by the cytochrome P4501 proteins, 
particularly by the low spin form cytochrome P450IA1
(Guengerich et ai., 1982a; Phillipson et ai., 1984). A similar 
increase was also seen in the 0-deethylation of ethoxy­
coumarin, a reaction which is again predominantly catalysed by 
cytochrome P450I proteins (Guengerich et ai., 1982a). 
Furthermore, pretreatment of rats with anthraflavic acid 
resulted in a marked increase in the ability of hepatic 
microsomal fractions to activate Glu-P-1 to mutagens in the 
Ames test, the activation being specifically catalysed by the 
high spin form of cytochrome P4501, cytochrome P450IA2
(Yamazoe et ai., 1984). These results suggest that 
anthraflavic acid stimulates the synthesis of the two forms of 
cytochrome P450I proteins, a result that was confirmed by 
western blot analysis using antibodies that recognize both 
isoenzymes (Rodrigues et ai., 1988).
Anthraflavic acid treatment resulted in a small but not 
significant increase in the 0-depentylation of 
pentoxyresorufin which although a substrate preferentially 
catalysed by the PB-inducible cytochrome P450IIB, is also 
catalysed to some extent by cytochrome P4501 (Lubet et ai., 
1985). The lack of induction of the cytochrome P450IIB
proteins was confirmed by western blot anlysis, thus 
demonstrating that anthraflavic acid, a rigid planar molecule 
(Ayrton et ai., 1987a) is a specific inducer of the cytochrome 
P450I family. This result was not surprising as many other 
planar inhibitors of cytochrome P450I proteins, such as
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ellipticine and methylenedioxyphenyl compounds, have an 
inhibition phase when administered in vivo, which is followed 
by an induction phase (Phillipson et ai., 1982; loannides et 
ai., 1985; Cresteil et ai., 1982). Moreover, structural 
studies have demonstrated that the overall conformation of the 
active site of P450I proteins is essentially the same as that 
of the Ah receptor, hence substrates and competitive 
inhibitors of this protein family, have molecular structures 
that may lead to the increased synthesis of cytochrome P4501 
proteins (Lewis et ai., 1986; 1987).
Since the P450I proteins play a major role in the 
activation of many groups of environmental chemical 
carcinogens (loannides and Parke, 1987), induction of these 
isoenzymes can be associated with enhcinced carcinogenic risk. 
However this is a strongly controversial point as some groups 
associate an induction with a decrease in cancer risk. This 
controversy arises from the fact that substrates and 
inhibitors of an enzyme frequently induce that enzyme in vivo 
on repeated exposure. Thus a single dose of an inhibitor 
administered shortly before or concurrently with the substrate 
will lead to a reduction in metabolism. In the case of a 
carcinogen this would result in decreased carcinogenic 
activity if the inhibitor specifically supresses activation 
(Gelboin et al 1970; Miller et al., 1958; Richardson, 1952; 
Meecham et al,, 1953; Wattenberg and Leong, 1970). However 
repeated administration, as would be the case with a dietary 
inhibitor, will lead to induction of enzyme synthesis, as 
shown with anthraflavic acid inducing cytochrome P450I, which 
will result in enhanced metabolism and increased carcinogenic 
activity of many chemical carcinogens ,
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An additional argument put forward for cytochrome 
P450I inducers causing a decrease in carcinogenesis stems, 
from the fact that many inducers of this system may also 
result in increased synthesis of detoxifying enzymes such as 
the glutathione-S-transferases and DT-diaphorase, as shown 
with administration of the potent cytochrome P450I inducer 
Sudan III (Fujita efc ai., 1988). However, it has previously 
been demonstrated that while microsomal enzymes such as 
cytochrome P450, can readily be induced at very low doses 
(Phillipson et ai., 1984), phase II enzymes are relatively 
resistant to induction (Thompson et ai., 1982). Indeed in the 
case of administration of anthraflavic acid, no change was 
seen in glutathione-S-transferase activity.
Finally although induction of phase II conjugation 
reactions enzymes has been shown to play an important role in 
the deactivation of polycyclic aromatic hydrocarbons (Oesch et 
ai., 1988) they have not been shown to have a significant role 
in the deactivation of heterocylic aromatic amines (section
1.11.2). In fact glutathione has been shown under certain 
conditions to enhance the activation of Trp-P-2 to bacterial 
mutagens (Saito et ai., 1984b). Bearing in mind that 
cytochrome P450I proteins play a large role in the metabolic 
activation of chemical carcinogens, and the fact that mice, 
sensitive to cytochrome P450I induction, the Ah "responsive" 
mice are more susceptible to chemically-induced tumourigenesis 
than "non-responsive" mice (Nebert et ai., 1974; 1978a; 1978b; 
Levitt et ai., 1979; Kouri et ai., 1974; 1973a; 1973b), it is 
probable that induction of this cytochrome P450 family plays a 
major role in enhancing an individuals susceptibility to
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carcinogenesis. Thus the inducing action of the in vitro 
antimutagen anthraflavic acid, is more likely to enhance the 
initiation of carcinogenesis by stimulating carcinogen 
activation, rather than act as an anticarcinogen.
Anthraflavic acid, in addition to its enhancing effect
on the microsomal activation of IQ, also enhanced the
cytosolic potentiation of its mutagenicity. The enhancement 
was seen regardless of whether the microsomal metabolites were 
generated by control or anthraflavic acid-induced microsomes. 
This finding may reflect an alteration in the metabolism of 
menadione, used to terminate microsomal metabolism, leading to 
a decrease in the extent of inhibition of cytochrome P450. 
Alternatively anthraflavic acid, like other quinones, may 
alter the oxidation status of the cytosol and consequently 
influence the oxidative/reductive enzymes that may be involved 
in the mutagenic response of IQ. It has been demonstrated that 
a redox enzyme SOD can enhance the formation of stable nitroso 
derivatives from parent N-hydroxylamines eg, N-hydroxy Trp-P-2 
which may act as a reservoir of mutagenic intermediates 
(Hiromoto et al,, 1988)
Ellagic acid has been shown to inhibit the mutagenicity
of chemicals by several mechanisms; inhibition of metabolic
activation (Del Tito at al,, 1983; Barch and Fox, 1988; 
Mukhtar at al., 1984a; 1984d; Das at al., 1985b; 1987),
scavenging of reactive intermediates, as in the case of B(a)P 
(Sayer at al., 1982) and finally by binding to critical sites 
on DNA thus preventing attack from reactive carcinogenic 
intermediates (Teel at al., 1987; Teel, 1986). Antimutagenic
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compounds have also demonstrated anticarcinogenic properties 
in vivo resulting in the inhibition of carcinogenesis by many 
chemical carcinogens (Lesca, 1983; Muhktar et al., 1984b; 
1986; Mandai et a i 1986). To investigate the effect of 
ellagic acid on the hepatic activation of IQ, ellagic acid was 
administered i.p. using a dose-regimen successfully employed 
in antitumorigenicity studies (Lesca, 1983). Administration of 
ellagic acid to rats at this dose, caused a decrease in body 
weight, which was accompanied by significant decreases in 
some rat liver parameters, such as total cytochrome P450, 
cytosolic and microsomal protein levels and
glutathione-S^transferase activity. These results indicate 
that ellagic acid administered i.p. for 5 days at 100 
mg/kg/day is toxic, lending support to the toxicity seen in 
previous studies conducted in mice (Lesca, 1983) where 
ellagic acid inhibited B(a)P-induced neoplasia.
In agreement with studies performed in mice (Das et al., 
1985a), intraperitoneal administration of ellagic acid 
resulted in a significant decrease in the 0-deethylation of 
ethoxycoumarin. Similarly decreases in both pentoxyresorufin 
0-depentylase and ethoxyresorufin 0-deethylase activities were 
observed in the present study, decreases that were less 
significant when expressed in terms of total cytochrome P450. 
The microsomal activation of Glu-P-1 was also similarly 
affected by treatment with ellagic acid, showing however 
control levels of activation when expressed per nmol P450. The 
results also showed a decrease in total hepatic cytochrome 
P450, which was also demonstrated by Das at al. (1985a), in 
both liver and lung, who concluded that this decrease in
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cytochrome P450 was a beneficial effect, as it appeared to 
selectively decrease cytochrome P450I activities could explain 
the decrease in PAH-induced tumourigenesis (Lesca, 1983). 
However the activities reported by Das and co-workers have 
poor specificity for individual isozymes of P450, whereas in 
the present employing specific chemical and immunological 
probes, a general decrease in both hepatic cytochrome P4501 
and P450IIB activities and apoproteins levels was observed. 
This effect of ellagic acid administration is obviously an 
undesirable effect as not only are there many endogenous roles 
of cytochrome P450 which may be adversely affected but also 
many of the isozymes of cytochrome P450 that are involved in 
the detoxication of chemical carcinogens and toxins may be 
similarly affected.
The absorption of i.p. administered ellagic acid was 
poor as a large proportion of the administered dose was
observed as solid yellow flecks remaining in the abdominal 
cavity, in agreement with a previous report using CD-I mice 
(Smart et ai,, 1986a). Orally administered ellagic acid is
also very poorly absorbed (Smart et ai. 1986a; Teel and
Martin, 1988) and, in addition, is rapidly eliminated 
regardless of the route of administration. These results show 
that the poor absorption and rapid elimination of ellagic acid 
would make it difficult to achieve tissue concentrations high 
enough to inhibit the carcinogenic process, especially as the 
main exposure to ellagic acid is via very low levels in the
diet, mainly in the form of ellagitannins. Ellagic acid is a
weak organic acid that is ionised at physiological pH (Sayer 
et al., 1982) and forms poorly soluble complexes with divalent
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cations (Press and Hardcastle, 1969; Bock et al., 1981), 
factors that will impair its absorption and may also prevent 
the antitumour activity of the phenol. The poor absorption is 
further highlighted by several reports of ellagic acid calculi 
(bezoars) in the gastrointestinal tract of monkeys and goats, 
whose natural diet contains high levels of ellagic acid (Van 
Tassel, 1973). The poor absorption and distribution could 
account for the lack of inhibition of DNA-bound adduct 
formation from B(a)P (Smart et al., 1986b) and the lack of 
effect on the tumourigenicity of B(a)P in mice (Chang et al., 
1985). Smart et ai. (1986b) were also unable to demonstrate 
any inhibitory effect of ellagic acid on 3MC-induced skin 
tumourigenesis in either CD-I or BALE/c mice, results which 
directly conflict with earlier work by (Mukhtar and
co-workers (1984b; 1986). The latter group (Das et ai., 1985a) 
also described a decrease in cytochrome P450 levels and 
associated activies in mice orally treated with ellagic acid, 
the decrease in cytochrome P450 levels and activities being 
greater than when ellagic acid was administered i.p. a result 
that does not correlate with the poor absorption of the phenol 
from the gastrointestinal tract.
The present studies have shown a decrease in
glutathione-S-transferase activity which is in contrast to 
previous studies (Das et ai., 1985), which show induction 
following i.p. administration of ellagic acid. The differences 
between our results and those reported by Mukhtar and
coworkers (Das efc al., 1985) may be the attributed to species 
and dose differences, but bearing in mind discrepancies 
between anti-tumourigenic. results obtained by Muhktar and
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coworkers and Smart and coworkers, using the same experimental 
procedures (Muhktar et al., 1984b; Smart efc al., 1986b), it 
may be the result of other more fundamental differences. 
Ellagic acid has recently been shown to enhance metastasis of 
tumour cells (Agostino and Agostino, 1980) and this together 
with its apparent toxicity, ability to complex with essential 
divalent cations and the fact that onë mechanism by which it 
inhibits mutagenicity is by covalent binding to DNA, which may 
also lead to alterations in DNA replication and translation, 
makes ellagic acid a very unlikely candidate for an 
anticarcinogenic agent.
4.6 Conclusions.
In summary, ellagic acid and anthraflavic acid, potent 
in vitro antimutagens, not only may have no beneficial effects 
in vivo but can elicit undesirable effects. Ellagic acid, when 
administered at a concentration that may provide adequate 
tissue concentrations to inhibit initiation of carcinogenesis, 
proved to be toxic to the liver giving rise to a non-selective 
decrease in enzyme activities. Anthraflavic acid a potent 
antimutagen was shown to selectively induce carcinogen 
activating enzymes ie., cytohrome P450I proteins and hence it 
may not only afford no protection against cancer in vivo but 
may actually act as a cocarcinogen. As many antimutagens so 
far discovered are structurally similar, extreme caution must 
be exercised when antimutagenic compounds evaluated in vitro 
are described as possible anticarcinogenic agents and their 
mechanism of inhibition extrapolated to in vivo situations. It 
is still possible that these compounds may play a role in
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inhibition of absorption and/or inhibit the formation of 
carcinogens in the gastrointestinal tract but as far as the 
liver is concerned presently studied antimutagens would appear 
to offer no protection against hepatocarcinogenesis in vivo. 
To examine the possible anti-initiator effects of chemicals it 
would be more rational to study the compounds in vivo, using 
different dose regimens of carcinogen and potential 
anticarcinogen ie, administer the phenol prior to, subsequent 
to and concurrent with the administration of chemical 
carcinogens, rather than waste time relying on inappropriate 
in vitro test systems such as the Ames test.
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CHAPTER 5 : MECHANISM OF THE IN VITRO ANTIMUTAGENIC ACTION OF
RETINOL
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5.1 INTRODUCTION
The carcinogenicity of chemicals is profoundly 
influenced by the diet which may afford protection against, or 
potentiate their effect (Parke and loannides, 1981). 
Deficiencies in certain nutrients such as vitamin A have been 
closely associated with increased susceptibility to the 
carcinogenicity of a variety of chemicals; thus vitamin A has 
been regarded as an anticarcinogen (Bollag and Hartmann, 
1983).
There is evidence to suggest that vitamin A does not 
influence the initiation stage of chemical carcinogenesis but 
expresses its anticarcinogenicity through inhibition of the 
promotion stage, by virtue of its role in the control of 
differentiation of epithelial tissues (Sporn and Roberts, 
1983). Indeed, vitamin A was effective in preventing 
chemically induced cancer even when administered to animals 
following completion of the treatment with a carcinogenic 
initiator (Grubbs efc al., 1977). Moreover, vitamin A 
deficiency failed to alter the mixed-function oxidase and 
glutathione transferase activity, two of the most important 
enzyme systems involved in the activation and detoxication of 
chemical carcinogens (Ayalogu efc al., 1987; Rozman efc al., 
1987) .
However, in studies employing histidine reversion in the 
Ames test as the biological end point, vitamin A has been 
shown to inhibit the mutagenicity of environmental 
precarcinogens such as 3-methylcholanthrene (Quin and Huang,
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1985), o-aminoazotoluene (Busk and Ahlborg, 1982b) as well as 
food mutagens such as aflatoxin Bn (Busk and Ahlborg, 1980) 
and the heterocyclic aromatic amines formed during the 
pyrolysis of amino acids and muscle food (Busk efc ai., 1982). 
With 2-aminofluorene and its acetylated derivative, vitamin A 
displayed a biphasic effect, increasing mutagenicity at low 
but inhibiting at higher concentrations (Busk and Ahlborg, 
1982a). In these studies it was inferred that the probable 
mechanism of action of vitamin A was inhibition of the 
metabolic activation of the carcinogen, although this was not 
always demonstrated. Furthermore, in some studies (McCormick 
efc ai., 1980; 1981), retinoids were effective as
anticarcinogens when administered prior to the carcinogen, 
suggesting a possible role in the initiation of chemical 
carcinogenesis.
The purpose of the present study was two-fold. Firstly, 
to investigate the possible antimutagenic effect of vitamin A 
against the actions of three aminoimidazozaarene, which belong 
to a group of precarcinogens generated during the cooking of 
certain proteinaceous foods (Spingarn efc ai., 1980; Felton efc 
ai., 1984; 1986a; 1986b), and to which man is exposed, along 
with vitamin A, through the diet. Secondly to elucidate the 
mechanism of action of vitamin A to gain a possible insight 
into its anticarcinogenic role in vivo.
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5.2 Materials.
Retinol and retinal (Sigma Co., Poole, Dorset, U.K.), 
were purchased. Salmonella typhimurium strain TA98, all other 
chemicals, reagents, substrates and cofactors were obtained as 
cited in chapter 2 (2.1).
5.3 Methods.
5.3.1 Animals and animal pretreatment.
Male Wistar albino rats (200-230g) were purchased from 
the Animal Breeding Unit, University of Surrey. Induction of 
the mixed-function oxidases was achieved by single i.p. 
administration of Aroclor 1254 (500 mg/kg), as previously
described (section 2.2.1)
5.3.2 Determination of mixed function oxidase activity.
Hepatic fractions were prepared as previously described
(2.2.2), and the following determinations carried out 
on the microsomal fraction: benzoxyresorufin-O-debenzylase,
ethoxyresorufin-O-deethylase, pentoxyresorufin-0-depentylase 
and NADPH-cytochrome c reductase activities, total cytochrome 
P-450 and protein, all as previously described (section 
2.2.7) .
5.3.3 Mutagenicity studies.
Activation of the various carcinogens to reactive 
mutagenic intermediates was determined using the Ames 
test (2.2.9) employing Salmonella typhimurium strain TA98. 
Activation systems contained 10% of the various hepatic 
fractions in the "S9" mix and the plate incorporation
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method was used. When activation systems comprised microsomes 
only, the activation system was supplemented with 1 unit/plate 
of glucose-6-phosphate dehydrogenase. To study the effects of 
various retinoids on the metabolic activation of IQ to 
mutagens, retinoids were added to the activation system 
concurrently with IQ. The mutagen was dissolved in DMSO so 
that less than lOOpl of the solvent was added to each plate. 
When the effect of retinol on the cytosolic potentiation of IQ 
was examined (section 2.2.9.4), IQ, microsomal activation 
system (10%) and bacteria were preincubated for 20 minutes 
prior to termination of the microsomal reaction by the 
addition of 1 OOjjlI per plate of menadione (900]jlM) . This was 
followed by the addition of retinol incorporated in either 
buffer or cytosol (10% ”S9" mix).
In order to assess the possible role of any interaction 
of the retinol with bacterial DNA, fresh overnight cultures of 
Salmonella typhimurium were incubated with retinol (37pg/ml) 
for 2h at 37°C in a shaking waterbath. Blank cultures were 
exposed to the solvent only. The incubation mixtures were 
centrifuged at 2,000 rpm in a bench centrifuge for lOmin, and 
the precipitated bacteria were washed, resuspended and 
centrifuged twice with nutrient broth. Finally the bacteria 
were resuspended in the original volume of nutrient broth and 
then utilised in the Ames test.
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5.3.4 In vitro microsomal enzyme inhibition studies.
The in vitro inhibition of hepatic mixed-function 
oxidase activity involved the incorporation of various amounts 
of retinol (in less than 1Opl ethanol) into the complete 
enzyme assay system, prior to the addition of NADPH. 
Inhibition of the mixed-function oxidases by retinol was 
examined in four microsomal enzymic reactions, namely, the 
0-dealkylations of ethoxyresorufin, benzoxyreorufin and 
pentoxyresorufin and the NADPH-dependent cytochrome c 
reductase, which were carried out as previously described 
(2,2.7).
5.3.5 Molecular shape calculations.
The molecular geometry of retinol was determined using 
the COSMIC package (written by J.G. Vinter, A.Davies and M.R. 
Saunders) from Smith, Kline and French Ltd. The PLUTO 
crystallographic package was used to generate the molecular 
plots, which are viewed in and perpendicular to the molecular 
plane. The following van der Waals radii were used to generate 
the molecular plots : carbon 1.6Â, nitrogen 1,5Â and hydrogen
1 . 2 Â .
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5.4 Results.
5.4.1 Inhibition of aminoimidazoazaarene mutagenicity by 
retinol and retinyl acetate
When incorporated into the activation system retinol 
caused a concentration-dependent decrease in the mutagenicity 
of IQ, MeIQ= and MelQ activated by hepatic S9 fraction derived 
from Aroclor 1254-pretreated rats (Fig 5.1).
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Figure 5.1: Inhibition of the S9-med1ated mutagenicity of Itnidazoazaarenes by retinoids.
The mutagen either IQ (A), MelQx ( • )  or MelQ ( ■ )  at a concentration of 
lOOng/plate were Incubated with Salmonella typhimurium strain TA98 and an 
Aroclor 1254-Induced hepatic S9 activation system (10%) In the absence or 
presence of retinol (O-lOOpg). The plates were Incubated for 48h at 37 C and the 
Induced histidine revertants were counted. Results are presented as MeantSD for 
triplicates. The spontaneous reversion rate of 47±2 has already been subtracted.
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The effect was particularly pronounced with MelQ where, at a 
carcinogen concentration of lOOng/plate and a retinol level of 
lOOpg/plate, some 70% decrease in the number of revertants was 
observed. Retinal similarly inhibited all three aminoimidazo- 
azaarenes but the effect was generally less pronounced (Fig
5.2).
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Figure 5.2: Inhibition of the S9-mediated mutagenicity of imidazoazaarenes by retinoids.
The mutagen either IQ (A), MelQX ( # )  or MelQ ( ■ )  at a concentration of 
lOOng/plate were incubated with Salmonella typhimurium strain TA98 and an 
Aroclor 1254-induced hepatic S9 activation system (10%) in the absence or 
presence of retinal acetate (O-lOOpg). The plates were incubated at 37°C for 48h 
* and the induced histidine revertants counted. Results are presented as the
MeanlSD for triplicates. The spontaneous reversion rate of 31±4 has already been 
subtracted.
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The inhibition of IQ mutagenicity was dependent on the 
concentration of both the carcinogen and retinol (Fig 5.3).
6000
5000 ■
4000 ■
3000
2000
1000
100755025
IQ concentration (ng/^late)
Figure 5.3: Inhibition of the S9-mediated mutagenicity of IQ by retinol.
IQ was incubated with Salmonella typhimurium strain TA98 and an Aroclor 
1254-induced hepatic S9 activation system (10%) in the absence (A) and presence of 
retinol; 25pg(B), 50pg(#), 75pg(^), lOOpg(x). The plates were incubated at 37°C for 
43h and the induced histidine revertants counted. Results are presented as MeanlSD 
for triplicates. The spontaneous reversion rate of 23±2 have already been 
subtracted.
page 122
When microsomes, instead of the S9 fraction were employed as 
an activation system, the mutagenic response to IQ was 
significantly lower, however once again retinol suppressed the 
mutagenicity of IQ, the effect being dependent on the 
concentration of both carcinogen and retinol (Fig 5.4)
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Figure 5.4: Inhibition of the microsome-mediated mutagenicity of IQ by retinol.
IQ was incubated with Salmonella typhimurium strain TA98 and an Aroclor
1254-induced hepatic microsomal activation system (10%, supplemented with 1 
unit/plate g 1ucose-6-phosphate dehydrogenase) in the absence (A) and presence of 
retinol; 25pg(B), 50pg(#), 75pg(^), lOOpg(x). The plates were incubated at 37“C 
for 48h and the induced histidine revertants counted. Results are presented as
MeantSD for triplicates. The spontaneous reversion rate of 37±7 have already been
subtracted.
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when the activation of IQ was catalysed by microsomes, 
supplementation of the activation system with cytosol, after 
termination of the microsomal metabolism, resulted in an 
increased mutagenic response. This potentiation of the 
microsome-mediated mutagenicity was not inhibited by retinol 
(Fig 5.5). If retinol was incorporated into the activation 
system subsequent to the termination of the microsomal 
activation, without the supplementation of cytosol only a 
small decrease in mutagenicity was observed, which was 
independent of the vitamin A concentration used (Fig 5.5).
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Figure 5.5: Effect of retinol on the cytosolic potentiation of the microsome-mediated 
mutagenicity of IQ.
IQ(IOng) was pre-incubated with SalmoneTTa typhimurium strain TA98 and an Aroclor 
1254-induced hepatic microsomal activation system (10%, supplemented with 
lunit/plate glucose 6-phosphate dehydrogenase) for 20min at 37°C in a shaking 
waterbath. The reaction was terminated by addition of lOOpl menadione (900pM). 
Cytosol (#) or buffer (■) containing various concentrations of retinol were then 
added and a further pre-incubâtion at 37°C was carried out for 20min. Control 
values ie in the absense of plant phenol are shown in the figure. Results are 
presented as MeanlSO for triplicates. The spontaneous reversion rate of 25±7 have 
already been subtracted.
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When the mutagenicity of IQ was determined using 
bacterial cultures preincubated with retinol(37ng/ml) for 2h 
at 37°C, with subsequent washing to remove free vitamin A, no 
difference was seen when compared to cultures preincubated 
with the same volume (lOpd) of ethanol (96%), which was used 
as the vehicle for retinol (Table 5.1).
Table 5.1: Effect of pretreatment with retinol on the response of
Salmonella typhimurium TA98 to the S9-mediated mutagenicity of IQ
Retinol concentration______________________________ Histidine revertants per plate
0 (ethanol lOpl) 1256± 48
129pM 1495±101
Bacteria and retinol (0.37mg/10ml overnight culture) were preincubated at 37°C 
for 2h in a shaking water bath. The bacteria were then washed 3 times in 
nutrient broth prior to use in the Ames test. IQ (25ng/plate), the pretreated 
bacteria and an Aroclor 1254-prtreated S9 activation system (10%) were 
incubated for 48h at 37°C. The spontaneous reversion rate of 19±6 has already 
been subtracted.
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5.4.2 In vitro alteration of hepatic microsomal enzyme 
activity by retinol.
Retinol gave rise to a concentration-dependent
inhibition of the 0-dealkylations of ethoxyresorufin,
pentoxyresorufin and benzoxyresorufin, the effect being more 
pronounced with the first substrate (Fig 5.6). Retinol had no 
effect on the NADPH-dependent reduction of cytochrome c.
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Figure 5.6: Inhibition of mixed-function oxidase activity by retinol.
Retinol was incubated with Aroclor 1254-induced microsomes during the 
determination of the following activities: pentoxyresorufin-O-depentylase (W« 
ethoxyresoruf in-O-deethylase ( A  ), benzoxyresoruf i n-O-debenzyl ase ( • )  and 
NADPH-cytochrome c reductase (♦). Control activities for the dealkylations of 
ethoxy-, benzoxy- and pentoxy-resorufin were 2.27±0.20, 0.05±0.01, and 0.68l0.23 
nmol/min per mg protein respectively, and the NADPH-dependent reduction of 
cytochrome c was 34.4±3.0 nmol/min per mg protein. Results are presented as 
MeantSD for three animals.
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5.4.3. Molecular shape calculations.
Retinol comprises a bulky alicyclic ring to which a 
polyene is attached, with computer-optimised dimensions as 
follows: length 17.9Â; width, 8.6Â; and depth, 6.7Â; giving an 
area/depth ratio of 23.4Â (Fig 5.7)
Fji^re 5.7: Space-filled model of retinol.
The PLUTO computer program was used to draw the model using the following van der Waals radii to 
generate the computer-graphical plot of the molecular geometry: carbon 1.6Â, hydrogen 1.2Â and 
oxygen 1.4Â.
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5.5 DISCUSSION
Both retinal and retinol, when incorporated into the 
activation system, gave rise to a concentration-dependent 
decrease in the mutagenicity of three imidazoazaarenes, with 
retinol generally being the more effective. A significant 
decrease in the mutagenicity was observed at concentrations as 
low as 25pg retinol/plate.
Retinol, like other antimutagenic compounds, may inhibit 
the mutagenicity of precarcinogens through one or more of the 
following mechanisms : (a) Selective inhibition of the
metabolic activation pathways, (b) scavenging of the reactive 
intermediate, (c) interaction with DNA in such a way, as to 
protect it from the genotoxicity of reactive intermediates, 
and/or (d) enhancement of detoxication pathways. The metabolic 
activation of the aminoimidazoazaarenes involves a microsomal 
pathway catalysed by the cytochrome P450-dependent 
monooxygenases in particular the A2 protein of the P450I 
family (Kato, 1983; 1986). Retinol showed a concentration- 
dependent decrease in the microsomal activation of IQ 
indicating that retinol inhibits the microsomal metabolism of 
IQ, presumably its N-hydroxylation.
A consideration of the molecular shape of vitamin A 
reveals that it has an area/depth ratio of 23.4Â placing it 
among compounds which show poor selectivity in their 
inhibition of the various cytochrome P450 isoenzymes (Lewis et 
al., 1986; 1987) a prediction that was conclusively shown 
experimentally. Retinol caused a concentration-dependent
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inhibition of the 0-depentylation of pentoxyresorufin, a 
reaction catalysed preferentially by the cytochrome P450IIB 
family of proteins (Lubet et al,, 1985), and the 
0-deethylation of ethoxyresorufin, a reaction catalysed 
exclusively by cytochrome P4501 proteins (Guengerich et al., 
1982a; Phillipson efc ai., 1984). In concert with the above
findings retinol inhibited, again in a concentration-dependent 
fashion, the 0-debenzylation of benzoxyresorufin, a reaction 
that is catalysed by many isoenzymes of cytochrome P450 
(Namkung efc al., 1988). Retinol had no effect on the 
NADPH-dependent reduction of cytochrome c demonstrating that 
the non-specific cytochrome P450 inhibition was not due to an 
interference in the electron transfer from NADPH, as has been 
previously demonstrated for two other cytochrome P450 
inhibitors quercetin (Buening efc al., 1981) and catechin 
(Steele and loannides, 1985).
No dose-dependent effect was seen when retinol was added 
to the microsomal incubation after termination of the 
microsomal metabolism, showing that the vitamin does not react 
significantly with the microsome-generated intermediates(s). 
Furthermore, retinol did not interfere with the cytosolic 
potentiation of the microsome-mediated activation of IQ. 
Finally no difference in the mutagenic response was evident 
when bacteria were exposed to retinol prior to the 
mutagenicity assay, demonstrating that no interaction takes 
place between retinol and bacterial DNA capable of protecting 
it from the genotoxic metabolites of IQ. In summary these 
findings clearly show that retinol inhibits the metabolic 
activation of IQ by non-specific inhibition of cytochrome
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P450-catalysed N-hydroxylation,
5.6 CONCLUSIONS
The question that arises from this work is whether such 
mechanisms which describe the in vitro antimutagenicity of 
retinol can explain its anticarcinogenic effect. Retinol 
caused a significant inhibition of the mixed-function oxidase 
activities and mutagenicity of IQ at levels of 1600pg/g liver 
equivalent. The rat hepatic vitamin A levels are lOOpg/g 
liver, indicating that tissue levels although 16-fold lower 
than inhibitory concentrations in vitro, may be sufficiently 
high to modulate the activation of chemical carcinogens by 
cytochrome P450. However, it has recently been demonstrated 
that there is no significant difference in mixed-function 
oxidase activity between vitamin A deficient rats and rats 
receiving a normal diet (Ayalogu et al., 1987). In the liver, 
retinol is present primarily as a retinyl palmitate ester 
which may be less effective than free retinol in inhibiting 
carcinogen metabolism. In this context, although the 
mutagenicity of both o-aminazotoluene and cyclophosphamide 
were suppressed by retinyl palmitate, this was to a much 
lesser extent than by free retinol or its acetate ester (Busk 
and Ahlborg, 1982b; Busk efc ai., 1984). The same workers 
pointed out that retinyl palmitate may not be uniformly 
distributed in the hepatic cells and most of the vitamin may 
be stored in non-parenchymal cells (Wake, 1980), so that 
levels in the hepatocyte endoplasmic reticulum may be 
considerably lower than estimated. In support of the role of 
retinoids in modulating the activation of chemical 
carcinogens, administration of vitamin A to rats was shown to
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inhibit the aryl hydrocarbon hydroxylase on one hand, and on 
the other stimulate glutathione-S-transferase activity, an 
enzyme involved in the deactivation of reactive intermediates; 
these changes were accompanied with a decreased in vivo 
binding of benzo(a)pyrene to DNA (McCarthy et al., 1987). In 
summary the function of retinoids in the modulation of 
carcinogenesis is complex but clearly a role exists, however 
small, in decreasing the activation of chemical carcinogens, 
so that supplementation of the diet with retinoids may 
possibly reduce carcinogenesis, by acting at several stages 
of the carcinogenic process. However, retinoids themselves are 
toxic at relatively low doses with a very small predicted 
therapeutic index and may themselves present a health hazard 
(Sporn, 1980). Hence the practical use of retinoids for cancer 
prevention will depend on the synthesis of new compounds with 
a more specific inhibitory effect on cytochrome P450I proteins 
and better pharmacodynamic, pharmacokinetic and toxicological 
properties.
As many competitive inhibitors of cytochrome P450 are 
substrates of this enzyme system it is interesting to 
speculate on the relationship between cytochrome P450, vitamin 
A and cancer. Recently evidence has been accumulating to 
support a role of cytochrome P450, in particular the P450I 
proteins in the metabolism and consequent excretion of vitamin 
A (Willemsens et al., 1989; Roberts, 1981; Roberts et al., 
1979). As induction of this family of proteins occurs upon 
exposure to chemical carcinogens (Astrom and Depierre, 1986; 
Ayrton efc al., 1988b; Rodrigues efc al., 1989) it is possible 
that the metabolism of retinol to more polar metabolites will
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be enhanced (Willemsens et al,, 1989), leading to a more rapid 
elimination of the vitamin, thus reducing tissue levels. This 
will have a secondary effect of removing the retinol control 
on differentiation and thus the chemical carcinogen can act 
as an initiator and, indirectly, as a promoter. In concert 
with this hypothesis is the fact that many lung cancer 
patients have low vitamin A status, although other factors may 
also be involved. Therefore vitamin A depletion could be a 
consequence of chemical carcinogenesis rather than a cause, a 
relationship that requires further investigation which 
unfortunately was outside the scope of this thesis.
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CHAPTER 6 : MODULATION OF METABOLIC ACTIVATION OF FOOD MUTAGEN 
BY STZ-INDUCED TYPE I INSULIN DEPENDENT DIABTES.
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6.1 Introduction
Diabetes mellitus is a universal health problem and is 
estimated to affect more than 90 million people worldwide 
(Krall, 1986). Perhaps the most striking form of the disease 
is the insulin-dependent type I diabetes, which affects 
nearly 10% of the diabetic population, and is associated 
with profound effects on endogenous metabolism.
Streptozotocin (STZ) and alloxan are two chemicals 
that, when administered to experimental animals, give rise to 
a condition that mimics type I diabetes, by selectively 
destroying the insulin-secreting 8-islet cells of the 
pancreas (Srivastava et ai.,1982). It is well established 
that administration of these diabetogenic agents results 
in dramatic changes in the hepatic mixed-function oxidase, 
consequently altering the metabolism of endogenous (Subbiah 
and Yanker, 1984) and exogenous substrates (Dixon et ai., 
1963; Ackerman and Liebman, 1977; Reinke et ai., 1978; 
Rouer and Leroux, 1980). Chemically-induced diabetes does not 
cause a general induction or suppression of all the 
cytochrome P450 proteins but tends to exhibit a selective 
induction of some isoenzymes at the expense of others. For 
example the levels of the constitutive forms of cytochrome 
P45G that catalyse the 16a-hydroxylation of testosterone 
are decreased in STZ-induced diabetes (Favreau and 
Schenkman, 1987) whereas the alcohol-inducible cytochrome 
P450IIE is increased (Thomas et ai., 1987). In this chapter 
the effects of STZ-induced diabetes on the two major families 
of cytochrome P450 proteins that play major roles in the
page 134
metabolism of xenobiotics, namely cytochromes P450IIB and 
cytochromes P450I are reported.
Since a majority of carcinogens are metabolised by the 
mixed-function oxidase system to form either reactive or 
inactive species it is reasonable to assume that their 
metabolic fate and organotropism will be altered by 
chemically induced diabetes. Indeed it has already been 
demonstrated that STZ administration to rats enhances the 
metabolism and hepatotoxicity of a number of carcinogenic 
nitrosamines (Peng et al., 1983; Lorr et al., 1984),
compounds that have been shown to be activated to mutagens 
preferentially by cytochrome P450IIE. It is likely that the 
carcinogenicity/mutagenicity of the food pyrolysis 
products, that are specifically activated by the 
cytochrome P450I family, could also be modified by diabetes, 
particularly as the cytochrome P450I family has already been 
shown to be increased in chemically-induced diabetic animals 
(Hietanen et ai., 1982; Yamazoe et al., 1988). In this
chapter, the ability of hepatic preparations isolated from 
STZ-induced diabetic rats to activate eight, food related 
promutagens namely IQ, MelQ, MelQx, Glu-P-1, Trp-P-1, 
Trp-P-2, N-nitrosopiperidine (NPIP) and N-nitrosopyrrolidine 
(NPYR) to mutagens in the Ames test was examined. In order 
to exclude the possibility that the changes observed are due 
to the chemical rather than the diabetic state, one group of 
animals was administered, in addition to STZ, nicotinamide 
which prevents the cytotoxicity of the drug and the onset of 
diabetes (Schein et al., 1967).
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6.2 Materials.
Aniline hydrochloride (B.D.H. Poole, U.K.), streptozo­
tocin, NPIP, NPYR, nicotinamide (Sigma Co., Poole, U.K.) 
and long-acting monocomponent human insulin (Ultratard; Novo 
Industries, Copenhagen, Denmark) were purchased. The 
Salmonella typhimurium strains, all other chemicals, 
reagents and cofactors were obtained from the sources cited in 
chapter 2.
6.3 Methods
6.3.1 Animals and animal pretreatment.
Male adult Wistar albino rats (180-250g), obtained 
from the Animal Breeding Unit, University of Surrey, were 
randomly divided into four groups, each comprising five 
animals. Group A served as a control, group B received a
single i.p. administration of STZ (65 mg/kg), group C was
also treated with STZ but in addition received two i.p. 
doses of nicotinamide (350 mg/kg), dissolved in saline (70 
mg/ml), 1Omin prior to and 3h after the administration
of STZ; finally animals in group D received, in addition to 
STZ, single daily subcutaneous doses of insulin at 1600h as 
follows: on day 7 each rat received 3 units, during days
8-12, 5 units increasing to 7.5 units on day 13, and from
day 14 until the end of the study 10 units daily. The rats 
were allowed free access to pellet diet and water ad 
libitum. Body weights, food and fluid intakes were monitored 
daily. All animals were sacrificed on day 24 by cervical 
dislocation. Blood samples obtained at death were used to
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determine plasma glucose (Stevens, 1971) and insulin 
concentrations (Flatt and Bailey, 1981).
6.3.2 Determination of mixed function oxidase activity.
Hepatic fractions were prepared as previously described
(section 2.2.2), and the following determinations 
carried out on the microsomal fraction : aniline
hydroxylase, ethoxycoumarin-O-deethylase, ethoxyresorufin-O-de- 
ethylase, pentoxyresorufin-O-dealkylase and NADPH-cytochrome c 
reductase activities, tota.1 cytochrome P-450, cytochrome b5 
and protein, all as previously described (section 2.2.7).
6.3.3 Mutagenicity studies.
Metabolic activation of the various carcinogens to 
reactive mutagenic intermediates was determined using the 
Ames test (section 2.2.9) employing Salmonella typhimurium 
strains TA98 with the pyrolysis products and strain TA1530 
with the nitrosamines. Activation systems contained 10% and 
25% of the hepatic S9 fraction in the S9 mix for the 
pyrolysis products and the nitrosamines respectively. The 
Ames test was performed with a 60 minute pre-incubation 
period at 37°C in a shaking water bath.
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6.4 Results.
6.4.1 Effects of STZ treatment on water and food intake 
and animal growth.
As expected, animal growth was impeded by the onset 
of STZ-induced diabetes (group B) despite the high food 
intake (Fig 6.1a & c). Rats treated with both nicotinamide 
and STZ (group C) showed a similar weight gain and food 
intake as the controls (group A). Water intake in groups A 
and C remained stable while that of group B showed a steady 
increase (Fig 6.1b). Similarly water intake in group D 
increased as in group B until day 8 when, as a result of 
insulin administration it started to decline. Water intake 
declined further on day 14 when the dose of insulin was 
increased.
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Figure 6.1: Effect of STZ on body growth, food and water consumption
Body weight (A), water Intake (B) and food intake (C) were monitored 
daily. Each point represents the Mean of five animals. (A), control; 
(□), streptozotocin; (+), streptozotocin + nicotinamide; (0)« 
streptozotocin with insulin treatment.
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6.4.2 Effect of STZ-induced diabetes on plasma insulin 
and glucose levels.
Plasma glucose and insulin levels at the time of death 
are shown in table 6.1. Glucose levels markedly increased in 
group B, while those in group D were intermediate 
between the control and diabetic groups. Insulin levels 
markedly decreased in group B whilst levels in group D, 
the STZ treated animals receiving insulin therapy, 
exceeded control values. Administration of nicotinamide 
appeared to block the diabetogenic effect of STZ.
Table 6.1: Plasma glucose and insulin levels
(results are presented as Mean ± S.E.M. for five animals)
Group Plasma glucose 
{mmol/I)
Plasma insulin 
{ng/ml)
(A) control 5.6±0.6 1.2±0.3
(B) streptozotocin 19.7±4.3* 0.6±0.3*
(C) streptozotocin + 7.7±0.4* 2.4±0.4*
nicotinamide
(D) Streptozotocin + 9.0±1.1- 4.0±2.8"
insulin
P< 0.05 when compared to control
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6.4.3 The effects of STZ-induced diabetes on some rat 
liver parameters.
STZ-induced diabetes gave rise to a marked increase 
in the cytochrome b5 and total cytochrome P450 levels when 
compared to controls, an effect that was prevented 
by concomitant administration of nicotinamide (Fig 6.2). The 
same pattern was also obtained with the NADPH-dependent 
reduction of cytochrome c. Treatment of animals with daily 
doses of insulin partially restored enzyme activity and 
cytochrome levels to control values.
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Figure 6.2: Effect of STZ-induced diabetes on some hepatic microsomal parameters in the rat 
Results are presented as MeantSEM for five animals. The differences between 
control and streptozotocin-treated animals were statistically significant in all 
cases (P<0.05). Group A served as control, animals in group B received 
streptozotocin only, while animals in groups C and D received in addition to 
streptozotocin, nicotinamide and insulin respectively.
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6.4.4 Hepatic microsomal cytochrome P450 dependent mixed- 
function oxidase activities in the diabetic rat.
Pretreatment of rats with streptozotocin gave rise 
to an increase in the enzyme activities measured, an effect 
that was prevented by simultaneous administration of 
nicotinamide and antagonised by daily insulin treatment of 
the diabetic rats (Fig 6.3).
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Figure 6.3: Hepatic microsomal mixed-function oxidase activities in STZ-induced diabetic rats
Results are presented as Mean±SEM for five animals. The differences between 
control and streptozotocin-treated animals were statistically significant in all 
cases (P<0.05). Groups are as shown in fig 6.1.
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6.4.5. Effect of STZ-induced diabetes on the metabolic 
activation of two cyclic nitrosamines.
Hepatic 89 fractions isolated from the diabetic rats 
was markedly more efficient than control in activating both 
nitrosamines, NPIP (Fig 6.4a) and NPYR (Fig 6.4b), to 
mutagens. This effect was prevented by co-administration of 
nicotinamide and successfully antagonised with insulin 
therapy.
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Figure 6.4: Effect of STZ-induced diabetes on the activation of nitrosamines to mutagens
The metabolic activation of nitrosopiperidine (a) and nitrosopyrrolidine (b) to mutagens in the
Ames test was investigated using Salmonella typhimurium strain TA1530 and employing 25% S9
activation systems derived from control (<^ ), streptozotocin (■), streptozotocin+nicotinamide (+) 
and streptozotocin+insulin ( • )  treated animals. Results are presented as MeanlSD for
triplicates. The spontaneous reversion rate of 13±1 has already been subtracted
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6.4.6 Effect of STZ-induced diabetes on the metabolic 
activation of dietary food pyrolysis products.
The effect of STZ-induced diabetes on the metabolic 
activation of three azaarenes is shown in Fig 6.5. Hepatic 
S9 fractions prepared from all groups could activate IQ to 
mutagens with the same efficiency. However, S9 preparations 
from STZ-treated animals were significantly more 
efficient than control in converting MelQ to mutagens, but 
the effect was not prevented by nicotinamide administration 
or by insulin therapy. A small increase in the activation 
of MéIQx by the diabetic animals was seen, an effect that 
was prevented by nicotinamide co-administration but not 
antagonised by insulin therapy.
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Figure 6.5: Effect of STZ-induced diabetes on the activation of three aminoimidzizoazaarenes
The metabolic activation of three aminoimidazoazaarenes to mutagens in the 
Ames test was investigated using Salnnonella typhimurium strain TA98, 
employing a 10% activation system derived from control (A), streptozotocin 
(♦), streptozotocin + nicotinamide (#) and streptozotocin + insulin (■) 
treated animals. Results are presented as Mean±SD for triplicates. The 
spontaneous reversion rate of 24±4 has already been subtracted.
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Treatment of animals with STZ markedly increased the 
capability of hepatic S9 fractions to activate Trp-P-1 and 
Trp-P-2 to mutagens. The increase was prevented by 
nicotinamide co-administration and antagonised by insulin 
therapy (Fig 6.6).
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Figure 6.6; Effect of STZ-induced diabetes on the activation of tryptophan pyrolysis products
The metabolic activation of two tryptophan pyrolysis to mutagens in the Ames test 
was investigated using Salmonella typhimurium strain TA98, employing a 10% 
activation system derived from control (A), streptozotocin (■), streptozotocin + 
nicotinamide (<#•) and streptozotocin + insulin (♦) treated animals. Results are 
presented as MeantSD for triplicates. The spontaneous reversion rate of 13±4 has 
already been subtracted.
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À structurally related carcinogen, Glu-P-1, was more 
effectively converted to mutagens by STZ treatment but this 
effect was neither reversed by insulin therapy nor prevented 
by nicotinamide treatment (Fig 6.7.)
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Figure 6.7: Effect of STZ-induced diabetes on the activation of Glu-P-1
The metabolic activation of Glu-P-1 to mutagens in the Ames test was investigated using 
SalnnneTla typhimurium strain TA98, employing a 10% activation system derived from 
control (♦), streptozotocin (■), streptozotocin + nicotinamide ( + )  and streptozotocin + 
insulin (#) treated animals. Results are presented as MeantSD for triplicates. The 
spontaneous reversion rate of 29±4 has already been subtracted.
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6.5 Discussion.
6.5.1 Induction, inhibition and antagonism of chemically-
induced diabetes.
Induction of type I diabetes by the administration of
chemical diabetogenic agents has been shown to result in
marked changes in the hepatic mixed function oxidases (Dixon 
et al., 1963; Ackerman and Liebman, 1977; Reinke et al.,
1978; Rouer and Leroux, 1980) which have been attributed at 
least in part, to the increased synthesis of a novel form
of cytochrome P450, cytochrome P450IIE. These
observations demonstrate that synthesis of the cytochrome 
P450IIE may be induced as a result of a pathological
condition. However one problem associated with the 
interpretation of a chemically-induced pathological
condition, is the distinction between the effect of the 
chemical per se and the effects resulting from the induced 
diabetic condition. Such a chemical effect could explain why 
aniline metabolism is decreased in STZ-induced diabetes whilst 
it is induced in alloxan-induced diabetes (Dixon et al., 
1963; Ackerman and Liebman, 1977 ). Furthermore induction of 
diabetes by STZ results in the induction of a 50,000 mol.
wt. microsomal protein (Peng et al., 1983) whereas 
alloxan-induced diabetes results in the induction of a 
unique protein having a mol. wt. 52,000 (Past and Cook, 
1982). In order to distinguish between the effects of the 
diabetic state and the effects of the chemical, one group
of animals, in addition to STZ, were administered 
nicotinamide to prevent the cytotoxicity of the drug and the 
onset of diabetes (Schein et al., 1967). The establishment
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of diabetes, the inhibitory effect of nicotinamide and the 
antagonism by insulin therapy are clearly indicated by the 
onset, the prevention and partial amelioration of the 
classical diabetic characteristics of the rat, such as body 
weight loss, hyperphagia, polydypsia, hyperglycaemia and 
insulin deficiency (Table 6.1 and Fig 6.1). It should also 
be noted that STZ was administered three weeks prior to 
sacrifice and was no doubt completely eliminated long before 
the animals were sacrificed.
6.5.2 Diabetic induced changes in hepatic mixed 
function oxidases activities.
In the present study STZ-induced diabetes was
characterized by an increase in the cytochrome P450I
proteins as exemplified by an induction of 
ethoxyresorufin-O-deethylase and ethoxycoumarin-O-deethylase 
activities (Guengerichefc al., 1982a; Phillipson efc ai., 
1984). In accordance with previous other studies an increase 
in the p-hydroxylation of aniline was seen (Reinke et ai., 
1978; Kato et ai., 1970) demonstrating a possible induction 
of cytochrome P450IIE. The most marked effect, however, was a 
7-fold increase in the 0-dealkylation of pentoxyresorufin 
which is catalysed by the cytochrome P450IIB family of 
proteins (Lubet et ai., 1985). Significant increases, in 
all the liver parameters measured, were observed in the 
diabetic rat when compared to control. It is therefore
clear that chemical induction of diabetes is associated with 
increases in the levels of cytochrome P450I- and
P450IIB-proteins, which has been conclusively shown by 
immunological techniques (C.R.Barnett personal communication).
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All effects on the microsomal activities and liver 
parameters could be antagonized by insulin therapy and 
inhibited by the co-administrâtion of nicotinamide, 
demonstrating that these changes could be attributed solely to 
the induced diabetic condition and were not artefacts 
produced by an independent chemical effect. Diabetic-induced 
changes in microsomal cytochrome P450 levels can be correlated 
with an increase in circulating ketone body levels (Favreau 
and Schenkman 1988a; 1988b). Indeed fasting, acetone
(Johansen et al., 1986; Peng et al.,1983) and medium chain 
triglyceride administration (Barnett et al., 1988), which 
induce hyper-ketonaemia without hyperglycaemia and hypo- 
insulinaemia, all bring about similar changes in the hepatic 
cytochrome P-450 system.
6.5.3 Influence of diabetes on the metabolic activation of 
food related carcinogens.
Epidemiological studies indicated that the diabetic 
population may be more susceptible to cancer (Volk and 
Wellman, 1977) and since the microsomal mixed function 
oxidases, which play a key role in the balance of 
activation and deactivation of chemical carcinogens, are
modulated by diabetes, it is reasonable to assume that
the bioactivation of chemical carcinogens will also be 
altered. Hepatic S9 fractions isolated from the diabetic 
animals were markedly more efficient in the metabolic 
activation of the cyclic nitrosamines NPIP and NPYR to 
mutagenic species, an effect that was abolished by
co-administration of nicotinamide and effectively 
antagonised by insulin therapy. The metabolic activation
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of this group of carcinogens is thought to proceed via 
hydroxylation of the a-carbon of the nitrosamine followed
by chemical rearrangement to produce the reactive,
mutagenic intermediates (reviewed by Dipple efc al., 1985). 
This reaction has been shown to be preferentially catalysed 
by the diabetes induced form of cytochrome P-450, cytochrome 
P450IIE {Garro et al., 1981; Yang efc al., 1985; Thomas efc 
al., 1987). Hence it is likely that this isoenzyme may be 
responsible for the enhanced bioactivation of the two 
nitrosoamines. However it has been previously demonstrated 
that activation of NPIP is also enhanced by induction 
of the cytochrome P450IIB proteins (Ayrton efc al., 1987b) 
which are also induced by diabetes and may also contribute 
to the increased activation.
The carcinogenic food pyrolysis products, Trp-P-1 and 
Trp-P-2, showed a similar enhanced activation to mutagens when 
S9 fraction isolated from the STZ-induced diabetic animals 
was used, and again the effect was inhibited and
antagonised by nicotinamide and insulin therapy respectively. 
As both these carcinogens are initially activated by
N-hydroxylation catalysed by cytochrome P4501 proteins (Ishii 
efc al., 1980a; Mita efc al., 1981a; 1981b; Kato, 1986), both 
high spin and low spin forms, it is probable that the
induction of this family in the diabetic state is
responsible for enhanced activation. However these 
compounds could also be N-oxidized by the microsomal
FAD-monooxygenase which is also induced in the diabetic 
state (Rouer efc al., 1988). Glu-P-1 showed a different
pattern, in that S9 from diabetic animals enhanced
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bioactivation, but the effect was not antagonised by 
insulin therapy and nicotinamide was unable to prevent 
the change. Glu-P-1 also requires N-hydroxylation as an 
initial step in its activation but this is specifically 
catalysed by the high spin cytochrome P450I protein, P450IA2 
(Yamazoe efc ai., 1984). Since the metabolism of 
ethoxyresorufin is poorly catalysed by this isoenzyme it is 
possible that this protein is induced not by the diabetic 
state as shown with the low spin form, cytochrome P450 
IA1, but by the diabetogenic agent itself. However this 
would appear unlikely as the chemical was administered 3 
weeks prior to sacrifice and the chemical should have been 
eliminated and any effect of the chemical on the cytochrome 
P450 proteins could not be sustained. It is therefore more 
likely that STZ causes some physiological change that is not 
prevented by the action of nicotinamide nor antagonized by 
insulin. Another possibility, is that the pyrolysis products 
are, like the nitrosamines, substrates for cytochrome
P450IIE and that it is the induction of this isoenzyme
that is responsible for the enhanced activation of the 
pyrolysis products. However this also is unlikely as it has 
been shown that induction of cytochrome P-450IIE by either 
ethanol or isoniazid, unlike alloxan-induced diabetes, does
not enhance the microsomal activation of the pyrolysis
products (Yamazoe efc ai., 1988, Loury efc ai., 1985). 
Furthermore induction of cytochrome P450IIE is antagonized by 
insulin treatment which, however, failed to antagonize the 
enhanced activation of Glu-P-1.
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The activation of the azaarene food pyrolysis products 
was less sensitive to STZ-induced diabetes. No significant 
changes were observed in the mutagenic response elicited 
by IQ and, in agreement with results obtained with 
alloxan-induced diabetes (Yamazoe et al., 1988), only a 
modest response was seen with MelQx. A marked increase in 
the activating efficiency by STZ-induced preparations was 
seen with MelQ, which was neither prevented nor antagonised 
by insulin therapy, indicating once again mechanisms that 
are independent of diabetes. As all the food pyrolysis 
products are activated via N-hydroxylation, by the 
cytochrome P4501 family, the differential effects on their 
activation shown in the diabetic animals may be due to changes 
in the cytochrome P-450 isoenzyme ratio which, in contrast 
with cytochrome P450IIE is not restored to control values by 
insulin therapy.
In the activation of all the carcinogens studied the 
cytosol has been shown to play a major role in the
metabolism of these compounds to their ultimate mutagens
(Ayrton et al., 1987b; Abu-Shakra efc al.,1986; Snyderwine 
efc al., 1988a; Hashimoto efc al., 1982a; Kato, 1986). As all
the activation systems used the S9 fraction, i.e. microsomes 
and cytosol, it may well be that the enhancement of metabolic 
activation to mutagens is brought about by changes in 
either, or both the microsomal and cytosolic steps, and it may 
be that changes in the cytosol lead to an enhanced activation 
which is not reversed by insulin therapy or prevented by 
nicotinamide co-administration, as in the case of the
azaarenes and Glu-P-1. Indeed when hepatocytes isolated from
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ethanol pretreated rats were used to activate pyrolysis 
products to mutagens it was found that the enhanced activation 
was not due to an increase in microsomal activation but was 
due to the enhancement of a non-microsomal activation process 
(Loury efc ai., 1985). Hence in identifying the risk posed to 
diabetics from these carcinogens it would be necessary to 
examine the role, if any, of the cytosol in the enhanced 
metabolic activation.
6.6 Conclusions.
In conclusion this study clearly demonstrates that 
diabetes A) modulates the levels of hepatic microsomal 
cytochrome P450 isoenzymes and B) enhances the hepatic 
activation of the tryptophan pyrolysate products (Trp-P-1 
and Trp-P-2) and the cyclic nitrosamines (NPIP and 
NPYR), all dietary carcinogens. The consequence of this is 
that the diabetic may be at a greater risk from the 
carcinogenic effects of some of these dietary carcinogens, 
compounds to which we are all exposed to daily. However 
insulin-dependent type I diabetes is clinically treated with 
insulin therapy, which, as shown, antagonized the enhanced 
metabolic activation, hence the inducing effect may only 
occur during periods of hyperglycaemia or not at all. Changes 
in cytochrome P450IIE have also been observed in 
genetically diabetic BE rats and were correlated to 
the extent of hyperketonaemia (Favreau and Schenkman 1988a; 
1988b; Bellward efc ai., 1987), a state that is not 
frequently sustained in the treated diabetic patient.
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Since the balance between activation/detoxication 
determines the extent of DNA damage, further work is required 
to assess the role of deactivating conjugation reactions 
in the diabetic state. Metabolic activation in the 
Ames test is predisposed towards activation by the 
cytochrome P450 system with the S9 mix not generally 
supplemented with conjugation cofactors, hence a further 
possibility is that the cytosolic activation steps are 
also enhanced by diabetes (eg.acetyl CoA transferase for 
the tryptophan pyrolysates), which may further modulate the 
ability of hepatic S9 to activate certain carcinogens to 
their reactive intermediates, pathways of activation that may 
not be so readily antagonised by insulin therapy.
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CHAPTER 11 MODULATION OF THE METABOLIC ACTIVATION OF THE FOOD 
MUTAGEN Glu-P-1 AND INDUCTION OF P450I PROTEINS BY 
AROMATIC AMINES MAY BE CORRELATED WITH THEIR 
CARCINOGENIC POTENTIAL.
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7.1 INTRODUCTION
Aromatic amines and amides comprise one of the largest 
groups of chemical carcinogens and are extensively used in 
industry primarily as dye intermediates. Many of these 
aromatic amines are mutagenic in the short term tests, such as 
the Ames mutagenicity assay, and display carcinogenicity in 
many animal models (lARC monographs, 1972; 1974). Like most 
other chemical carcinogens the aromatic amines require 
metabolic activation in order to express their mutagenicity 
and carcinogenicity, through reactive intermediates that 
interact covalently with DNA to cause genotoxicity. The 
initial step in the activation of these amines is 
N-hydroxylation (Miller and Miller, 1977), while ring 
hydroxylations result in inactive readily excretable products; 
indeed N-hydroxy-derivatives of aromatic amines are highly 
mutagenic, while ring hydroxylated products display no 
mutagenicity (Masson efc al., 1983; Tong efc al., 1986). The
hydroxylamines are regarded as proximate carcinogens/mutagens 
and can be metabolised to more potent reactive electrophiles 
by acétylation or conjugation with glutathione, sulphate and 
glucuronic acid (Miller and Miller, 1981; Weeks efc al., 1978; 
Miller, 1978; Wirth efc al., 1980).
In the liver, two enzyme systems are involved in the 
N-hydroxylation of aromatic amines: (a) The FAD-monooxygenase 
(Pelroy and Gandolfi, 1980) and (b) the cytochrome P450 
dependent mixed function oxidases (Thorgeirsson efc al., 1973). 
As stated earlier (section 1.3) the members of the cytochrome 
P450 family of enzymes differ in their substrate specificity
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and regio-selectivity and it is the cytochrome P450I family 
of proteins which has primarily implicated in the 
N-hydroxylation of aromatic amines and amides (loannides and 
Parke, 1987). This enzyme system accepts as substrates planar 
compounds (Lewis et al., 1986; 1987) and selectively catalyses 
the N-hydroxylation of aromatic amines and amides such as 
2-aminofluorene, 2-naphthylamine (Hammons efc al., 1985; Tong 
efc al. , 1986) , 4-aminobiphenyl (Masson efc al., 1983),
2-acetylaminofluorene (Astrom and DePierre, 1985b) and 
heterocyclic aromatic amines (HAAs) formed during the cooking 
process or the pyrolysis of amino acids (Kato, 1986) Of the 
two cytochrome P450I proteins, cytochrome P450IA1 and A2, it 
is the latter which preferentially catalyses the 
N-hydroxylation of aromatic amines (Hammons et al., 1985; 
Yamazoe efc al., 1984).
In the untreated rat the P450I proteins comprise less 
than 5% of the total hepatic microsomal cytochrome P450 
(Pickett efc al., 1981; Luster efc ai., 1982), so that hepatic 
microsomal preparations from untreated rats failed to convert 
or very weakly, converted carcinogenic aromatic amines such as 
2-naphthylamine and 2-acetylaminofluorene to mutagenic 
intermediates (Phillipson and loannides, 1983). In contrast, 
pretreatment of the animals with Aroclor 1254, which markedly 
increases the levels of P450I, enhances the activation of 
these amines to mutagenic intermediates (Steele and loannides, 
1986; Hyde et al., 1987). However, many carcinogenic aromatic 
amines selectively stimulate the synthesis of P450I proteins 
and their own activation (Astrom and DePierre, 1985a; Masson 
efc al., 1983; Steele and loannides, 1986) as well as the
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activation of other carcinogenic amines such as the HAAs 
(Degawa et ai., 1985b). Hence it is not unreasonable to assume 
that amines which selectively stimulate synthesis of P450I 
proteins will be more potent carcinogens and cocarcinogens 
than those that fail to do so. Indeed non-carcinogenic 
compounds that are substrates of P450I that fail to, or weakly 
induce this enzyme system could be competitive inhibitors of 
aromatic amine carcinogenesis.
The present study has therefore been undertaken in order 
to establish if a relationship exists between the 
carcinogenicity of aromtic amines and their ability to induce 
the synthesis of P450I proteins, and to evaluate the role of 
the amino-group in the induction process. Secondly, these 
studies aimed to evaluate the effect these compounds may have 
on the metabolic activation of other amines in particular the 
HAAS.
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7.2 MATERIALS
Glu-P-1 (Wako Fine Chemicals, FRG), anthracene (Koch 
Light Labs. Ltd., UK), 1-aminoanthracene, 2-aminoanthracene, 
2-acetylaminoflùorene, biphenyl, 2-aminobiphenyl (R.N. 
Emmanuel Ltd., ÜK), fluorene, 3-aminobiphenyl,
4-aminobiphenyl, naphthalene (Sigma Co., UK), 2-aminofluorene, 
2-acetylfluorene (Chemsyn Science Labs., USA), 1- and 
2-naphthylamines (ICI Central Toxicology Labs., UK), 
Salmonella typhimurium TA98, ail other reagents and cofactors
7.3 METHODS
7.3.1 Animals and animal pretreatment.
Male Wistar albino rats (150-200g) were purchased from 
the Animal Breeding Unit, University of Surrey. They were 
given a single intraperitoneal dose (20mg/kg) of the chemical 
(1Omg/ml), dissolved in corn oil, while the group serving as 
controls received the corresponding volume of corn oil. 
Animals were killed by cervical dislocation 24 hr after the 
administration.
7.3.2 Determination of mixed-function oxidase activity.
Hepatic fractions were prepared as previously described
(section 2.2.2) and the following determinations carried 
out on the microsomal fraction: ethoxyresorufin-O-deethylase, 
pentoxyresorufin-0-dealkylase, and benzoxyresorufin
0-debenzylase activities, total cytochrome P-450 and protein, 
all as previously described (section 2.2.7).
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7.3.3 Western blot analysis of microsomal cytochrome P450 
proteins.
Hepatic microsomal suspensions (2mg microsomal 
protein/ml) isolated from control, and pretreated rats were 
solubilized as previously described (section 2.2.4), by 
incubation at 4°C for 40 minutes with cholate (Img sodium 
cholate/mg microsomal protein) and Emulgen 911 (0.14% v/v) and
treated with SDS prior to separation by SDS-PAGE 
electrophoresis (section 2.2. 4 and 2.2.5). Separated proteins 
were transferred overnight onto nitrocellulose paper and 
immunostained as described previously (section 2.2.6) using 
monospecific polyclonal antibodies which could detect both 
P450IA1 and A2 proteins.
7.3.4 Mutagenicity studies.
Microsome-mediated metabolic activation of Glu-P-1 to 
reactive mutagenic intermediates was determined using the 
Ames test (section 2.2.9) and employing Salmonella 
typhimurium strain TA98. Activation systems contained 20% of 
microsomal preparation in the "S9" mix and were supplemented 
with glucose-6-phosphate dehydrogenase (1 unit/plate). Glu-P-1 
was dissolved in DMSO (lOOpl). The Ames test was performed 
using a 60min pre-incubation period at 37°C in a shaking water 
bath.
Statistical analysis was carried out using the Student's 
t-test.
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7.4 RESULTS
The carcinogenic and mutagenic properties of the various 
chemicals employed in the present study are shown in Table 7.1 
(IARC, 1979; 1980).
Table 7.1: Mutagenicity and carcinogenicity characteristics of 
the compounds employed in the present study
Compound Mutagenicity in Carcinogenicity
the Ames test Rodent bioassays
Anthracene
1-Aminoanthracene (lAA) + +
2-Aminoanthracene (2AA) + +
Fluorene (F)
2-Acetylfluorene (2AcF) NAD NAD
2-Aminofluorene (2AF) + +
2-Acetylaminofluorene (2AAF) + +
Biphenyl (B)
2-Aminobiphenyl (2AB)
3-Aminobiphenyl (3AB) - ?+
4-Aminobiphenyl (4AB) + +
Naphthalene (N)
1-Naphthylamine (1NA) ?+
2-Naphthylamine (2NA) + +
?+, possibly a weak mutagen or carcinogen 
NAD, no available data
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P450IA1
P450IA2
S  O  ZCO O  OJ
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Figure 7.1; Immunoblot analysis of solubilised hepatic microsomes derived from rats pretreated with 
aromatic amines.
Solubilised microsomes were resolved by 10%(w/v) SDS-PAGE and transferred 
e1ectrophoretica11y to nitrocellulose. The immunoblot was carried out with sheep 
anti-cytochrome P450IA1 (diluted 1:12,000) followed by peroxidase-labelled donkey 
anti-sheep IgG (diluted 1:1,000). Each well was loaded with 20pg protein with the 
exception of the positive control (lOpg).
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TABLE 7.3: MeataboUc activation of G1u-P-1 to mutagens by hepatic microsomal preparations from
rats pretreated with various aromatic amines
Mutagenicity studies were carried out using Salmonella typhimurium strain TA98 and 
microsomal activation systems (20%) supplemented with 1 unit/plate glucose 
6-phosphate dehydrogenase. The activation system, mutagen and bacteria were 
pre-incubated for Ih at 37“C in a shaking water bath. The spontaneous reversion rate 
of 21±5 has already been subtracted. Results are presented as MeaniSO of 
triplicates.
Pretreatment Histidine Revertants/P1ate
Control 223± 52
Anthracene 174± 18
^1-Ami nanthracene 3256± 22***
2-Ami noanthracene 851± 46---
Control 996± 19
Fluorene 1832±173**
2-Acetylf1uorene 2522±528*
2-Aminofluorene 3665± 55---
2-Acetylam i nof1uorene 1975±679*
Control 369± 42
Biphenyl 173± 16**
2-Aminobiphenyl 209± 55*
3-Aminobiphenyl 334± 43
4-aminobiphenyl 1572± 54---
Control 706±123
Naphthalene 4671124*
1-Naphthy1amine 13491 88***
2-Naphthy1amine 12131 99***
•P<0.0S; ■“ P<0.01; — P<0.001
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7.4.1 Effect of anthracene cuid its isomeric-amines on 
microsomal cytochrome P450 activities and the microsomal 
activation of Glu-P-1.
Neither anthracene nor its amino-analogues increased the 
hepatic microsomal levels of cytochrome P450 or protein (Table 
7.2). However, they all markedly enhanced the 0-deethylation 
of ethoxyresorufin, the amino-derivatives being more potent 
than anthracene itself. A similar but less pronounced pattern 
of induction was seen in the 0-debenzylation of 
benzoxyresorufin. All three chemicals gave rise to small 
increases in the 0-depentylation of pentoxyresorufin. The 
amino-derivatives, but not anthracene, stimulated the 
metabolic activation of Glu-P-1 (Table 7.3). All three 
increased the levels of P450I apoproteins as shown by western 
blotting, increasing the synthesis of both A1 and A2 proteins 
(Fig 7.1).
7.4.2 Effect of fluorene and its amino-, and 
acetyl-derivatives on microsomal cytochrome P450 activities 
and the microsomal activation of Glu-P-1.
All four fluorenes markedly induced the O-deethylation 
of ethoxyresorufin, with 2-aminofluorene being by far the most 
effective agent (Table 7.2). The dealkylations of both 
benzoxyresorufin and pentoxyresorufin were also increased, but 
to a much lesser extent, by 2-aminofluorene only. No changes 
were observed in the total microsomal protein levels but all 
the compounds tended to decrease the levels of total 
cytochrome P450. Hepatic microsomal preparations from the 
treated animals were more efficient than controls in 
converting Glu-P-1 to mutagens, the most effective being
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derived from 2-aminofluorene-treated animals (Table 7.3). The 
western blot showed that apoprotein levels of both P450I 
proteins were increased, with 2-aminofluorene clearly being 
the most potent (Fig 7.1).
7.4.3 Effect of biphenyl and its isomeric-amines on microsomal 
cytochrome P450 activities and the microsomal activation of 
Glu-P-1.
Biphenyl and its three isomeric amino-derivatives had no 
effect on the levels of microsomal protein but all tended to 
decrease the total cytochrome P450 levels, 4-aminobiphenyl 
exhibiting the most marked effect (Table 2). None of the 
compounds had any significant effect on the 0-deethylation of 
ethoxyresorufin and similarly no significant changes occurred 
in the 0-debenzylation of benzoxyresorufin. However the 3 and 
4 aminoisomers gave rise to significant increases in the 
0-depentylation of pentoxyresorufin. Hepatic prepations from 
only 4-aminobiphenyl were more efficient in the activation of 
Glu-P-1 (Table 7.3). Immunoblot analysis showed that 
2-aminobiphenyl had no effect on the P450I levels while the 
other biphenyls increased the levels of both isoenzymes with 
the 3- and 4-aminobiphenyls clearly the most effective (Fig 
7.1).
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7.4.4 Effect of naphthalene and its cunino-derivatives on 
microsomal cytochrome P450 activities and the microsomal 
activation of Glu-P-1.
Naphthalene and the two napthylamine isomers had no 
effect on either total cytochrome P450 or microsomal protein 
levels (Table 7.2). The O-deethylation of ethoxyresorufin was 
induced only by the amino-derivatives with 2-naphthylamine 
being by far the most potent. Both amines enhanced the 
0-debenzylation of benzoxyresorufin whereas only the 2-amino 
derivative increased the 0-depentylation of pentoxyresorufin. 
Both naphthylamines enhanced the bioactivation of Glu-P-1 to 
mutagens (Table 7.3). In immunoblot analysis the two 
amino-derivatives, in contrast to naphthalene, induced the 
synthesis of both P450I isoenzymes, with 2-naphthylamine 
clearly the most effective (Fig 7.1).
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7.5 DISCUSSION
For a procarcinogen to exhibit genotoxicity in a living 
organism, two fundamental prerequisites must be satisfied. 
Firstly, the chemical must have the potential to be converted 
to a reactive, electrophilic intermediate(s) which can 
interact covalently with nucleophilic sites of cellular 
macromolecules. Secondly the organism must possess the 
necessary enzyme system capable of catalysing the activation 
of these chemicals. For example, the Guinea pig is resistant 
to aromatic amine carcinogenesis due to an inability of the 
animal to activate these amines. In the case of the aromatic 
amines the enzyme system is the P450I family of haemoproteins 
(loannides and Parke, 1987).
Genotoxicity of chemicals is usually determined in short 
term mutagenicity tests, the most widely employed being the 
Ames test. Since the bacteria used as target organisms in this 
test cannot catalyse the phase I biotransformation of 
chemicals, an exogenous mammalian hepatic system is 
incorporated into the test to ensure metabolic activation. The 
enzyme system commonly used is derived from the liver of rats 
pretreated with Aroclor 1254. In such a system the P450I 
family comprises 50% of total cytochrome P450 (Thomas et ai.,
1983) in contrast to the untreated animal where less than 5% 
of this form exists (Pickett et ai., 1981 ; Luster et ai.,
1982). So even if a positive mutagenic response is seen in the 
Ames test it is unsound to assume that the same levels of 
reactive intermediate(s) will be formed in vivo. Indeed, 
activation systems from untreated animals failed to elicit a
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response with a variety of established human and animal 
carcinogens, including aromatic amines and polycyclic aromatic 
hydrocarbons (Phillipson and loannides, 1983; 1989). However, 
it appears that many chemical carcinogens can selectively 
induce the P450I proteins responsible for their activation and 
in this way enhance the production of reactive intermediates 
and consequently their carcinogenicty (loannides and Parke, 
1987). Furthermore this will also result in the enhanced 
carcinogenicity of other chemical procarcinogens activated by 
the same cytochrome P450I isozyme. It is logical therefore, to 
argué that chemicals that can selectively enhance their own 
activation pathways are more likely to display
carcinogenicity, and to test this hypothesis was the major
objective of this work.
Alterations in the levels of cytochrome P450I proteins 
were monitored by the use of specific chemical probes and also 
immunologically employing specific polyclonal antibodies that 
recognise only the two P450I proteins A1 and A2. The
O-deethylation of ethoxyresorufin is a specific and sensitive 
assay for the P450I family, in particular the A1 enzyme 
(Guengerich et ai., 1982a; Phillipson et ai., 1984; Namkung et 
ai., 1988). The 0-depentylation of pentoxyresorufin was also 
determined as it primarily reflects the activity of the 
phenobarbital-inducible cytochrome P450IIB family, although it 
also responds to a much lesser extent to inducers of P450I 
proteins (Lubet et ai., 1985). The 0-debenzylation of
benzoxyresorufin is enhanced by several inducers of different 
families including P450I (Namkung et ai., 1988).The microsomal 
activation of the amino acid pyrolysate Glu-P-1 to mutagens
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was used to indicate P450I activity, in particular the A2 
isoenzyme (Yamazoe et al,, 1984). The specific activities of 
the P450I related enzymes are expressed per nmole of total 
cytochrome P450 in order to establish selective induction of 
this family.
Naphthalene, a non-carcinogen, failed to induce the 
P450I family while 2-naphthylamine, an established human 
carcinogen, is a potent inducing agent compatible with the 
hypothesis. 2-Naphthy1amine is mutagenic in the Ames test when 
the activation system is derived from the liver of rats 
pretreated with P450I inducing agents (Tong et al., 1986). Its 
N-hydroxy derivative, a direct-acting mutagen which is formed 
by N-hydroxylation catalysed by the A2 isoenzyme (Hammons et 
ai., 1985) is responsible for the mutagenicity as ring 
hydroxylated products display no mutagenicity (Tong et ai.,
1986). In contrast, 1-naphthylamine, generally considered as a 
non-carcinogen, is a much poorer inducer of the O-deethylation 
of ethoxyresorufin than the 2-isomer (Fig 7.2). Similarly in 
the immunoblot analysis 1-naphthylamine was a relatively poor 
inducer, however both isomers were equivalent in their ability 
to induce the activation of Glu-P-1. 1-Naphthylamine is
non-mutagenic or at best a very weak mutagen in the Ames test. 
In contrast, the hydroxylamine derivative is a very potent 
direct acting mutagen (McCann et ai., 1975; Rosenkranz and 
Poirier, 1979), indicating that the poor mutagenicity of the 
parent reflects a very low rate of N-hydroxylation by hepatic 
microsomal preparations. Indeed, neither purified cytochrome 
P450 isoenzymes, including the P450I family, nor purified 
flavin monooxygenase could N-hydroxylate 1 -naphthylamine but
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could readily form ring hydroxylated products (Hammons et al., 
1985). It is of interest that even naphthalene is a substrate 
of P450IA1, forming a 1,2-arene oxide, which presumably is not 
genotoxic (van Bladeren et al., 1985). Among the three 
naphthalene derivatives only the carcinogenic 2-naphthylamine 
was a potent inducer of P450I activities.
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Figure 7.2: Ethoxyresorufin 0-deethylase activity and metabolic activation of Glu-P-1 to mutagens 
by hepatic microsomal preparations pretreated with naphthalene and its ami no-isomers. 
Both ethoxyresorufin-O-deethylase activity (a) and the metabolic activation of 
Glu-P-1 to mutagens (b) are expressed in terms of total cytochrome P450 levels. The 
metabolic activation of Glu-P-1 to mutagens in the Ames test was determined using 
Salmonella typhimurium strain TA98. Bacteria, microsomal activation systems (20% 
supplemented with lunit/plate glucose-6-phosphate dehydrogenase) and Glu-P-1 
(2pg/plate) were preincubated for 60 min at 37°C in a shaking waterbath. The plates 
were incubated for 48h at 37^C and the induced histidine revertants were counted. 
Results are presented as MeanlSD for triplicates. The spontaneous reversion rate of 
15±8 has already been subtracted.
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All four fluorene derivatives induced the P450I family 
as exemplified by the O-deethylation of ethoxyresorufin and 
the activation of Glu-P-1. In both cases clearly
2-aminofluorene is the most potent inducer (Fig 7.3) which is 
confirmed by immunoblot analysis (Fig 7.1).
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Figure 7.3: Ethoxyresorufin 0-deethylase activity and metabolic activation of Glu-P-1 to mutagens 
by hepatic microsomal preparations pretreated with fluorene and its amino and acetyl 
derivatives.
Both ethoxyresorufin-O-deethylase activity (a) and the metabolic activation of 
Glu-P-1 to mutagens (b) are expressed in terms of total cytochrome P450 levels. The 
metabolic activation of Glu-P-1 to mutagens in the Ames test was determined using 
Salmonella typhimurium strain TA98. Bacteria, microsomal activation systems (20% 
supplemented with lunit/plate g 1ucose-6-phosphate dehydrogenase) and Glu-P-1 
(2pg/plate) were preincubated for 60 min at 37°C in a shaking waterbath. The plates 
were incubated for 48h at 37°C and the induced histidine revertants were counted. 
Results are presented as Mean±SD for triplicates. The spontaneous reversion rate of 
15±8 has already been subtracted.
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Fluorene is neither a carcinogen nor a mutagen and the 
carcinogenicity of 2-acetylfluorene has not been previously 
examined, but it appears to be a weak mutagen (M. Liest 
personal communication). 2-Aminofluorene and its N-acetylated 
derivitive are both mutagenic in the Ames test (Phillipson and 
loannides, 1983; Hyde et al., 1987) and are readily 
N-hydroxylated to direct-acting mutagens by the P450I family 
(Hammons et al., 1985; Astrom and DePierre, 1985a; 1985b;
Kawajiri et al.y 1983). Fluorene, despite being an inducing 
agent, cannot form reactive, genotoxic intermediates (McCann 
et ai., 1975) . and is a not carcinogenic, in contrast to the 
carcinogens 2-aminofluorene and 2-acetylaminofluorene which 
are both mutagenic and inducers of the P450I.
All three anthracenes induced the P450I family with 
anthracene itself being the weakest. Both the 
amino-derivatives are mutagenic in the Ames test, i.e.they 
can be converted to genotoxic intermediates, in contrast to 
anthracene which displays neither carcinogenicity nor 
mutagenicity. 2-Aminoanthracene is converted to mutagens, 
through N-hydroxylation catalysed by the P450IA2 protein 
(Norman et ai., 1979). The metabolism of anthracene is 
catalysed by P450IA1 to a 1,2-arene oxide which is presumably 
not genotoxic (van Bladeren et al., 1985). The metabolic 
activation of 1-aminoanthracene appears not to have been 
studied but the chemical is mutagenic in the Ames test in the 
presence of an activation system (McCann et ai., 1975; 
Rosenkranz and Poirier, 1979). Both the 1- and 2-amino 
derivatives, especially the 1-isomer, were potent inducers of 
the P450IA2 protein as demonstrated by a marked increase in
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the metabolic activation of Glu-P-1 (Fig 7.4) and the 
apoprotein levels (Fig 7.1), of the anthracene derivatives 
only the carcinogenic amino-derivatives were inducers of 
cytochrome P450I.
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Figure 7.4; Ethoxyresorufin 0-deethylase activity and metabolic activation of Glu-P-1 to mutagens 
by hepatic microsomal preparations pretreated with anthracene and its amino-isomers. 
Both ethoxyresorufin-O-deethylase activity (a) and the metabolic activation of 
Glu-P-1 to mutagens (b) are expressed in terms of total cytochrome P450 levels. The 
metabolic activation of Glu-P-1 to mutagens in the Ames test was determined using 
Salmonella typhimurium strain TA98. Bacteria, microsomal activation systems (20% 
supplemented with lunit/plate g 1ucose-6-phosphate dehydrogenase) and Glu-P-1 
(2pg/plate) were preincubated for 60 min at 37°C in a shaking waterbath. The plates 
were incubated for 48h at 37°C and the induced histidine revertants were counted. 
Results are presented as MeantSD for triplicates. The spontaneous reversion rate of 
15±8 has already been subtracted.
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Nsither biphenyl nor its amino—derivatives significantly 
stimulated the O-deethylation of ethoxyresorufin, but
4-aminobiphenyl markedly enhanced the activation of Glu-P-1 to 
mutagens (Fig 7.5).
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Figure 7.5: Ethoxyresorufin 0-deethylase activity and metabolic activation of Glu-P-1 to mutagens 
by hepatic microsomal preparations pretreated with biphenyl and its amino-isomers. 
Both ethoxyresorufin-O-deethylase activity (a) and the metabolic activation of 
Glu-P-1 to mutagens (b) are expressed in terms of total cytochrome P450 levels. The 
metabolic activation of Glu-P-1 to mutagens in the Ames test was determined using 
Salmonella typhimurium strain TA98. Bacteria, microsomal activation systems (20% 
supplemented with lunit/plate g 1ucose-6-phosphate dehydrogenase) and Glu-P-1 
(2pg/plate) were preincubated for 60 min at 37°C in a shaking waterbath. The plates 
were incubated for 48h at 37°C and the induced histidine revertants were cxxunted. 
Results are presented as MeantSD for triplicates. The spontaneous reversion rate of 
15±8 has already been subtracted.
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The immunoblots (loaded on an equal protein basis) 
showed that 4- and 3-aminobiphenyls and, to lesser extent 
biphenyl induced the P450I apoproteins, in particular the A2 
protein. 3-Aminobiphenyl is not a carcinogen despite being a 
weak inducer, indeed it is not mutagenic in the Ames test. 
Although the N-hydroxy derivative is formed it is not, in 
contrast to the 2- and 4-hydroxyaminobiphenyls, a 
direct-acting mutagen (loannides et al,, 1989) . The
carcinogenic 4-aminobiphenyl is activated to the hydroxylamine 
by the P450I family (Masson at al,, 1983; Kamataki at al,,
1983), particularly the high spin A2 protein which it 
specifically induces. Biphenyl is also a substrate of P450I, 
forming hydroxylated products at the 2- and 4- positions which 
are not mutagenic (Burke and Mayer, 1975).
The P450I family of proteins is induced by and accepts 
as substrates only planar molecules (Lewis at al,, 1986; 
1987), hence most compounds used in the present study would be 
expected to give a positive response. However it appears that 
planarity is a prerequisite but not a condition for P450I 
induction, e.g. naphthalene. In all cases, however, the 
introduction of an amino group enhanced the P450I induction of 
the chemical, except where addition of an amino group distorts 
the planarity of the ring. This was the case for 
2-aminobiphenyl where the presence of an amino group at the 
2-position distorts the planarity forming a dihedral angle of 
40® (Fig 7.6), and the loss of planarity prevents induction of 
P450I proteins.
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2-AMHOBIPHD«L
J-AKXtOBIPHENYL
4-AMDOBIPKQWL
Figure 7.6: Space-filled models of the isomeric forms of aminobiphenyl.
Models were drawn using the PLUTO computer program and 
utilizing the following van der Waal radii to generate the 
computer graphical plots of the molecular geometry, carbon 
1.6Â, hydrogen 1.2Â and nitrogen 1.5Â.
In some cases total P450 protein levels were supressed 
whilst the P450I family were induced, in such cases it 
appears that the levels of constitutive forms of P450 were 
supressed. The induction of one family of cytochrome P450 
proteins at the expense of others has already been documented 
(Dannan et al., 1983; Yeowell at al., 1987).
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7.6 CONCLUSIONS
The study was undertaken primarily to investigate the 
possible relationship between carcinogenic potential of 
aromatic amines and their ability to induce the synthesis of 
the enzyme system responsible for their activation, e.g. the 
P450I family. In the present study all chemicals that are 
carcinogenic were also inducers of the P450I family.A number 
of compounds considered to be non-carcinogens were also 
inducing agents, although within each individual series they 
were always the weakest. These compounds however could not 
form genotoxic metabolites as demonstrated by the lack of a 
mutagenic response in the Ames test. However such compounds 
may act as co-carcinogens, increasing the levels of the enzyme 
system that activates other carcinogens such as the HAAs to 
genotoxic products. It is also interesting to note that 
compounds such as naphthalene, anthracene and fluorene are 
weak inducers and substrates of P450I proteins and as such 
administered shortly before or concurrently with a carcinogen 
requiring P450I activation would result in competitive 
inhibition of activation and hence of carcinogenesis. This has 
been demonstrated effectively before with anthracene and 
naphthalene, which when co-administered with a carcinogenic 
polycyclic hydrocarbon decreased the number of tumours formed, 
thus making these compounds anticarcinogenic. In some cases a 
mutagen may demonstrate non-carcinogenicity as it is unable to 
induce P450I activity, e.g. benzo(e)pyrene which is not an 
inducer nor a carcinogen but which however, is a mutagen in 
the Ames test (loannides et al,, 1984).
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The importance of induction in chemical carcinogenesis 
has been emphasised by other workers, indeed the 
susceptibility of ten different generations of Donryu rats to 
the hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene was 
related to their sensitivity to P450I induction (Yoshimoto et 
ai., 1985). Similarly sex and species differences in the 
carcinogenicity of several HAAs were correlated to the extent 
of P450I induction (Degawa et ai., 1986). Finally, many amines 
such as 4-aminobiphenyl, 2-aminoanthracene and 2-naphthylamine 
could selectively enhance their own activation to mutagens, 
when mutagenicity is expressed in terms of total cytochrome 
P450 levels, by selectively inducing P450I levels (Masson et 
ai., 1983; Steele and loannides, 1986).
With respect to carcinogenicity in man it is pertinent 
to point out that proteins, orthologous to mammalian hepatic 
P450I have been detected immunologically in the liver and 
other tissues in man (Wrighton et ai.,1986), proteins which 
also appear to be induced, e.g. by smoking (Pelkonen et ai., 
1986; Pasanen et ai., 1988). Hence it would appear that the 
environmental and dietary inducers of P450I proteins must play 
a large role in the activation and carcinogenicity of 
carcinogens such as the HAAs to which man is exposed daily 
through the diet. HAAs like many other promutagens are poorly 
activated by control animals (Kato, 1986; Abu-Shakra, 1986), 
however upon exposure of the animals to inducing agents such 
as carcinogenic amines the activation of one typical food 
mutagen, Glu-P-1, is increased several fold. Thus in 
estimating the carcinogenic risk of food mutagens to man, 
several factors including exposure of man to P450I inducers in
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the environment and through diet must be considered
page 179
CHAPTER 8 : INDUCTION OF P4501 PROTEINS AND MODULATION OF THE
METABOLIC ACTIVATION OF THE FOOD MUTAGENS BY
2-AMIN0-3-METHYLIMIDAZ0[4,5-f]QUINOLINE.
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8.1 INTRODUCTION
Many chemical carcinogens are known to express 
carcinogenic and mutagenic activity only after undergoing 
oxidative metabolism catalysed by cytochrome P450 proteins, in 
particular by the 3-methylcholanthrene (3MC)-inducible 
cytochrome P450T isozymes (Parke and loannides, 1987). 
Recently sex, species, and organ dependent induction by 
carcinogenic aromatic amines such as Trp-P-1 and Trp-P-2 
appear to be correlated, at least in part, with increased 
induction rate and/or activity of the carcinogen metabolising 
enzymes of the target organ in the initiation phase of 
carcinogenesis (Degawa et al,,1986). Indeed the importance 
of enzyme induction in chemical carcinogenesis is highlighted 
in studies conducted in two strains of mice. Strains which are 
sensitive to cytochrome P450I induction are more susceptible 
to polycyclic aromatic hydrocarbon (PAH) carcinogenicity 
compared to strains that are refractive to induction (Kouri et 
al,, 1974; Legraverend efc al., 1980; Nebert at al., 1978). 
Similarly results using descendants of Donryu rats that were 
resistant to 3'methyl-diaminoazobenzidine (MeDAB)-induced 
carcinogenesis, demonstrated that the resistance was due to a 
poor inducibility of cytochrome P450I proteins (Yoshimoto et 
al,, 1985). We have also demonstrated that a characteristic of 
several carcinogenic PAHs and aromatic amines is their ability 
to induce P450I proteins, a characteristic which discriminates 
them from their non-carcinogenic isomers and analogues 
(chapter 7; Ayrton et al., 1989).
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The cytochrome P450I family of proteins is also involved 
in the metabolic activation of aminoimidazoazaarenes which 
have been isolated from broiled fish and meat (Yamazoe et al,,
1984). They are mutagenic in a number of in vitro systems 
(Nagao et ai., 1981; Wild et al,, 1985; Thompson et al., 1983;
1987), activate oncogenes (Ishikawa et ai., 1985; Ishizaka et 
al,, 1987) and induce tumours in the liver and other organs
of rodents (Ohgaki et ai., 1984; Takayama et ai., 1984b;
Tanaka et al,, 1985). The prototype is IQ whose activation 
proceeds through an initial N-hydroxylation catalysed by 
cytochrome P4501 proteins, in particular the P450IA2 isozyme, 
to yield a proximate mutagen/carcinogen (Yamazoe et ai., 1983;
1984) which undergoes further metabolism to generate the 
ultimate mutagen/carcinogen (Abu-Shakra et ai., 1986). IQ and 
many other hetrocyclic aromatic amines (HAAs) are found in the
human diet and the present study was undertaken to establish
a) If IQ induces rat hepatic mohooxygenase activity and b) 
selectively induces the isozymes that facilitate its 
activation.
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8.2 MATERIALS
hll chemicals, Salmonella typhimurium strain TA98f and 
cofactors were obtained as cited in chapter 2.
8.3 METHODS
8.3.1 Animals and animaT pretreatment.
Male Wistar albino rats (140-160g) were purchased from 
the Animal Breeding Unit, University of Surrey. They received 
single daily intraperitoneal doses of IQ (20mg/kg) dissolved 
in corn oil (5mg/ml), for three days while the group serving 
as controls received the corresponding volume of corn oil. 
Animals were killed by cervical dislocation 24 hr after the 
administration.
8.3.2 Determination of mixed function oxidase activity.
Hepatic fractions were prepared as previously described
(section 2.2.2) and the following determinations carried 
out on the microsomal fraction: ethoxycoumarin-O-deethylase, 
ethoxyresorufin-O-deethylase, pentoxyresorufin-0-depentylase
and nitrosodimethylamine-N-demethylase activities, total 
cytochrome P450, cytochrome bs and protein, all as previously 
described (section 2.2.7).
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8.3.3 Western blot analysis of microsomal cytochrome P450 
proteins.
Hepatic microsomal suspensions (2mg microsomal 
protein/ml) isolated from control, and IQ-pretreated rats were 
solubilized as previously described (section 2.2.4), by 
incubation at 4°C for 40 minutes with cholate (Img sodium 
cholate/mg microsomal protein) and Emulgen 911 (0.14% v/v) and 
treated with SDS prior to separation by SDS-PAGE 
electrophoresis. Separated proteins were transferred onto 
nitrocellulose paper and immunostained as described previously 
(section 2.2.5 and 2.2.6) using monospecific polyclonal 
antibodies which could detect both P450IA1 and A2 proteins.
8.3.4 Mutagenicity studies.
The metabolic activation of IQ was assayed using the 
Ames test (section 2.2.9), employing Salmonella typhimurium 
strain TA98. The S9 and microsomal fractions (1ml=250mg liver 
wet wt.) were mixed with buffer and cofactors to a final 
concentration of 20% (v/v) and 0.5ml of the activation system 
was used per plate. When the activation system comprised 
microsomes only it was supplemented with glucose-6-phosphate 
dehydrogenase (1 unit/plate). The activation system, bacteria 
(lOOpl) and premutagen (dissolved in 10Opl DMSO) in a total 
volume of 0.7ml were preincubated for 1h at 37°C in a shaking 
waterbath, unless otherwise stated. Microsomal activation of 
the premutagen Glu-P-1 was carried out as above except that IQ 
was replaced with Glu-P-1.
In studies where the effect of the cytosol on the
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microsomal activation of IQ was studied (section 2.2.9.4), IQ 
(200ng) was preincubated with the bacteria and microsomal 
activation system for 30min at 37°C in a shaking waterbath 
prior to termination of the microsomal metabolism by the 
addition of lOOpl of menadione (90OpM). Cytosol (SOOpl of a 
20% preparation) was added and a further 30min incubation 
carried out.
8.3.5 Molecular shape.
The molecular geometry of IQ was determined by using the 
COSMIC package (written by J.G. Vinter, A. Davis and M. 
Saunders) from Smith, Kline and French Ltd. The PLUTO 
crystallographies package was used to generate the molecular 
plots which were viewed both in and perpendicular to the 
molecular plane. The following van derWaals radii were used 
to generate the molecular plots : carbon 1. 6Â, hydrogen 1. 2Â
and nitrogen 1.5Â.
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8.4 RESULTS
8.4.1 Effect of IQ on some rat liver parameters.
Pretreatment of rats with IQ caused a small but not 
significant decrease on liver weight, microsomal protein 
levels, total cytochrome P450 and NADPH-dependent cytochrome c 
reductase activity (Table 8.1). In contrast, a significant 
decrease in cytochrome bs levels was observed in IQ-treated 
rats.
Table 8.1: Effect of treatment of IQ on some liver parameters.
Results are presented as Mean ±SEM for five animals. Animals were given 
intraperitoneal doses of IQ (20 mg/kg) daily for three days while controls recieved 
the corresponding volume of vehicle, namely corn oil. All animals were killed 24h 
after the last administration i.e. on the fourth day.
Parameter control IQ-pretreated
Liver mass/body mass(XlOO) 5.9 ±0.3 5.5 ±0.2
Microsomal protein 
{mg/g liver)
32.3 ±3.1 24.2 ±2.7
Cytochrome P450 
nmol/mg protein)
0.57±0.04 0.42±0.1
Cytochrome bo 
(nmol/mg protein)
0.72±0.03 0.49±0.05"-
NADPH-cytochrome c reductase 
{nmol/min per mg protein)
32.3 ±3.1 24.3 ±2.7
** P<0.01
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8.4.2 Effect of IQ-pretreatment on rat hepatic microsomal 
mixed-function oxidase activities.
IQ-pretreatment resulted in enhanced levels of both 
ethoxycoumarin and ethoxyresorufin 0-deethylase activities. No 
such increase was observed with the 0-depentylation of 
pentoxyresorufin and a decrease was observed in the 
N-demethylation of dimethylnitrosamine (Table 8.2)
Table 8.2; Effect of IQ-treatment on some hepatic monooxygenase activities.
Results are presented as Mean ±SEM for five animals. Animals were given 
intraperitoneal doses of IQ (20 mg/kg) daily for three days while controls 
recieved the corresponding volume of vehicle, namely corn oil. All animals 
were killed 24h after the last administration i.e. on the fourth day.
Parameter control IQ-pretreated
Ethoxyresorufin 0-deethylase 
{pmol/min per mg protein) 
(pmol/min per nmol P450)
4.4± 0.5 
9.2± 2.5
19.9± 3.2-" 
43.7± 14.2
Pentoxyresorufi n 0-depentylase 
{pmol/min per mg protein) 
{pmol/min per nmol P450)
1.3+ 0.1 
2.1± 0.4
1.2± 0.2 
3.5± 1.0
Ethoxycoumarin 0-deethylase 
{pmol/min per mg protein) 
(pmol/min per nmol P450)
43.4± 5.7 
77.U11.6
100.3± 13.7- 
273.4±122.0
Dimethynitrosêimine N-demethylase 
(nmol/min per mg protein) 
(pmol/min per nmol P450)
2.4± 0.2 
4.1± 0.2
1.4± 0.5 
3.1± 0.6
P<0.05, ** P<0.01
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8.4.4 Effect of IQ pretreatment on rat hepatic microsomal 
activation of Glu-P-1 to mutagens.
Isolated microsomes from IQ-pretreated rats were 
markedly more efficient than controls in activating Glu-P-1 to 
mutagen in the Ames test (Fig. 8.1).
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Figure 8.1: A comparison of IQ-induced and control microsomes in the activation of the mutagen Glu-P-1.
The mutagenicity was determined in the Ames test using Salmonella typhimurium TA98 and 
activation systems (20%), supplemented with 1 unit/plate of glucose-6-phosphate dehydrogenase, 
containing microsomes from control (A) and IQ-induced (□) animals. The plates were incubated 
for 48h at 37*C and the induced histidine revertants were counted. Results are presented as 
MeanfSD for triplicates. The spontaneous reversion rate of 19±5 has already been subtracted. 
The experiment was repeated using activation systems from different but similarly treated 
animals, with the same results.
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8.4.5 Effect of IQ pretreatment on the levels of hepatic 
cytochrome P450I and P450IIB apoproteins.
When solubilised microsomal proteins were resolved by 
SDS-PAGE employing 10% gels, blotted onto nitrocellulose paper 
and probed with antibodies against cytochrome P450I proteins, 
both the low spin P450IA1 and the high spin P450IA2 were seen 
to be clearly induced by IQ-pretreatment, when compared to 
control (Fig. 8.2a). 3MC- and isosafrole-treated rats, as a 
positive controls, gave the expected response.
Figure 8.2; Immunoblot analyasis employing anti-P450IA1 and anti-P450IIB1 polyclonal antibodies.
Solubilised microsomes were resolved by 10%(w/v) SDS-PAGE and transferred electrophoretically 
to nitrocellulose. In (a), the immunoblot was carried out with sheep anti-cytochrome 
P450IA1(diluted 1:12,000) followed by peroxidase-labelled donkey anti-sheep IgG(diluted 
1:1,000). Solubilised microsomes were loaded as follows: Lane 1, 3-methylcholanthrene (2.5pg 
protein). Lane 2, IQ (lOpg protein), Lane 3 control(lOpg protein). Lane 4, isosafrole (2.5pg 
protein). Bands are labelled a and b to show cytochromes P450IA1 and A2 respectively. In (b) 
the immunoblot was performed with rabbit anti-cytochrome P450IIB1 (diluted 1:2,000) followed 
by peroxidase-labelled donkey anti-rabbit IgG (diluted 1:1,000). Solubilised microsomes were 
loaded as follows: Lane 1, control (lOpg protein). Lane 2, IQ (lOpg protein) and lane 3, 
phénobarbital (2.5pg protein).
When the transferred proteins were probed with 
antibodies against cytochrome P450IIB there was no obvious
difference between the IQ-pretreated microsomes and control
(Fig. 8.2b). Microsomes from phénobarbital (PB)-treated rats, 
used as a positive control, gave the expected response.
page 189
8.4.6 Effect of IQ pretreatment on rat hepatic activation of 
IQ to mutagens.
Pretreatment of rats with IQ gave rise to a marked
increase in the ability of the hepatic S9 fraction to activate 
IQ to mutagens in the Ames test (Fig 8.3a). When the
microsomal fraction was used as an activation system a similar
but less pronounced enhancement was seen with microsomes
isolated from IQ pretreated rats (Fig 8.3b).
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Figure 8.3; The activation of IQ to mutagens by hepatic microsomal and S9 preparations from control and 
IQ-treated rat
The mutagenicity of IQ in the Ames test was determined using Salmonella typhimurium 
TA98 and activation systems (20%) either S9(a) or microsomes(b). Hepatic fractions 
were derived from either control (A) or IQ-treated rats (□). When microsomes were 
used for activation, activation systems were supplemented with 1 unit/plate 
glucose-6-phosphate dehydrogenase. The plates were incubated for 48h at 37°C and the 
induced histidine revertants were counted. The spontaneous reversion rate of 21±5 
has already been subtracted. Results are presented as MeaniSD for triplicates.
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8.4.7 Effect of IQ pretreatment on the cytosolic potentiation 
of the microsome-mediated mutagenicity of IQ.
When microsomal metabolism of IQ was terminated by 
addition of menadione, cytosolic fraction from untreated rats 
did not result in a significant increase in mutagenicity when 
compared with addition of buffer. This effect was independent 
of the source of the microsomes (Fig 8.4). Pre-treatment with 
IQ however, enhanced the cytosol-mediated potentiation of its 
mutagenicity, an effect that was particularly marked when 
microsomes were derived from the IQ-treated rats.
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Figure 8.4; Effect of treatment with IQ on the cytosolic potentiation of the mutagenicity 
of IQ
IQ (200ng) was preincubated at 37°C for 1h with Salmonella typhimurium strain TA98 
and a microsomal activation system (20%) derived from either control or IQ-treated 
rats. The microsomal reacrtion was terminated by the addition of ICOpl menadione 
(900pM). Buffer(B) or cytosol from either control( @ ) or IQ-treated rats were added 
and a further Ih incubation at 37°C was performed. The plates were Incubated for 48h 
at 37°C and the induced histidine revertants were counted. The spontaneous reversion 
rate of 21±5 has already been subtracted. Results are presented as MeaniSD for 
triplicates.
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8.4.8 Molecular shape.
The computer-optimised dimensions of IQ were: length
11.0Â, width 7.4Â and depth 4.0Â, giving it an area/depth 
ratio of 20.5Â, showing that it is a large essentially planar 
molecule (Fig 8.5).
Figure 8.5: Space-filled model of IQ.
The PLUTQ computer program was used to draw the model using the following van der Waals radii 
to generate the computer-graphical plot of the molecular geometry: carbon 1.6Â, hydrogen 1.2Â 
and nitrogen 1.5Â.
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8.5 DISCUSSION
Many chemical carcinogens can selectively stimulate 
their own activation eg. the polycyclic aromatic hydrocarbons, 
aromatic amines and amides, which selectively induce the 
cytochrome P4501 family of haemoproteins and the cytochrome 
P450 isozymes that mediate their activation (Thomas et al., 
1983; Masson et ai., 1983; Steele and loannides, 1986). Indeed 
it has been suggested that this potential for "auto-induction" 
is necessary for the initiation of the process of 
carcinogenesis. This hypothesis has been largely proved to be 
true in studies where animals resistant to chemically-induced 
carcinogenesis failed to respond to P4501-inducers (Kouri et 
al., 1974; Legraverend et ai., 1980; Nebert et ai., 1978;
Yoshimoto et ai., 1985). Furthermore in a previous study
(chapter 7) we have demonstrated that the ability to induce 
cytochrome P450I proteins is an inherent characteristic that 
may distinguish between carcinogenic amines and their 
non-carcinogenic analogues. The same studies also showed that 
this inherent property of the molecule is due to its overall 
molecular geometry, with cytochrome P450I induction being 
caused by the interaction of the Ah receptor with essentially 
planar molecules, ie. molecules with a large area/depth ratio 
and a small depth. However planarity is a prerequisite but not 
a condition for cytochrome P450I induction.
A computergraphic analysis of the molecular shape of IQ 
showed that it clearly meets the necessary criteria for 
interaction with the Ah receptor and induction of P450I 
proteins (Lewis et al., 1986; 1987). Indeed pretreatment of
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rats with IQ gave rise to a dose-dependent increase in the 
cytochrome P450I catalysed 0-deethylation of ethoxyresorufin 
(Phillipson et ai.,1984; Guengerich et al., 1982a), the extent 
of induction being comparable to that observed with other 
aromatic amines (Steele and loannides, 1986; Iwasaki et aiV,
1986). A similar increase was also observed in the 
0-deethylation of ethoxycoumarin was also observed, a reaction 
catalysed by P450I proteins (Guengerich et al., 1982a). The 
induction of cytochrome P450I proteins by IQ was selective as 
treatment with this compound, had no effect on the 
0-depentylation of pentoxyresorufin and caused a small 
decrease in the N-demethylation of dimethylnitrosamine, 
reactions catalysed by other cytochrome P450 proteins, namely 
P450IIB and P450IIE1 respectively (Lubet et ai., 1985; Thomas 
et al., 1987). Selectivity of induction of P450I was further
confirmed by western blot techniques; an increase was observed 
in the levels of P450I apoproteins but not those of the 
P450IIB family. Furthermore immunoblot analysis demonstrated 
that IQ induces both P450I proteins in particular P450IA2, 
which was confirmed by the marked increase in the activation 
of Glu-P-1 to mutagens, a reaction preferentially catalysed by 
P450IA2 (Yamazoe et ai., 1984). Since the levels of total 
cytochrome P450 decreased following IQ pretreatment it is 
likely that induction of P450I occurred at the expense of 
other P450 proteins, as seen with other inducing agents 
(Dannan et ai., 1983).
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Since IQ is selectively activated to mutagens by the 
P450I family, it would be anticipated that its mutagenicity 
would be enhanced when activation systems from IQ-pretreated 
animals are employed, and indeed, S9-mediated and to a lesser 
extent the microsome-mediated activation of IQ was also 
increased by treatment with the carcinogen. Such an effect has 
been reported for the tryptophan pyrolysis products which 
induced both cytochrome P450I proteins and their own hepatic 
activation (Degawa et al., 1987a), and also, subsequent to the 
publication of our work, induction was also shown to occur 
with all the HAAs including IQ (Degawa et ai.,1989).
The activation of IQ by S9 fractions is not solely due 
to microsome-mediated activation (Abu-Shakra et ai., 1986) but 
also involves potentiation of microsomar metabolism by an
Aroclor-1254 inducible cytosolic step. The microsome-mediated 
activation of IQ by IQ-induced preparations was markedly lower
than S9-mediated activation, therefore S9-activation must
represent an increase in both microsomal activation and 
cytosolic potentiation. Indeed IQ-induced cytosol was more
effective than control in potentiating the microsome-mediated 
mutagenicity of IQ, the effect being independent of the origin 
of the microsomes.
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8.6 CONCLUSIONS
This study clearly demonstrates IQ to be a selective
inducer of the cytochrome P4501 system. This is of interest as
IQ is found readily in a cooked meat diet, and thus man is
exposed to this and other HAAs, which also induce cytochrome
P450I proteins (Degawa et al., 1909), on a daily basis. Thus
these compounds are not only carcinogenic (Sugimura et ai.,
1985) but also potentiate not only their own activation but
also the activation of other cytochrome P4501 dependent
carcinogens, and consequently may promote initiation of
carcinogenesis. As human liver has an orthologous protein to
rat P450IA2, P450pA (the phenacetin 0-deethylase) an enzyme
also involved in the activation of HAAs to mutagens (Shimada
et al., 1989), it logical to speculate that the human protein
will also be sensitive to induction by HAAs and may account,
at least in part, for the relationship between diet and
cancer. Furthermore it has been shown that the tt/z of
phenacetin is markedly decreased following human consumption
of charcoal-broiled beef (Conney et al., 1976). As the 
>
polycyclic hydrocarbons are more specific at inducing 
cytochrome rat P450IA1 (Ayrton et ai., 1988c), orthologous to 
human P-,-450 (a benzo(a)pyrene hydroxylase)„the increase in 
clearance may very likely be due to HAAs in the meat. In 
conclusion, IQ although a weak carcinogen (TDso 0.2mg/kg/day,
Sugimura, 1986b) compared to Aflatoxin B-, (TDso 932ng/kg/d, 
Gold et ai., 1984), is also an inducer of P450I and a likely 
enhancer of chemical carcinogenesis.
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CHAPTER 9 : CYTOSOLIC POTENTIATION OF MICROSOME-MEDIATED
ACTIVATION OF IQ.
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9.1 INTRODUCTION
The initial step in the activation of aromatic amines is 
an N-hydroxylation, which is catalysed primarily by the 
microsomal cytochrome P450 mixed-function oxidases found in 
the microsomal fraction (loannides and Parke, 1987; Mason et 
al., 1983; Hammons et al., 1985). N-Hydroxylation generates 
the proximate mutagenic species, the N-hydroxylamine, which is 
subject to further metabolism by liver enzymes such as the 
membrane-bound UDP-glucuronyltransferases or cytosolic enzymes 
such as sulphotransferases, N-acyltrans ferase ^ N ,0-acy1trans- 
ferase and glutathione transferases, to form a more potent 
ultimate genotoxic metabolite (Miller, 1978; Weeks et al., 
1978; Krieck, 1974; Irving et al., 1969; Kadlubar and Beland, 
1985).
Studies using the highly mutagenic heterocylic aromatic 
amines (HAAs) formed during the pyrolysis of proteinaceous 
food or amino acids, have shown that the initial step in their 
metabolic activation also occurs via N-hydroxylation 
catalysed by the cytochrome P4501 family of proteins, in 
particular the high spin form P450IA2 (Kato and Yamazoe,
1987). The N-hydroxylamines formed are direct-acting 
frame-shift mutagens which require no further activation by 
microsomal enzymes (Snyderwine et al., 1987; 1988a; 1988b;
Negishi et al., 1989a; Kato and Yamazoe, 1987); however they 
are not direct-acting in the same sense as potent 
DNA-alkylating agents, since they interact poorly with 
proteins and nucleic acids at physiological pH, and may 
undergo additional metabolism by bacterial enzymes. Thus
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further metabolic activation is necessary for the conversion 
of the hydroxylamine to a potent reactive electrophiles.
The mutagenic and DNA-binding potency of 
heterocyclic-hydroxylamines can be markedly enhanced by the 
cytosol. One factor present in the cytosol was found to be 
induced by Aroclor 1254 pretreatment, and could potentiate the 
microsome-mediated mutagenicity of IQ without the addition of 
co-factors for phase II metabolism (Abu-Shakra et ai.,1986). 
The mutagenic response of HAAs and their hydroxylamine 
derivatives can also be modified by the presence of cytosol 
supplemented with cofactors for phase II conjugation reations 
(Saito et ai., 1984; Snyderwine et ai., 1988a). Similarly it 
has been demonstrated that the DNA-binding of some 
heterocyclic aromatic hydroxylamines can be dramatically 
enhanced by the addition of cytosol supplemented with 
cofactors for either the acyltransferases (Shinohara et ai., 
1985; Snyderwine et ai. , 1988a) or prolyl-tRNA synthetase
(Yamazoe et ai., 1985).
Since the cytosol has been shown to modulate the 
microsome-mediated mutagenicity of a number promutagens such 
as nitrosamines (Ayrton et ai., 1987b) polycyclic aromatic 
hydrocarbons (Saccone and Pariza, 1981) aromatic amines and 
amides (Smith and loannides, 1987; Saccone and Pariza, 1981), 
as well as direct-acting mutagens such as quercetin (Ochiai et 
ai., 1984), the role of the cytosolic fraction in the 
enhancement of the microsomal activation of the HAA, IQ, was 
investigated and its role in the in vivo activation of this 
compound evaluated.
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9.2 Materials.
L-Ascorbate, xanthine (BDH chemicals Ltd., Poole, 
Dorset), reduced glutathione, UDPGA, menadione, quercetin, 
superoxide dismutase (Sigma Co., Poole, Dorset) Salmonella 
typhimurium strain TA98, all other reagents and cofactors were 
obtained as cited in section 2.1. Salmonella
typhimurium strains TA98NR and TA98/1,8DNPs were generous 
gifts from Prof. H.Rosenkranz(Cleveland, USA).
9.3 Methods.
9.3.1 Animals and animal pretreatment.
Male Wistar albino rats (200-230g) were purchased from 
the Animal Breeding Unit, University of Surrey.Induction of 
the mixed function oxidases was achieved by a single i.p. 
administration of Aroclor 1254 (500 mg/kg), as previously
described (2.2.1)
9.3.2 Preparation of hepatic fractions.
All hepatic fractions were prepared as previously 
described (chapter 2.2.2).
9.3.3 Dialysis of the cytosolic fraction.
Cytosol prepared as previously described was dialysed in 
3 X 2L of 1OmM sodium phosphate buffer containing glycerol 
(10%) overnight at 4°C.
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9.3.4 Treatment of the cytosol with proteinase K.
Cytosol was incubated with proteinase K (2mg/ml cytosol) 
at 37°C for 60min in a shaking waterbath. Cytosol without 
addition of proteinase K was also taken through the same 
process as a control.
9.3.5 Mutagenicity studies.
Activation of IQ to reactive mutagenic intermediates
was. monitored using the Ames test (2.2.9) employing
-
Salmonella typhimurium strains TA98, TA98NR and TA98/1,8DNPs. 
Activation systems contained 10% of the various hepatic 
fractions and the plate incorporation method was used. When 
activation systems comprised microsomes only, the activation 
system was supplemented with glucose-6-phosphate dehydrogenase 
(1 unit/plate). IQ was dissolved in DMSO so that a maximum of 
100]jl1 of DMSO was added to each plate.
The role of the cytosol in potentiating the microsomal 
activation of IQ was investigated (2.2.9.4) by preincubating 
IQ, the microsomal activation system (10%) and bacteria for 20 
min at 37°C in a shaking waterbath prior to termination of 
the microsomal reaction by the addition of 100pi of menadione 
(900pM). Buffer or cytosol was then added, followed by a 
further 20 min incubation period.
9.3.6 In Vitro binding of ['•'‘ClIQ to DNA and purification of 
DNA-IQ adducts.
Rat liver fractions ie. S9, microsomes and cytosol were 
prepared as described above. Incubations were carried out with 
['‘'*C]IQ (50]ig) as previously described (2.2.10) in a shaking
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water bath at 37°C for 0-3h for the time course study and for 
3h when comparing activation systems. The reaction was 
terminated with ethyl acetate and the DNA purified as 
previously described (2.2.11)
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9.4 Results
9.4.1 A comparison of the microsome- and S9-mediated 
mutagenicity of IQ towards TA98, TA98NR and TA98/1,8DNPs.
IQ was equally mutagenic towards both Salmonella 
typhimurium strains TA98 and TA98NR in the presence of an 
Aroclor 1254-induced hepatic S9 fraction (Fig 9.1). The 
mutagenicity of IQ was less pronounced when the microsomal 
fraction was used, but again mutagenic activity was the same 
in both strains. No significant mutagenicity was seen in 
TA98/1,SDNPe when IQ was activated by microsomes only, whereas 
a weak mutagenic response was observed when the S9 fraction 
was used as an activation system. Regardless of the bacterial 
strain used, the S9 fraction was always markedly more
efficient than microsomes in the activation of IQ.
12000
10000
8000
6000
4000
TA 98 + m i c r o s o m e :
TA 98 NR +MICROSOME
2000
TA98 ' 1 B 0 N P .  ♦ S9  
4|lTA98 1 S O N M I C R O S O M E S
3023 73 1000
IQ cxmoentratlon (ng/^late)
Figure 9.1; Mutagenic dose-response curves for IQ towards TA98, TA98NR and TA98/1.8DNP6 
with either S9 or microsomal mediated activation.
IQ and either Salmonella typhimurium strain TA98, TA98/1,8DNPb and TA98NR were 
added to an Aroclor 1254-induced S9 or microsomal activation system (10%) 
supplemented with lunit/plate glucose-6-phosphate dehydrogenase when
microsomes only were used. The plates were incubated for 48h at 37°C and the 
induced histidine revertants were counted. Results are presented as MeantSD 
for triplicates. The spontaneous reversion rates of 20±6, 15±4 and 30±3 have 
already been subtrated from TA98, TA98/1,8DNPg and TA98NR respectively.
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9.4.2 Potentiation of the microsomal mutagenicity of IQ by 
cytosol isolated from Aroclor 1254-pretreated rats.
When the microsomal activation was terminated following 
a 20min incubation period by the addition of menadione, 
subsequent addition of the cytosol and a further incubation 
period of 20min resulted in an increase in the mutagenic 
response when compared to the addition of buffer only (Table
9.1) .
Cytosolic potentiation of the microsome-mediated
mutagenicity of IQ
Activation system Histidine revertants/plate
Microsomes + cytosol 253±21
Microsomes + buffer 138±25
Cytosolic potentiation 114±15
IQ (lOng) was pre-incubated for 20 min with 
Salmonella typhimurium strain TA98 and an 
Aroclor 1254-induced hepatic microsomal 
activation system (10%, supplemented with 
lunit/plate glucose-6-phosphte dehydrogenase) 
isolated from Aroclor pretreated rats and the 
reaction was terminated by the addition of lOOpl 
of menadione (900pM). Buffer or cytosol was then 
added and a further incubation of 20 min carried 
out. Results are presented as Mean±S.D. for 3 
plates. The spontaneous reversion rate of 25+5 
has already been subtracted.
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9.4.3 Effect of dialysis, proteinase K treatment and heating 
on the cytosolic enhamcement of microsomal activation of IQ.
Dialysis of the cytosol resulted in no loss of enhancing 
activity of the cytosol but in contrast incubation of the 
cytosolic mix for 20min at 60°C resulted in a total loss of 
this activity (Table 9.2). Similarly incubation with 
proteinase K resulted in loss of cytosolic activity. None of 
the cytosolic activity was lost by further centrifugation of 
the 105,000g supernatant.
Table 9.2: Cytosolic potentiation of the microsome-mediated mutagenicity of IQ 
using heat-treated and proteinase K-treated cytosol.
Activation system__________________________ Histidine revertants/plate
Microsomes + cytosol (IX 105,000g spin) 855±64
Microsomes + cytosol (2X 105,000g spin) 864±33
Microsomes + dialysed cytosol 809±29
Microsomes + heated cytosol (60°C for 20min) 563±98
Microsomes + proteinase K-treated cytosol control 694± 8
Microsomes + proteinase K-treated cytosol 310± 6
Microsomes + buffer 398± 2
IQ (lOng) was pre-incubated for 20 min with Salmonella typhimurium 
strain TA98 and an Aroclor 1254-induced hepatic microsomal 
activation system (10%), supplemented with glucose-6phosphate 
dehydrogenase. The reaction was terminated by the addition of lOOpl 
of menadione (900pM) and buffer, cytosol or treated-cytosol was 
then added and a further incubation of 20 min carried out. Results 
are presented as MeanlS.D. for 3 plates. The spontaneous reversion 
rate of 25±5 has already been subtracted.
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9.4.4 Mutagenicity of IQ in the Ames test in the presence of 
various phase II cofactors.
The results from experiments in which various cofactors 
for phase II conjugation reactions were added to the 
incubation mixture are summarised in Table 9.3. 
Microsome-mediated mutagenicity was significantly decreased by 
the addition of acetyl CoA, UDPGA and glutathione, both 
oxidised and reduced. Addition of these cofactors into the S9 
activation system resulted in the same but more pronounced 
decrease in mutagenic activity. S9-mediated activation was 
also significantly decreased in the presence of ATP and 
proline.
Table 9.3; Effect of phase II cofactors on the microsome- and S9- 
medited activation of IQ.
Cofactor addition S9 activation Microsomal activation
None 1669±123 658±32
ATP(lOmM) 1530±232 710±104
ATP(1OmM)+Proli ne(1 nfi) 1390± 60* 634±48
Acetyl CoA(lmM) 1274± 12** 361±71*
GSH(lOfifl) 1193±191* 531±45*
UDPGA(5(tW) 1393± 31* 505±32**
Xanthine(lmM) 1585± 20 668±78
L-Ascorbate(lmM) 1937±204 2161±222***
* P<0.05; ** P<0.01; --- P<0.001
IQ (lOng) was pre-incubated with Salmonella typhimurium
TA98, phase II cofactor(s) and Aroclor 1254-induced 
microsomal or S9 activation system (10%), supplemented with 
glucos-6-phosphate dehydrogenase when microsomes only were 
used. Results are presented as mean ±S.D. for 3 plates. The 
spontaneous reversion rate of 29±4 has already been 
subtracted.
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9.4.5 Effect of ascorbic acid on either microsomal or S9 
mediated activation of IQ.
Addition of ascorbic acid to the microsomal activation 
system resulted in a highly significant increase in the 
microsome-mediated mutagenicity of IQ, which abolished the 
difference between microsome- and S9-mediated activation of IQ 
(Table 9.3). When incorporated into the S9 activation system a 
small but non-significant increase was observed. If ascorbic 
acid was added subsequent to the termination of microsomal 
metabolism, again an increase in mutagenicity was seen that
mimicked the cytosolic potentiation (Fig 9.2)
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Figure 9.2; Enhancement of the microsome-mediated mutagenicity of IQ by superoxide 
dismutase and vitamin C.
IQ (lOng) was pre-incubated for 20 min with Salmonella typhlmurlum 
strain TA98 and an Aroclor 1254-induced hepatic microsomal activation 
system (10%), supplemented with lunit/plate glucose-6phosphate 
dehydrogenase. The reaction was terminated by the addition of lOOpl of 
menadione (900pM). Buffer, cytosol or superoxide dismutase (25 or 50 
units/plate) was then added and a further incubation of 20 min carried 
out. Results are presented as MeantSD for 3 plates. The spontaneous 
reversion rate of 29±4 has already been subtracted.
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9.4.6 The enhancing effect of superoxide dismutase on the 
microsome-mediated mutagenicity of IQ.
Addition of superoxide dismutase to the microsomal 
activation system resulted in an increase in mutagenicity that 
was dependent upon the amount of enzyme added (Fig 9.3). The 
same effect was observed even when microsomal metabolism was 
terminated prior to the addition of superoxide dismutase (Fig
9,2), the effect being less pronounced in the latter case.
2000
1500
1000
500
a t
Figure 9.3: Enhancement of microsomal activation of IQ by superoxide dismutase and vitamin C.
IQ (lOng) was pre-incubated for 30 min with Salmonella typhlmurlum strain TA98 an 
Aroclor 1254-induced S9 or microsomal (supplemented with 1 unit/plate 
glucose-6-phosphate dehydrogenase) activation system (10%), in the presence or 
absence of superoxide dismutase (expressed as units/ plate). Results are 
presented as MeantS.D. for 3 plates. The spontaneous reversion rate of 27±5 has 
already been subtracted.
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9.4.7 Covalent binding of [■‘'*C]IQ to DNA
When [T*C]IQ was incubated in the presence of Aroclor 
1254-induced rat liver S9 fraction with cofactors at 37*C, 
incorporation of radioactivity into calf thymus DNA was 
observed. Covalent binding was strongly suggested since the 
bound radioactivity was neither removed by the extraction 
procedure nor by ethanol precipitation. Binding of IQ to DNA 
increased in a time-dependent manner (Fig 9.4).
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Figure 9.4: Binding of [14C]IQ to calf thymus DNA with S9 activation.
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There was no significant difference between S9- and 
microsome-mediated binding of IQ to the DNA, with microsomes 
producing a slightly higher degree of binding (Table 9.4). No 
significant binding to DNA was observed with the cytosol only.
Table 9.4: Activation of [14C]IQ to DNA-binding species by
various hepatic subcellular fractions isolated
from Aroclor pretreated rat.
Liver fraction nmol IQ bound/mg DNA
Microsomes 0.42±0.03**
S9 0.29±0.08*
Cytosol 0.02±0.01
* P<0.05; ** P<0.01
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9.5 Discussion
The microsomal metabolite of IQ, N-hydroxy-IQ(NOHIQ) is 
a proximate mutagen (Yamazoe et al. , 1983; Snyderwine et al., 
1988a; Okamoto et al., 1981) which is further activated by
enzymic and non-enzymic pathways to ultimate mutagen(s) 
capable of covalently binding to bacterial DNA and inducing 
mutations (Abu-Shakra et ai., 1986; Kato and Yamazoe, 1987; 
Kato, 1986; Snyderwine et ai., 1988a; 1988b).
The mutagenic response elicited by IQ in the presence of 
hepatic S9, ie microsomes plus cytosol, from Aroclor 
1254-induced rats is clearly greater than that induced by 
microsomes isolated from the same animal. Since cytosol on its 
own cannot activate IQ to mutagens it is obvious that the 
cytosol facilitates the formation of mutagenic microsomal 
metabolites or participates in further metabolism of the 
microsomal metabolites to ultimate mutagens. Using a 
previously established experimental protocol (Ayrton efc ai., 
1987b), whereby the microsomes metabolise IQ, prior to 
termination of microsomal activity by addition of menadione 
and subsequent addition of either cytosol or buffer, the role 
of the cytosol in the further activation of microsomal 
metabolites was demonstrated. This potentiating effect of the 
cytosol was shown to be enzyme-mediated as it was 
undialysable, destroyed by heating and by treatment with 
proteinase K.
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In the Ames test, the S9 activation systems possess very 
limited phase II activity (Greim et al., 1980) and as a rule 
are supplemented solely with the cofactors required for 
microsomal metabolism of compounds ie. NADPH, thus excluding 
phase II conjugation reactions being involved, to any 
significant extent, in the cytosolic potentiation. Cytosolic 
enzymes however, have been associated with the ability to 
further activate N-hydroxy derivatives of heterocyclic 
aromatic amines to even more genotoxic metabolites (Kato and 
Yamazoe, 1987; Kato, 1986) . It has already been demonstrated 
that the cytosol can enhance the DNA-binding of N-hydroxy 
derivatives of HAAs in the presence of acetyl CoA (Shinohara 
et al., 1985; Snyderwine et al., 1988a), ATP and proline
(Yamazoe et al., 1985), cofators required for acyltranferases 
and prolyl-tRNA synthetase respectively. To investigate the 
effect of phase II conjugation reactions on IQ mutagenicity, 
cofactors required for phase II metabolism were incorporated 
into the activation system. The results showed a decrease in 
microsome-mediated activation of IQ in the presence of acetyl 
CoA, glutathione and UDPGA, suggesting that the microsomal 
metabolite(s) of IQ is either enzymically or non-enzymically 
conjugated to UDPGA, catalysed by glucuronosyltransferase, 
acetyl CoA and glutathione, all resulting in apparent 
detoxication. When 59 was used as an activation system similar 
results were obtained again, suggesting conjugation resulting 
in apparent detoxication. These results conflict with previous 
findings obtained in DNA-binding experiments using NOHIQ, 
where binding was markedly enhanced by addition of acetyl CoA 
and cytosol. One possible explanation is that addition of 
acetyl CoA results in a detoxifying N-acetylation reaction,
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however N-acetylation with other HAAs results in compounds 
with the same mutagenic activity as the parent compound thus 
suggesting that N-acetylation plays no major role in the 
mutagenicity of HAAs (Negishi efc ai., 1986; Brunborg et ai.,
1988). Another possibility is that the bacterial ultimate 
mutagen is not the same as the ultimate DNA-binding species, 
or, more likely, the ultimate mutagen, due to its very 
reactive and unstable nature, cannot gain entry into the 
bacteria and must be formed from the proximate mutagen within 
the bacteria. This was demonstrated convincingly for Glu-P-1 
(Saito et ai., 1985) where acétylation of the N-hydroxy 
derivative of Glu-P-1 (NOHGlu-P-1) by bacterial 
O-acetytransferase to the ultimate mutagen resulted in 
inhibition of mutagenicity if the reaction was performed 
outside the bacteria. Conjugation to a very reactive ultimate 
species must therefore occur in the presence or in the 
vicinity of DNA. Due to the similarities in the metabolism and 
structure of Glu-P-1 and IQ, this is a likely explanation for 
the apparent detoxication of IQ and NOHIQ by acetyl CoA. Such 
a hypothesis may also explain why prolyl-tRNA synthetase, 
another enzyme system also implicated in the formation of the 
ultimate genotoxic species of HAAs, also resulted in a 
significant decrease in mutagenicity. Ërom the results it is 
difficult to distinguish whether UDPGA and glutathione will 
result in detoxication or activation of IQ in vivo and 
requires further investigation in another test system.
Vitamin C has previously been reported to enhance the 
mutagenicity of direct-acting mutagens such as the 
N-hydroxyderivative of 2-acetylaminofluorene (NOHAAF),
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quercetin and NOHIQ (Snyderwine et al,, 1988; Ochiai et ai., 
1984; Sakai et ai., 1978). Addition of vitamin C into the 
activation system clearly showed that microsomal activation 
but not S9 activation, was enhanced. As the effect was not 
seen with S9 this may eliminate an enhancing effect of vitamin 
C on microsomal metabolism of IQ. Furthermore the addition of 
vitamin G abolished the differences between buffer and 
cytosol, thus mimicking the cytosolic potentiation of 
microsome-mediated activation of IQ. Vitamin C could have two 
effects, it could act as 1) an antioxidant and 2) act as a 
scavenger of superoxide anions (Nishikimi, 1975).
The removal of superoxide anions can also be catalysed 
by superoxide dismutase (SOD) which, like vitamin C, was 
shown to enhance the mutagenicity of quercetin (Ochiai et ai,, 
1984). Superoxide dismutase enhanced the microsomal activation 
of IQ, the effect being dependent on the amount of enzyme 
present, demonstrating unequivocally that this cytosolic 
enzyme plays a role in the activation of IQ by S9. Furthermore 
the observation that it also enhanced the mutagenicity of 
microsome-generated metabolites, subsequent to the termination 
of the microsomal reaction, also demonstrates a possible role 
for SOD in the cytosolic potentiation of IQ mutagenicity, 
however the enhancement by SOD was less pronounced than when 
added to the complete microsomal activation system. This may 
reflect an involvement of menadione in the production of 
superoxide anions, by redox cycling in the absence of 
NADPH-dependent menadione reductase, an enzyme which may also 
have an important role in the cytosolic potentiation. The 
hypothesis that SOD is involved in the potentiation of the
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activation of aromatic amines is supported by previous work 
with NOHAAF where mutagenicity was enhanced by at least three 
cytosolic factors which were partially purified (Saccone et 
al.f 1981). The molecular weights of these factors were
determined as 33,500, 22,000 and 16,250. This suggests that
the largest protein could be SOD (molecular weight of the 
homodimer is 32,000-38,000) and that the lowest molecular 
weight protein is possibly the monomeric form (Ochiai et al,, 
1984).
It has been previously demonstrated that superoxide can 
catalyse the chemical oxidation of the N-hydroxy derivative of 
Trp-P-1 to the nitroxide and eventually the nitroso derivative 
(Hiramoto et ai., 1988). This reaction provides a more stable 
metabolite which can serve as a reservoir of mutagenicity.
Superoxide and vitamin C both mimic the cytosol in
potentiating microsomal activation and it is therefore likely 
that these factors modulate the activation of IQ by 
stabilising the microsomal NOHIQ metabolite through oxidation
to the nitrosoIQ which can then enter the bacteria and undergo 
reduction to generate the NOHIQ within the bacteria where it 
interacts with the DNA (Fig 9.5). A similar hypothesis for the 
formation of a stable intermediate, was also put forward for 
the enhancement of the mutagenicity of NOHAAF by ascorbic acid 
(Andrews et ai., 1978).
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Figure 9.6; The mechanism and factors affecting the mutagenicity of IQ in the Salmonella test system.
page 216
This hypothesis is supported by the DNA-binding 
experiments where, in contrast to the mutagenicity studies, 
the microsomes are as efficient as the S9 in the
activation of IQ. Hence, the cytosol without cofactors added, 
appears to have no role in the activation of IQ possibly due 
to the direct interaction of NOHIQ as it is generated, with 
the DNA without the need to form a stable intermediate that 
can be transported into the bacterial cell. This was confirmed 
by other workers who reported that the cytosol, without 
cofactors, actually decreased the covalent binding of NOHIQ 
to DNA (Snyderwine et ai., 1988a), probably by forming less 
reactive nitro- or nitroso-derivatives. It was suggested that 
glutathione, present in the cytosol, may prevent the 
degradation of N-hydoxylamines (saito et al., 1984) and that 
this may explain the enhancing effect of the cytosol on 
mutagenicity; however this can be discounted as addition of 
exogenous glutathione to the system actually decreased the 
mutagenictity of IQ regardless of whether activation was 
achieved by 89 or microsomes. In this case the glutathione may 
by preventing NOHIQ oxidation to the nitroso derivative hence 
inhibiting mutagenicity.
Results from assays of the mutagenicity of IQ in the 
0-acetyltransferase deficient strain TA98/1,8DNPe (McCoy at 
ai., 1983), show that, like many other HAAs (Saito et ai., 
1983b), the high mutagenic activity of IQ in the presence of 
an S9 activation system is totally dependent on the bacterial 
O-acetytransferase (Fig 9.5). Furthermore it is also 
demonstrated that, like the S9-generated mutagen(s) the 
microsome-generated mutagen(s) are also characterised by this
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dependence. Two conclusions may be drawn; 1) the microsomal 
and S9 mutagenic products of IQ that enter the bacteria, are 
similar or in fact identical but that the S9 produces them at 
a greater rate than microsomes and 2) that neither metabolites 
can bypass the need to be acetylated. IQ is as potent a 
mutagen in the Ames test using both TA98 and TA98NR, a strain 
lacking nitroreductase(s) (Rosenkranz and Poirier, 1979). This 
result suggests that the previous conclusion that the 
mutagenic product of IQ from S9 activation is a nitro- or 
nitroso-derivative is incorrect. However it has been shown 
that TA98NR is not resistant to the mutagenicity of IQ-NO and 
thus must still be capable of reducing this compound to the 
N-hydroxy derivative required for 0-acetylation.
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9.6 Conclusions
In conclusion from the results of the present studies 
and previously reported by us and other groups it would appear 
that : 1) the f actors which enhance the in vitro mutagenicity
of IQ and other aromatic amines may be very different from 
those which enhance in vitro DNA-binding; 2) the role of the 
cytosol in enhancing the microsome-mediated mutagenicity is 
to produce a more stable intermediate, which can enter the 
bacteria; and 3) the cytosol, vitamin C and superoxide 
dismutase may play a role in the metabolic activation of IQ by 
facilitating oxidation forming a stable intermediate that can 
be transported into the bacteria (Fig 9.5).
Which of the two in vitro systems reflects the in vivo 
activation of IQ is difficult to assess, however the need for 
IQ to undergo bacterial metabolism to express its high 
mutagenic activity raises concern over the relevance of the 
mutagenicity of this compound in predicting its 
carcinogenicity. Similarly the fact that the N-hydroxy 
derivative of IQ is, like many other hydroxylamines, so 
unstable means that this compound is unlikely to reach nuclear 
DNA and thus the proximate mutagen needs to be protected by 
factors that are thought to decrease carcinogenic risk, such 
as vitamin C and superoxide dismutase. As the cell is 
multicompartmental the necessity may exist in vivo for a 
stable intermediate to exist which can move freely from one 
compartment of a cell to another, before conversion from the 
proximate to the ultimate mutagen can occur at a site proximal 
to DNA. However it is very difficult to determine the presence
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of these intermediates in vivo and requires further 
investigation. This is important as the requirment and 
transport of a stable metabolite may represent a fundamental 
difference between in vitro mutagenicity and in vivo 
carcinogenicity of aromatic amines.
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CHAPTER 10: GENERAL DISCUSSION AND CONCLUSIONS
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10 DISCUSSION
The heterocyclic aromatic amines (HAAs) formed during 
the cooking process and pyrolysis of amino acids are powerful 
mutagens in many in vitro assays (Nagao et al., 1981 ; Wild et 
al,, 1985; Thompson efc al,, 1983; 1987), activate oncogenes 
(Ishikawa et ai.,1985) and are carcinogenic in rats and 
mice (Sugimura 1985). Human liver microsomes have been shown 
to activate both isolated HAAs (Schimada et ai.,1989) and 
mutagens in the basic fraction of fried beef (Felton and 
Healy, 1984), and since mutagens derived from fried beef are 
found in human urine (Murray et ai., 1989), mutagens similar 
to those excreted by the rat after treatment with MelQx 
(Gooderham et ai.,1987; 1988), it is concluded that HAAs are 
metabolised and activated to genotoxic species by human liver 
and other organs. Thus HAAs may well be active in the 
initiation of some human cancers, a hypothesis that seems to 
be supported by recent epidemiological studies (Kuratsune et 
ai.,1986). To evaluate the potential health risk posed by 
these compounds it is important to investigate factors that 
may either make an individual more or less susceptible to 
HAA-induced carcinogenesis.
10.1 Factors which alter cytochrome P450 protein levels.
Considerable evidence has now been accumulated in 
support of the view that increases in cytochrome P450I levels 
can enhance tumourigenesis. The HAAs are initially activated, 
like many other carcinogenic aromatic amines, by 
N-hydroxylation catalysed by the cytochrome P450I family of 
proteins; in the case of the majority of the HAAs this is
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most efficiently catalysed by cytochrome P45.01A2 (Kato efc 
al,, 1983; Yamazoe efc al,, 1984). In this thesis the 
influenceof three factors on cytochrome P450I levels and the 
consequent modulation of HAA activation are reported.
10.1.1 Effect of dietary inhibitors/inducers of cytochrome 
P450
Anthraflavic acid was shown to be antimutagenic towards 
IQ in vitro (chapter 3) by virtue of its ability to interact 
with and inhibit cytochrome P450l-mediated activation of the 
mutagen. However on repeated administration in vivo (chapter 
4) this compound was, like many other cytochrome P450
family of proteins 
Thus the probable
inhibitors, an inducer of the particular 
towards which it was an in vifcro inhibitor, 
effect of this "antimutagen" in vivo will be to enhance 
metabolic activation of IQ and other carcinogens dependent on 
P450I proteins for activation.
As many so called antimutagens exert their effect by 
selective inhibition of cytochrome P450I, many of these 
compounds will have the same effect as anthraflavic acid in 
vivo and enhance rather than decrease the activation of 
carcinogenic initiators. It has been argued that induction of 
P450I is a beneficial effect as administration of "inducers" 
decreases tumourigensis (see section 1.4). This argument is 
frequently based on results of experiments in which the 
inducer was co-adminstered with the carcinogen. In these 
situations the inducer competitively inhibits the activation
of the carcinogen. The results of the current work suggests
that this will most likely be true of anthraflavic acid.
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However administration would have to occur simultaneously 
with the carcinogen or shortly after exposure, inhibition 
will occur followed by an induction phase that would enhance 
activation of a second exposure of a carcinogen. Furthermore 
it has been suggested that administration of an inhibitor of 
P450I activity concurrently with the chemical carcinogen 
resulted in a decrease in tumours at the target organ but an 
increase in tumours at other sites, the inhibitor resulted 
merely in a shift in organotropism (Conney, 1982). Therefore 
even under conditions where anthraflavic acid is inhibiting 
the hepatic metabolic activation by cytochrome P450I, the 
HAAs may be activated in other tissues by other enzyme 
systems such as the prostaglandin synthetase system. Thus 
altering the sites of tumours from the liver to tissues with 
high levels of prostaglandin synthetase.
Retinol was shown to inhibit IQ-induced mutagenesis by 
virtue of its ability to inhibit cytochrome P450I activity 
(chapter 5). As this occurred at near physiological 
concentrations, retinol may decrease the activation of 
chemical carcinogens. However because of specific storage, 
binding to plasma proteins and generally poor 
tissue-distribution of the vitamin this is unlikely to occur 
in vivo. Furthermore the inhibition of cytochrome P450 
activity was non-specific and resulted in the inhibition of 
cytochrome P4501 proteins and other families of cytochrome 
P450, proteins that may participate in detoxication 
reactions. It cannot therefore be concluded that the effects 
of retinol will be totally beneficial in vivo; in fact the 
ratio between physiological and toxic tissue levels is
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relatively small and retinol supplementation could produce 
adverse effects (Sporn, 1980).
10.1.2 Effect of environmental carcinogens on cytochrome P450
Administration of several carcinogenic aromatic amines 
and their non-carcinogenic isomeric amino-derivatives to rats
led to the conclusion that a characteristic of the
carcinogenic compounds is their ability to induce cytochrome 
P450I proteins and hence their Own activation pathway 
(chapter 7). This is necessary for the carcinogen to express 
its effect, as in control rats cytochrome P450I proteins 
represent less than 5% of the total hepatic cytochrome P450, 
hence activation of many chemical carcinogens is poor. 
However on repeated administration of the carcinogen, the
activation is enhanced by induction of cytochrome P450I. 
Exposure of the rat to these environmental contaminants will 
not only enhance their own activation but also the activation 
of other carcinogens including the HAAs (chapter 7).
Similarly IQ, on repeated administration to rats, resulted in 
induction of cytochrome P4501 proteins and consequently its 
own activation (chapter 8). Hence IQ, although a relatively 
weak carcinogen, will enhance the activation of many other 
carcinogens and thus potentiate initiation.
Recently a human cytochrome P450 isozyme, P450pA has 
been shown to be orthologous to rat cytochrome P450IA2 
(Wrighton efc al., 1986), and interestingly this protein, also 
catalyses the activation of HAAs (Shimada efc ai., 1988; 
1989). Hence it is conceivable that this protein, like the 
orthologous rat protein will be influenced by similar
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inhibitors and inducers. Thus exposure of man to HAAs and 
other inducers/inhibitors in the diet, will result not only 
in exposure to a potential chemical carcinogen, but also to a 
compound that may increase the susceptibility of the 
individual to other chemical carcinogens.
10.1.3 Effect of patho-physiological conditions
Chapter 6 describes the effect of chemically-induced 
diabetes on cytochrome P450 protein levels, with results 
demonstrating an increase in cytochrome P450IIB2, I and IIEI 
proteins. These increases in protein levels resulted in the 
enhanced activation of two types of food mutagens, 
nitrosamines and HAAs, thus indicating that the diabetic rat 
is more likely to be susceptible to carcinogenesis by these 
compounds than the non-diabetic. However before these 
observations are extrapolated to the in vivo situation a 
number of questions must be adequately addressed:-
a) Does diabetes perturb the metabolic pathways 
leading to deactivation, and what is the overall effect on 
the balance of activation/detoxication? Preliminary studies 
have revealed that diabetes may modulate a number of 
detoxication pathways (Younes efc ai., 1980; Rouer efc ai., 
1981);
b) Repeated exposure to chemical carcinogens results in 
selective induction of the enzymes that catalyse their 
activation (loannides and Parke, 1987; Ayrton efc ai., 1988; 
1989; chapter 8). Are diabetic animals refractive or 
sensitive to induction by such agents? Increased sensitivity 
is likely to render the diabetic population particularly 
susceptible to some carcinogens;
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Finally the enhanced activation of carcinogens may not 
prevail in the human diabetic population receiving insulin 
therapy, as the experimental diabetes was uncontrolled, and 
in general insulin administration could reverse the adverse 
effects.
10.2 Dietary antimutagens not affecting cytochrome P450.
Ellagic acid, like many other plant polyphenols was 
shown to inhibit mutagenesis of a variety of chemicals 
including IQ (chapter 3).Its mechanism of action, like that 
of many other polyphenols, was complex to elucidate but 
differs from anthraflavic acid by not being mediated by 
inhibition of cytochrome P450I; may include a chemical 
interaction with the proximate or ultimate mutagenic species 
(Sayer efc ai., 1982) or by binding to and protecting critical 
nucleophilic sites on DNA (Teel, 1986). Binding to DNA would 
appear to be as undesirable as attack by a mutagen since this 
too could result in a genotoxic effect, although at present 
there is no evidence to support this speculation. Interaction 
with the proximate mutagen is an alternative mechanism by 
which antimutagens may be able to act as anticarcinogens; 
however this assumes that the compound is readily absorbed 
and is non-toxic at a concentration required to interact 
efficiently with the proximate mutagen at the target organ. 
Ellagic acid and many other plant polyphenols are hydrophilic 
and consequently poorly absorbed and, at least in the case of 
ellagic acid, toxic if administered systemically (chapter 4), 
resulting in a general decrease in hepatic enzyme activities. 
Carcinogenesis may be prevented by a decrease in hepatic P450 
but this cannot be conceived as a beneficial effect, since it
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shows no specificity and possibly suppress the levels of 
constitutive forms of the cytochrome active in endogenous 
metabolism and therefore vital to the well-being of the cell.
10.3 SUMMARY
In summary, results derived from the antimutagenicity 
studies with ellagic and anthraflavic acid (10.1.1) 
demonstrate that antimutagenicity tests in vifcro have little 
relevance to the development of anticancer agents. With 
regard to the possible prevention of cancer caused by HAAs it 
might be suggested that exposure should be avoided, 
particularly with individuals genetically susceptible to 
induction of cytochrome P450I proteins and hence 
carcinogenesis. However exposure is unavoidable in man due to 
the prevalence of these compounds in the diet and an 
alternative strategy for reducing exposure would be to 
prevent or reduce the formation of these compounds during the 
cooking process. In this context inhibitors of the maillard 
reaction (eg sulphite) might have a useful potential.
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